<html class="gs_el_sm gs_pfcs"><head><title>‪ANTONIO PAGLIUCA‬ - ‪Google Scholar‬</title><meta http-equiv="Content-Type" content="text/html;charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="referrer" content="origin-when-cross-origin"><meta name="viewport" content="width=device-width,initial-scale=1,minimum-scale=1,maximum-scale=2"><meta name="format-detection" content="telephone=no"><link rel="shortcut icon" href="/favicon.ico"><link rel="canonical" href="https://scholar.google.co.uk/citations?user=B_fNeq0AAAAJ&amp;hl=en"><meta name="description" content="‪Professor of Haematology‬ - ‪‪Cited by 9,394‬‬ - ‪Stem Cell Transplantation‬ - ‪Cellular therapy‬"><meta property="og:description" content="‪Professor of Haematology‬ - ‪‪Cited by 9,394‬‬ - ‪Stem Cell Transplantation‬ - ‪Cellular therapy‬"><meta property="og:title" content="ANTONIO PAGLIUCA"><meta property="og:image" content="https://scholar.google.com/citations/images/avatar_scholar_256.png"><meta property="og:type" content="website"><meta name="twitter:card" content="summary"><style>html,body,form,table,div,h1,h2,h3,h4,h5,h6,img,ol,ul,li,button{margin:0;padding:0;border:0;}table{border-collapse:collapse;border-width:0;empty-cells:show;}html,body{height:100%}#gs_top{position:relative;box-sizing:border-box;min-height:100%;min-width:964px;-webkit-tap-highlight-color:rgba(0,0,0,0);}#gs_top>*:not(#x){-webkit-tap-highlight-color:rgba(204,204,204,.5);}.gs_el_ph #gs_top,.gs_el_ta #gs_top{min-width:320px;}#gs_top.gs_nscl{position:fixed;width:100%;}body,td,input,button{font-size:13px;font-family:Arial,sans-serif;line-height:1.24;}body{background:#fff;color:#222;-webkit-text-size-adjust:100%;-moz-text-size-adjust:none;}.gs_gray{color:#777777}.gs_red{color:#dd4b39}.gs_grn{color:#006621}.gs_lil{font-size:11px}.gs_med{font-size:16px}.gs_hlt{font-weight:bold;}a:link{color:#1a0dab;text-decoration:none}a:visited{color:#660099;text-decoration:none}a:hover,a:hover .gs_lbl{text-decoration:underline}a:active,a:active .gs_lbl,a .gs_lbl:active{color:#d14836}.gs_el_tc a:hover,.gs_el_tc a:hover .gs_lbl{text-decoration:none}.gs_pfcs a:focus,.gs_pfcs button:focus,.gs_pfcs input:focus,.gs_pfcs label:focus{outline:none}.gs_a,.gs_a a:link,.gs_a a:visited{color:#006621}.gs_a a:active{color:#d14836}a.gs_fl:link,.gs_fl a:link{color:#1a0dab}a.gs_fl:visited,.gs_fl a:visited{color:#660099}a.gs_fl:active,.gs_fl a:active{color:#d14836}.gs_fl{color:#777777}.gs_ctc,.gs_ctu{vertical-align:middle;font-size:11px;font-weight:bold}.gs_ctc{color:#1a0dab}.gs_ctg,.gs_ctg2{font-size:13px;font-weight:bold}.gs_ctg{color:#1a0dab}a.gs_pda,.gs_pda a{padding:7px 0 5px 0}.gs_alrt{background:#f9edbe;border:1px solid #f0c36d;padding:0 16px;text-align:center;box-shadow:0 2px 4px rgba(0,0,0,.2);border-radius:2px;}.gs_spc{display:inline-block;width:12px}.gs_br{width:0;font-size:0}.gs_ibl{display:inline-block;}.gs_scl:after{content:"";display:table;clear:both;}.gs_ind{padding-left:8px;text-indent:-8px}.gs_ico,.gs_icm{display:inline-block;background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png);background-position:-23px -161px;background-size:169px;width:21px;height:21px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_ico,.gs_icm{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);}}.gs_el_ta .gs_nta,.gs_ota,.gs_el_ph .gs_nph,.gs_oph{display:none}.gs_el_ta .gs_ota,.gs_el_ph .gs_oph{display:inline}.gs_el_ta div.gs_ota,.gs_el_ph div.gs_oph{display:block}.gs_sth_g{visibility:hidden;max-height:0;}.gs_sth_vis .gs_sth_g{max-height:1000px;}.gs_sth_vis .gs_sth_b{position:fixed;top:0;}@keyframes gs_anm_spin{0%{transform:rotate(0deg);}100%{transform:rotate(360deg);}}.gs_rimg{display:block;background-color:#e5e5e5;border-radius:50%;overflow:hidden;position:relative;z-index:1;}.gs_rimg>img{position:absolute;margin:auto;left:0;top:0;bottom:0;right:0;}.gs_in_txtw{display:inline-block;vertical-align:middle;}.gs_in_txtb{display:block;}.gs_in_txt{color:#000;background-color:#fff;font-size:16px;box-sizing:border-box;height:29px;line-height:23px;border:1px solid #d9d9d9;border-top-color:#c0c0c0;padding:3px 6px 1px 8px;border-radius:1px;outline:none;-webkit-appearance:none;-moz-appearance:none;}.gs_el_tc .gs_in_txt{font-size:18px;}.gs_in_txtb .gs_in_txt{width:100%;}.gs_in_txt:hover{border-color:#b9b9b9;border-top-color:#a0a0a0;box-shadow:inset 0 1px 2px rgba(0,0,0,.1);}.gs_in_txte .gs_in_txt{border-color:#dd4b39;}.gs_in_txt:focus{border-color:#4d90fe;box-shadow:inset 0 1px 2px rgba(0,0,0,.3);}.gs_in_txt:disabled{color:#b8b8b8;border-color:#f1f1f1;box-shadow:none;}.gs_in_txtm .gs_in_txt{font-size:13px;height:24px;line-height:16px;padding:3px 6px;}.gs_el_tc .gs_in_txtm .gs_in_txt{height:29px;line-height:21px;}.gs_in_txts{font-size:13px;line-height:18px;color:#666;}.gs_in_txte .gs_in_txts{color:#dd4b39;}button{position:relative;z-index:1;box-sizing:border-box;font-size:13px;cursor:pointer;height:29px;line-height:normal;min-width:72px;padding:0 8px;color:#444;border:1px solid rgba(0,0,0,.1);border-radius:3px;text-align:center;background-color:#f5f5f5;-webkit-user-select:none;user-select:none;}button.gs_btn_rnd{border-radius:14px;padding:0 12px;}button.gs_btn_rnd.gs_btn_rndci{padding-left:4px;}button.gs_btn_lrge{height:41px;min-width:82px;padding:0 9px;}button.gs_btn_lrge.gs_btn_rnd{border-radius:20px;padding:0 16px;}button.gs_btn_lrge.gs_btn_rnd.gs_btn_rndci{padding-left:10px;}button.gs_btn_cir{border-radius:14.5px;min-width:29px;}button.gs_btn_lrge.gs_btn_cir{border-radius:20.5px;min-width:41px;}button.gs_btn_mini{padding:0;border:0;}.gs_el_ph button.gs_btn_mph,.gs_el_ta button.gs_btn_mta{height:41px;}button .gs_wr{position:relative;display:inline-block;width:100%;height:100%;}button .gs_wr:before{content:"";width:0;height:100%;}button .gs_wr:before,button .gs_ico,button .gs_rdt,button .gs_lbl,button .gs_icm{display:inline-block;vertical-align:middle;}button .gs_wr{font-size:13px;text-transform:none;}.gs_btn_lrge .gs_wr{font-size:15px;}.gs_btn_lsb .gs_wr{font-size:11px;font-weight:bold;}.gs_btn_lsu .gs_wr{font-size:11px;text-transform:uppercase;}.gs_btn_lrge.gs_btn_lsb .gs_wr,.gs_btn_lrge.gs_btn_lsu .gs_wr{font-size:13px;}.gs_btn_half,.gs_el_ta .gs_btn_hta,.gs_el_ph .gs_btn_hph{min-width:36px;}.gs_btn_lrge.gs_btn_half,.gs_el_ta .gs_btn_lrge.gs_btn_hta,.gs_el_ph .gs_btn_lrge.gs_btn_hph,.gs_el_ta .gs_btn_mta,.gs_el_ph .gs_btn_mph{min-width:41px;}.gs_btn_slt{border-radius:3px 0 0 3px;}.gs_btn_srt{margin-left:-1px;border-radius:0 3px 3px 0;}.gs_btn_smd{margin-left:-1px;border-radius:0;}button:hover{z-index:2;color:#222;border-color:rgba(0,0,0,.2);background-color:#f8f8f8;}button.gs_sel{background-color:#dcdcdc;}button:active{z-index:2;background-color:#f1f1f1;}button:focus{z-index:2;}button::-moz-focus-inner{padding:0;border:0}button:-moz-focusring{outline:1px dotted ButtonText}.gs_pfcs button:-moz-focusring{outline:none}a.gs_in_ib{position:relative;display:inline-block;line-height:16px;padding:6px 0 7px 0;-webkit-user-select:none;user-select:none;}a.gs_btn_lrge{height:40px;padding:0;}a.gs_in_ib .gs_lbl{display:inline-block;padding-left:21px;color:#222;}a.gs_in_ib .gs_lbl:not(:empty){padding-left:29px;}button.gs_in_ib .gs_lbl:not(:empty){padding-left:4px;}a.gs_in_ib:active .gs_lbl,a.gs_in_ib .gs_lbl:active,a.gs_in_ib :active~.gs_lbl{color:#d14836;}.gs_el_ta .gs_btn_hta .gs_lbl,.gs_el_ph .gs_btn_hph .gs_lbl,.gs_el_ta .gs_btn_mta .gs_lbl,.gs_el_ph .gs_btn_mph .gs_lbl,.gs_el_ta .gs_btn_cta .gs_lbl,.gs_el_ph .gs_btn_cph .gs_lbl{display:none;}a.gs_in_ib .gs_ico{position:absolute;top:3px;left:0;}.gs_in_ib.gs_md_li .gs_ico{left:14px;}.gs_el_tc .gs_in_ib.gs_md_li .gs_ico{top:11px;}.gs_in_ib.gs_md_li.gs_md_lix .gs_ico{top:10px;left:16px;}a.gs_btn_lrge .gs_ico{top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}.gs_in_ib .gs_ico{opacity:.55;}.gs_in_ib:hover .gs_ico{opacity:.72;}.gs_in_ib:active .gs_ico,.gs_in_ib .gs_ico:active,.gs_in_ib :active~.gs_ico{opacity:1;}.gs_in_ib:disabled .gs_ico,.gs_in_ib.gs_dis .gs_ico{opacity:.28;}.gs_in_ib.gs_btn_act .gs_ico,.gs_in_ib.gs_btn_cre .gs_ico{opacity:1;}.gs_btn_act:disabled .gs_ico,.gs_btn_cre:disabled .gs_ico{opacity:.72;}.gs_rdt{position:relative;width:0;height:21px;}.gs_rdt:before{content:"";position:absolute;top:2px;right:1px;width:5px;height:5px;border-radius:50%;background-color:#dd4b39;}button.gs_btn_flat{border-color:transparent;background-color:transparent;}button.gs_btn_flat:hover{background-color:rgba(0,0,0,.05);}button.gs_btn_flat:active{background-color:rgba(0,0,0,.1);}button.gs_btn_flat.gs_btn_flact{color:#1a0dab;}button.gs_btn_act{color:#fff;-webkit-font-smoothing:antialiased;background-color:#4d90fe;}button.gs_btn_act:hover{color:#fff;background-color:#3983fe;}button.gs_btn_act.gs_sel{background-color:#2f6bcc;}button.gs_btn_act:active{background-color:#357ae8;}button.gs_btn_cre{color:#fff;-webkit-font-smoothing:antialiased;background-color:#d14836;}button.gs_btn_cre:hover{color:#fff;background-color:#c53727;}button.gs_btn_cre.gs_sel{background-color:#992b1e;}html:not(.gs_pfcs) .gs_btn_act:focus:not(:active){box-shadow:inset 0 0 0 1px rgba(255,255,255,.5);}button.gs_btn_cre:active{background-color:#b0281a;}button:disabled,button:disabled:hover,button:disabled:active{cursor:default;color:#b8b8b8;border-color:rgba(0,0,0,.05);background-color:transparent;z-index:0;}button.gs_btn_flat:disabled{color:#b8b8b8;border-color:transparent;}button.gs_btn_act:disabled{color:#fff;background-color:#a6c8ff;}button.gs_btn_cre:disabled{color:#fff;background-color:#e8a49b;}a.gs_in_ib.gs_dis{cursor:default;pointer-events:none}a.gs_in_ib.gs_dis .gs_lbl{color:#b8b8b8;text-decoration:none}.gs_ttp{position:absolute;top:100%;right:50%;z-index:10;pointer-events:none;visibility:hidden;opacity:0;transition:visibility 0s .13s,opacity .13s ease-out;}button:hover .gs_ttp,button:focus .gs_ttp,a:hover .gs_ttp,a:focus .gs_ttp{transition:visibility 0s .3s,opacity .13s ease-in .3s;visibility:visible;opacity:1;}.gs_md_tb.gs_sel .gs_ttp{transition:none;visibility:hidden;}button.gs_btn_lrge.gs_btn_cir .gs_ttp{top:75%;}.gs_ttp .gs_aro,.gs_ttp .gs_aru{position:absolute;top:-2px;right:-5px;width:0;height:0;line-height:0;font-size:0;border:5px solid transparent;border-top:none;border-bottom-color:#595959;z-index:1;}.gs_ttp .gs_aro{top:-3px;right:-6px;border-width:6px;border-top:none;border-bottom-color:white;}.gs_ttp .gs_txt{display:block;position:relative;top:2px;right:-50%;padding:4px 6px;background:#595959;color:white;font-size:11px;font-weight:bold;line-height:normal;white-space:nowrap;border:1px solid white;border-radius:3px;box-shadow:inset 0 1px 4px rgba(0,0,0,.2);}.gs_press,.gs_in_se,.gs_tan{touch-action:none;}.gs_in_se .gs_lbl:not(:empty){padding-right:14px;}.gs_in_se .gs_icm{position:absolute;top:50%;margin-top:-5.5px;right:0;width:7px;height:11px;background-position:-21px -88px;opacity:.55;}.gs_in_se:hover .gs_icm{opacity:.72;}.gs_in_se:active .gs_icm{opacity:1;}.gs_in_se:disabled .gs_icm{opacity:.28;}.gs_el_ta .gs_btn_hta .gs_icm,.gs_el_ph .gs_btn_hph .gs_icm,.gs_el_ta .gs_btn_mta .gs_icm,.gs_el_ph .gs_btn_mph .gs_icm,.gs_el_ta .gs_btn_cta .gs_icm,.gs_el_ph .gs_btn_cph .gs_icm{display:none;}.gs_btn_mnu .gs_icm{margin-top:-3.5px;height:7px;background-position:0 -110px;}.gs_in_se.gs_btn_act .gs_icm,.gs_in_se.gs_btn_cre .gs_icm{margin-top:-3.5px;height:7px;background-position:-42px -44px;opacity:1;}.gs_btn_act:disabled .gs_icm,.gs_btn_cre:disabled .gs_icm{opacity:.72;}button.gs_btnG .gs_ico{width:21px;height:21px;background-position:-92px -253px;}button .gs_bs{position:absolute;top:50%;left:50%;margin-top:-10px;margin-left:-10px;box-sizing:border-box;width:20px;height:20px;border-radius:50%;border:2px solid #eee;border-top-color:#4d90fe;visibility:hidden;animation:gs_anm_spin .8s linear infinite;}button.gs_bsp .gs_bs{visibility:visible;transition:visibility 0s .4s;}.gs_md_d{text-transform:none;white-space:nowrap;position:absolute;top:0;left:0;border:1px solid #ccc;border-color:rgba(0,0,0,.2);background:#fff;box-shadow:0 2px 4px rgba(0,0,0,.2);z-index:1100;text-align:left;visibility:hidden;max-height:0;margin-top:-1000px;opacity:0;transition:opacity .13s,visibility 0s .13s,max-height 0s .13s,margin-top 0s .13s;}.gs_md_d.gs_vis{visibility:visible;max-height:10000px;margin-top:0;opacity:1;transition:all 0s;}.gs_el_tc .gs_md_d{transform-origin:100% 0;transform:scale(1,0);transition:opacity .218s ease-out,transform 0s .218s,visibility 0s .218s,max-height 0s .218s,margin-top 0s .218s;}.gs_el_ios .gs_md_d{-webkit-backface-visibility:hidden;}.gs_el_tc .gs_md_d.gs_ttzi{transform-origin:50% 50%;transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_ttzr{transform:scale(0,0);}.gs_el_tc .gs_md_d.gs_vis{transform:scale(1,1);transition:transform .218s ease-out;}.gs_md_r{position:relative;display:inline-block;}.gs_md_rmb>.gs_md_d{top:29px}.gs_md_rmbl>.gs_md_d{top:41px}.gs_md_ul{list-style-type:none;word-wrap:break-word;display:inline-block;vertical-align:top;}.gs_md_ul.gs_md_ul_tb{display:block;}.gs_md_li,.gs_in_cb.gs_md_li,.gs_md_li:link,.gs_md_li:visited{display:block;padding:6px 44px 6px 16px;font-size:13px;line-height:16px;color:#222;cursor:pointer;text-decoration:none;position:relative;z-index:0;}a.gs_md_li:hover .gs_lbl,a.gs_md_li:active .gs_lbl{text-decoration:none}.gs_el_tc .gs_md_li{padding-top:14px;padding-bottom:10px;}.gs_md_li.gs_md_lix{font-size:16px;line-height:20px;padding:12px 16px 8px 16px;}.gs_md_li:before{content:"";background-color:#f1f1f1;position:absolute;left:0;right:0;top:0;bottom:0;opacity:0;transition:opacity .13s;z-index:-1;}.gs_md_li:hover:before,.gs_md_li:focus:before{opacity:1;transition:all 0s;}a.gs_in_ib.gs_md_li .gs_lbl{color:#222}a.gs_in_ib.gs_md_li.gs_in_gray .gs_lbl{color:#444}.gs_md_li:active:before{background-color:#ddd}.gs_md_li.gs_sel,a.gs_in_ib.gs_md_li.gs_sel .gs_lbl{color:#d14836}.gs_md_d:focus,.gs_md_li:focus{outline:none}a.gs_md_lix .gs_lbl,a.gs_md_lix .gs_lbl:not(:empty){padding:0 0 0 40px;}a.gs_in_cb:link,a.gs_in_cb:visited,a.gs_in_cb:active,a.gs_in_cb:hover{cursor:pointer;color:#222;text-decoration:none;}.gs_in_cb,.gs_in_ra{position:relative;line-height:16px;display:inline-block;-webkit-user-select:none;user-select:none;}.gs_in_cb.gs_md_li{padding:6px 44px 6px 16px;}.gs_in_cb input,.gs_in_ra input{position:absolute;top:1px;left:1px;width:15px;height:15px;margin:0;padding:0;opacity:0;z-index:2;}.gs_in_ra input{top:0;left:0}.gs_el_tc .gs_in_cb input{top:9px}.gs_el_tc .gs_in_ra input{top:8px}.gs_in_cb.gs_in_cbj input{top:15px;left:15px}.gs_in_cb label,.gs_in_cb .gs_lbl,.gs_in_ra label{display:inline-block;padding-left:21px;min-height:16px;}.gs_in_cb label:empty:before,.gs_in_cb .gs_lbl:empty:before,.gs_in_ra label:empty:before{content:"\200b";}.gs_el_tc .gs_in_cb label,.gs_el_tc .gs_in_cb .gs_lbl,.gs_el_tc .gs_in_ra label{padding-top:8px;padding-bottom:5px;}.gs_in_cb.gs_in_cbj label,.gs_in_cb.gs_in_cbj .gs_lbl{padding:13px 0 12px 41px;}.gs_in_cbb,.gs_in_cbb label,.gs_in_cbb .gs_lbl{display:block;}.gs_in_cb .gs_cbx,.gs_in_ra .gs_cbx{position:absolute}.gs_in_cb .gs_cbx{top:2px;left:2px;width:11px;height:11px;border:1px solid #c6c6c6;border-radius:1px;}.gs_md_li .gs_cbx{top:8px;left:18px}.gs_el_tc .gs_in_cb .gs_cbx{top:10px}.gs_el_tc .gs_md_li .gs_cbx{top:16px}.gs_in_cb.gs_in_cbj .gs_cbx{top:15px;left:15px}.gs_el_tc .gs_in_ra .gs_cbx{top:8px}.gs_in_ra .gs_cbx{top:0;left:0;border:1px solid #c6c6c6;width:13px;height:13px;border-radius:7px;}.gs_in_cb:hover .gs_cbx,.gs_in_ra:hover .gs_cbx{border-color:#666;box-shadow:inset 0 1px 1px rgba(0,0,0,.1);}button.gs_in_cb:hover .gs_cbx{border-color:#c6c6c6;}.gs_in_cb :focus~label,.gs_in_ra :focus~label{outline:1px dotted #222;outline:auto -webkit-focus-ring-color;}.gs_pfcs .gs_in_cb :focus~label,.gs_pfcs .gs_in_ra :focus~label{outline:none;}.gs_in_cb:active .gs_cbx,.gs_in_ra:active .gs_cbx,.gs_in_cb .gs_cbx:active,.gs_in_ra .gs_cbx:active,.gs_in_cb :active~.gs_cbx,.gs_in_ra :active~.gs_cbx{border-color:#666;background-color:#ebebeb;}button.gs_in_cb:active .gs_cbx{border-color:#a6a6a6;}.gs_in_cb :disabled~.gs_cbx,.gs_in_ra :disabled~.gs_cbx,button.gs_in_cb:disabled .gs_cbx{border-color:#f1f1f1;box-shadow:none;}.gs_in_cb :disabled~label,.gs_in_ra :disabled~label{color:#b8b8b8;}.gs_in_cb.gs_err .gs_cbx{border-color:#eda29b;}.gs_in_cb .gs_chk,.gs_in_ra .gs_chk{position:absolute;z-index:1;top:-3px;left:-2px;width:21px;height:21px;}.gs_md_li .gs_chk{top:3px;left:14px}.gs_el_tc .gs_in_cb .gs_chk{top:5px}.gs_el_tc .gs_md_li .gs_chk{top:11px}.gs_in_cb.gs_in_cbj .gs_chk{top:10px;left:11px}.gs_in_ra .gs_chk{top:4px;left:4px;width:7px;height:7px;border-radius:4px;}.gs_el_tc .gs_in_ra .gs_chk{top:12px}.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -69px -67px;opacity:.62;}.gs_in_ra input:checked~.gs_chk{background-color:#666}.gs_in_cb.gs_par .gs_chk{background:no-repeat url(/intl/en/scholar/images/1x/sprite_20161020.png) -21px -44px;opacity:.55;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){.gs_in_cb input:checked~.gs_chk,.gs_in_cb.gs_sel .gs_chk,.gs_in_cb.gs_par .gs_chk{background-image:url(/intl/en/scholar/images/2x/sprite_20161020.png);background-size:169px;}}.gs_in_cb input:checked:disabled~.gs_chk{opacity:.22}.gs_in_ra input:checked:disabled~.gs_chk{background-color:#f1f1f1}.gs_ico_x{background-position:-113px -22px;opacity:.55;}.gs_ico_x:hover{opacity:.72;}.gs_ico_x:active{opacity:1;}.gs_ico_X{background-position:-71px 0;opacity:.55;}.gs_ico_X:hover{opacity:.72;}.gs_ico_X:active{opacity:1;}.gs_el_tc .gs_ico_Xt{background-origin:content-box;background-clip:content-box;padding:10px 6px 10px 14px;}.gs_ico_P{background-position:0 0;opacity:.55;}.gs_ico_P:hover{opacity:.72;}.gs_ico_P:active{opacity:1;}.gs_btnP .gs_ico{background-position:-21px 0;}.gs_btnC .gs_ico{background-position:0 -66px;}.gs_btnL .gs_ico{background-position:-92px -44px;}.gs_ico_LB{background-position:-50px -44px;height:16px;}.gs_btnJ .gs_ico{background-position:-92px -22px;}.gs_btnM .gs_ico{background-position:-92px 0;}.gs_btnMW .gs_ico{background-position:-21px -22px;}.gs_btnSB .gs_ico{background-position:0 -44px;}.gs_btnTSB .gs_ico{background-position:-115px -253px;}.gs_btnPL .gs_ico{background-position:-148px -66px;}.gs_btnPR .gs_ico{background-position:-21px -66px;}.gs_btnPLW .gs_ico{background-position:-0 -230px;}.gs_btnPRW .gs_ico{background-position:-23px -230px;}.gs_btnZI .gs_ico{background-position:-148px -22px;}.gs_btnZO .gs_ico{background-position:-127px -44px;}.gs_btnDE .gs_ico{background-position:-134px 0;}.gs_btnFI .gs_ico{background-position:-50px -66px;}.gs_btnAD .gs_ico{background-position:-141px -88px;opacity:.55;}.gs_btnAD:hover .gs_ico{opacity:.72;}.gs_btnAD:active .gs_ico,.gs_btnAD .gs_ico:active,.gs_btnAD :active~.gs_ico{opacity:1;}.gs_btnBA .gs_ico{background-position:-50px -22px;}.gs_btnADD .gs_ico{background-position:-92px -66px;}.gs_btnMRG .gs_ico{background-position:-113px 0;}.gs_btnLBL .gs_ico{background-position:0 -161px;}.gs_btnCNCL .gs_ico{background-position:-71px 0;}.gs_btnDWL .gs_ico{background-position:-28px -88px;}.gs_btnMNU .gs_ico{background-position:0 -88px;}.gs_btnMNT .gs_ico{background-position:-46px -161px;}.gs_btnALT .gs_ico{background-position:-92px -161px;}.gs_btnART .gs_ico{background-position:-115px -161px;}.gs_btnGSL .gs_ico{background-position:-69px -161px;}.gs_btnCLS .gs_ico{background-position:-138px -161px;}.gs_btnXBLU .gs_ico{background-position:-138px -253px;}.gs_btnSSB .gs_ico{background-position:0 -276px;}.gs_btnSSW .gs_ico{background-position:-23px -276px;}.gs_btnFLT .gs_ico{background-position:0 -184px;}.gs_btnXT .gs_ico{background-position:-46px -184px;}.gs_btnPD .gs_ico{background-position:-69px -184px;}.gs_btnPU .gs_ico {background-position:-92px -276px;}.gs_btnCP .gs_ico{background-position:-92px -184px;}.gs_btnTP .gs_ico{background-position:-138px -184px;}.gs_btnML .gs_ico{background-position:-115px -276px;}.gs_btnCHK .gs_ico{background-position:-71px -66px;}.gs_btnDNB .gs_ico{background-position:-115px -230px;}.gs_btnDNW .gs_ico{background-position:0 -207px;}.gs_btnACA .gs_ico{background-position:-23px -207px;}.gs_btnAPT .gs_ico{background-position:-46px -207px;}.gs_btnAPTW .gs_ico{background-position:-92px -230px;}.gs_btnAFL .gs_ico{background-position:-69px -207px;}.gs_btnAN .gs_ico{background-position:-46px -276px;}.gs_btnAI .gs_ico{background-position:-69px -276px;}.gs_btnPBL .gs_ico{background-position:-92px -207px;}.gs_btnUCT .gs_ico{background-position:-115px -207px;}.gs_btnVRF .gs_ico{background-position:-138px -207px;}.gs_btnLSI .gs_ico{background-position:-46px -230px;}.gs_btnLSG .gs_ico{background-position:-69px -230px;}.gs_btnMOR .gs_ico{background-position:-23px -253px;}.gs_btnADV .gs_ico{background-position:-46px -253px;}.gs_btnPRO .gs_ico{background-position:-69px -253px;}.gs_ico_star{background-position:-71px -44px;width:13px;height:13px;}.gs_btnPLSW .gs_ico{background-position:-138px -230px;}.gs_btnPDF .gs_ico{background-position:0 -253px;}.gs_btnS .gs_ico{background-position:-138px -276px;}.gs_btnUNS .gs_ico{background-position:0 -299px;}.gs_btnMORR .gs_ico{background-position:-23px -299px;}.gs_btnTW .gs_ico{background-position:-46px -299px;}.gs_btnIN .gs_ico{background-position:-69px -299px;}.gs_btnFB .gs_ico{background-position:-92px -299px;}#gs_hdr_drs,#gs_hdr_drw{position:fixed;top:0;left:0;width:100%;height:100%;z-index:1200;visibility:hidden;}#gs_hdr_drs{opacity:0;background-color:#fff;transition:opacity .15s,visibility 0s .15s;}.gs_el_ta #gs_hdr_drs,.gs_el_ph #gs_hdr_drs{background-color:#666;}#gs_hdr_drs.gs_vis{visibility:visible;opacity:.5;transition:opacity .15s,visibility 0s;}.gs_el_tc #gs_hdr_drs{transition:opacity .218s,visibility 0s .218s;}.gs_el_tc #gs_hdr_drs.gs_vis{transition:opacity .218s,visibility 0s;}#gs_hdr_drw{overflow:auto;width:228px;background-color:#fff;box-shadow:2px 2px 4px rgba(0,0,0,.15);outline:none;transform:translate(-100%,0);transition:transform .15s ease-in-out,visibility 0s .15s;}#gs_hdr_drw.gs_vis{visibility:visible;transform:translate(0,0);transition:transform .15s ease-in-out,visibility 0s;}.gs_el_tc #gs_hdr_drw{transition:transform .3s cubic-bezier(.4,0,.6,1),visibility 0s .3s;}.gs_el_tc #gs_hdr_drw.gs_vis{transition:transform .225s cubic-bezier(0,0,.2,1),visibility 0s;}#gs_hdr_drw.gs_abt,.gs_el_tc #gs_hdr_drw.gs_abt{transition:none;}#gs_hdr_drw_in{position:relative;box-sizing:border-box;min-height:100%;padding:0 0 8px 0;}.gs_el_ta #gs_hdr_drw_in,.gs_el_ph #gs_hdr_drw_in{padding:0 0 65px 0;}#gs_hdr_drw_top{position:relative;height:63px;border-bottom:1px solid #e5e5e5;margin-bottom:8px;}.gs_el_ta #gs_hdr_drw_top,.gs_el_ph #gs_hdr_drw_top{height:57px;}#gs_hdr_drw_mnu,#gs_hdr_drw_lgo{position:absolute;top:0;height:100%;}#gs_hdr_drw_mnu{left:0;width:55px;}#gs_hdr_drw_lgo{left:56px;}.gs_hdr_drw_sec:before{display:block;content:" ";height:0;border-bottom:1px solid #e5e5e5;margin:8px 0;}.gs_hdr_drw_sec:first-child:before{display:none;}#gs_hdr_drw_bot{display:none;}.gs_el_ta #gs_hdr_drw_bot,.gs_el_ph #gs_hdr_drw_bot{display:block;position:absolute;left:0;bottom:0;width:100%;height:65px;}#gs_hdr_drw_bot .gs_md_li:before{opacity:0;}#gs_hdr_drw_bot .gs_hdr_pp{display:block;position:absolute;bottom:14px;left:15px;pointer-events:none;}#gs_hdr_drw_bot .gs_lbl{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}#gs_hdr{position:relative;height:63px;background-color:#f5f5f5;border-bottom:1px solid #e5e5e5;display:flex;}.gs_el_ta #gs_hdr,.gs_el_ph #gs_hdr{height:57px;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_lgo,#gs_hdr_lgt,#gs_hdr_md,#gs_hdr_sre,#gs_hdr_act{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}#gs_hdr_md{flex:1 1 auto;}#gs_hdr .gs_hdr_mbo,#gs_hdr .gs_hdr_mbo,.gs_el_ta #gs_hdr .gs_hdr_dso,.gs_el_ph #gs_hdr .gs_hdr_dso{display:none;}.gs_el_ta #gs_hdr .gs_hdr_mbo,.gs_el_ph #gs_hdr .gs_hdr_mbo{display:inline-block;}#gs_hdr_mnu,#gs_hdr_bck,#gs_hdr_sre{width:55px;margin-right:1px;}#gs_hdr_lgo,#gs_hdr_drw_lgo{width:149px;background:no-repeat url('/intl/en/scholar/images/1x/scholar_logo_24dp.png') 0% 50%;background-size:149px;}@media(-webkit-min-device-pixel-ratio:1.5),(min-resolution:144dpi){#gs_hdr_lgo,#gs_hdr_drw_lgo{background-image:url('/intl/en/scholar/images/2x/scholar_logo_24dp.png');}}#gs_hdr_lgo{margin-right:31px;}.gs_el_ph #gs_hdr_lgo{margin-right:0;}#gs_hdr_lgt{min-width:164px;margin-right:16px;}#gs_hdr_lgt:empty{display:none;}#gs_hdr_md{margin-right:16px;min-width:1px;}#gs_hdr_lgt,#gs_hdr_md h1{padding:19px 0 0 0;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:20px;line-height:25px;font-weight:normal;color:#666;max-width:100%;text-align:left;}.gs_el_ta #gs_hdr_md h1,.gs_el_ph #gs_hdr_md h1{padding:16px 0 0 0;}#gs_hdr_srch{padding:14px 0 0 0;max-width:600px;}.gs_el_ta #gs_hdr_srch,.gs_el_ph #gs_hdr_srch{padding:10px 0 0 0;max-width:none;}#gs_hdr_frm{position:relative;padding-right:39px;}#gs_hdr_tsi{height:38px;border-radius:2px 0 0 2px;}#gs_hdr_tsi::-ms-clear{display:none;}#gs_hdr_tsc{display:none;position:absolute;top:3px;right:41px;width:21px;height:21px;padding:6px 10px 7px 10px;}.gs_in_acw[dir="rtl"]~#gs_hdr_tsc{right:auto;left:1px;}#gs_hdr_tsb{position:absolute;top:0;right:0;width:40px;height:38px;border-radius:0 2px 2px 0;}#gs_hdr_frm_ac{top:37px;right:40px;}.gs_el_ph #gs_hdr_frm_ac{right:0;}.gs_el_ph .gs_hdr_ifc #gs_hdr_mnu,.gs_el_ph .gs_hdr_ifc #gs_hdr_bck,.gs_hdr_src #gs_hdr_srch,.gs_hdr_src #gs_hdr_lgt,.gs_hdr_srx #gs_hdr_sre,.gs_hdr_srx #gs_hdr_md h1,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_mbo,.gs_hdr_srx #gs_hdr_md h1.gs_hdr_dso,.gs_el_ta .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_lgo,.gs_el_ph .gs_hdr_srx #gs_hdr_mnu,.gs_el_ph .gs_hdr_srx #gs_hdr_bck{display:none;}.gs_el_ph .gs_hdr_ifc #gs_hdr_md,.gs_el_ph .gs_hdr_srx #gs_hdr_md{margin-left:16px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="ltr"]{padding-right:41px;}.gs_el_tc .gs_hdr_tsc #gs_hdr_tsi[dir="rtl"]{padding-left:41px;}.gs_el_tc .gs_hdr_tsc .gs_in_acw~#gs_hdr_tsc{display:block;}#gs_hdr_act{min-width:64px;max-width:200px;text-align:right;float:right;}.gs_el_ta #gs_hdr_act,.gs_el_ph #gs_hdr_act{display:none;}#gs_hdr_act_i,#gs_hdr_act_s{display:inline-block;padding:23px 24px 23px 16px;max-width:100%;box-sizing:border-box;font-size:13px;line-height:17px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:#444;}#gs_hdr_act_s{text-transform:uppercase;}.gs_el_sm #gs_hdr_act_i,.gs_el_sm #gs_hdr_act_s{padding:23px 16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ta #gs_hdr_act_s,.gs_el_ph #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_s{padding:20px 16px;}#gs_hdr_act_i:active,#gs_hdr_act_s:active{color:#d14836;}#gs_hdr_act_i,.gs_el_sm #gs_hdr_act_i{padding-top:15px;padding-bottom:16px;}.gs_el_ta #gs_hdr_act_i,.gs_el_ph #gs_hdr_act_i{padding-top:12px;padding-bottom:13px;}#gs_hdr_act_i .gs_hdr_pp{vertical-align:top;}#gs_hdr_act_d{top:63px;left:auto;right:24px;min-width:288px;max-width:400px;}.gs_el_sm #gs_hdr_act_d{right:16px;}.gs_el_ta #gs_hdr_act_d{top:57px;}.gs_el_ph #gs_hdr_act_d{top:57px;min-width:280px;max-width:280px;max-width:90vw;}/* Account dialog body. */#gs_hdr_act_aw,#gs_hdr_act_ap,.gs_hdr_act_am,#gs_hdr_act_ab{display:block;padding:10px 20px;word-wrap:break-word;white-space:normal;}#gs_hdr_act_aw{background-color:#fef9db;font-size:11px;}#gs_hdr_act_ap,.gs_hdr_act_am{border-bottom:1px solid #ccc;}#gs_hdr_act_ap{padding:20px;}.gs_el_ph #gs_hdr_act_ap{padding:10px;}#gs_hdr_act_apb{margin-top:12px;}#gs_hdr_act_aa:link,#gs_hdr_act_aa:visited{float:right;margin-left:8px;color:#1a0dab;}#gs_hdr_act_aa:active{color:#d14836}.gs_hdr_act_am:link,.gs_hdr_act_am:visited{color:#222;text-decoration:none;background:#fbfbfb;}.gs_hdr_act_am:hover,.gs_hdr_act_am:focus{background:#f1f1f1;}.gs_hdr_act_am:active{background:#eee;}#gs_hdr_act_ab{background:#fbfbfb;padding:10px 0;display:table;width:100%;white-space:nowrap;}#gs_hdr_act_aba,#gs_hdr_act_abs{display:table-cell;padding:0 20px;}#gs_hdr_act_abs{text-align:right;}.gs_el_ph #gs_hdr_act_aba,.gs_el_ph #gs_hdr_act_abs{display:block;padding:10px;text-align:center;}.gs_el_ph #gs_hdr_act_aba button,.gs_el_ph #gs_hdr_act_abs button{width:100%;}#gs_hdr_act_a1,#gs_hdr_act_a2{position:absolute;top:-9px;right:7.5px;width:0;height:0;z-index:1;border:8.5px solid transparent;border-top:none;border-bottom-color:#333;border-bottom-color:rgba(0,0,0,.2);}#gs_hdr_act_a2{top:-8px;border-bottom-color:#fff;}.gs_hdr_act_mw #gs_hdr_act_a2{border-bottom-color:#fef9db;}.gs_hdr_pp{border-radius:50%;overflow:hidden;}#gs_hdr_act_ap .gs_hdr_pp,.gs_hdr_act_am .gs_hdr_pp{float:left;}#gs_hdr_act_ap .gs_hdr_pm{margin-left:116px;}.gs_hdr_act_am .gs_hdr_pm{margin:6px 0 0 58px;}#gs_ab{position:relative;height:41px;border-bottom:1px solid #e5e5e5;display:flex;white-space:nowrap;background-color:#fff;z-index:1000;}.gs_el_ta #gs_ab.gs_nta,.gs_el_ph #gs_ab.gs_nph{display:none;}#gs_ab_g{height:42px;}.gs_sth_vis #gs_ab{position:fixed;}#gs_ab_ico,#gs_ab_ttl,#gs_ab_md,#gs_ab_btns{display:inline-block;vertical-align:top;position:relative;height:100%;flex:0 0 auto;}.gs_el_ph #gs_ab_md{display:block;}#gs_ab_ico{width:55px;margin-right:1px;}#gs_ab_ico .gs_ico{position:absolute;top:50%;left:50%;margin:-10.5px 0 0 -10.5px;}#gs_ab_ttl{min-width:172px;padding-right:8px;}.gs_el_sm #gs_ab_ttl{min-width:68px;}.gs_el_ta #gs_ab_ttl,.gs_el_ph #gs_ab_ttl{min-width:0;}#gs_ab_ttl,#gs_ab_ttll{font-size:18px;color:#666;text-transform:none;}.gs_el_sm #gs_ab_ttl,.gs_el_sm #gs_ab_ttll{font-size:16px;}#gs_ab_ttll{overflow:hidden;text-overflow:ellipsis;max-width:200px;}#gs_ab_md{flex:1 0 auto;}.gs_ab_st #gs_ab_md{flex:1 1 auto;font-size:13px;line-height:17px;padding:0 8px;color:#999;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gs_ab_st #gs_ab_md{visibility:hidden;padding:0;}#gs_ab_btns{margin-right:8px;}.gs_el_sm #gs_ab_btns{margin-right:0;}.gs_el_ta #gs_ab_btns,.gs_el_ph #gs_ab_btns{margin-right:4px;}#gs_ab_ttl:before,#gs_ab_md:before,#gs_ab_btns:before{content:"";display:inline-block;width:0;height:100%;vertical-align:middle;}#gs_ab_md>button,#gs_ab_btns>button,#gs_ab_md>.gs_in_ib,#gs_ab_btns>.gs_in_ib,#gs_ab_md>.gs_md_r,#gs_ab_btns>.gs_md_r,#gs_ab .gs_ab_mdw,#gs_ab .gs_ab_btw{margin:0 8px;vertical-align:middle;}#gs_ab .gs_ab_mdw,.gs_ab_btw{display:inline-block;margin:0;}#gs_ab_btns>.gs_in_ib{margin:0 16px 0 8px;}#gs_ab .gs_ab_btw{margin:0 12px 0 16px;}.gs_el_ta .gs_ab_sel #gs_ab_ico,.gs_el_ph .gs_ab_sel #gs_ab_ico,.gs_el_ta .gs_ab_sel #gs_ab_ttl,.gs_el_ph .gs_ab_sel #gs_ab_ttl,.gs_el_ta .gs_ab_sel #gs_ab_btns,.gs_el_ph .gs_ab_sel #gs_ab_btns{display:none;}#gs_bdy{display:table;table-layout:fixed;width:100%;}#gs_bdy_sb{vertical-align:top;width:228px;word-wrap:break-word;display:none;}.gs_el_sm #gs_bdy_sb{}.gs_el_ta #gs_bdy_sb,.gs_el_ph #gs_bdy_sb{}.gs_bdy_sb_sec{margin:0 40px 0 56px;}.gs_bdy_sb_sec:before{display:block;content:" ";height:0;margin:13px 0;border-top:1px solid #eee;}.gs_bdy_sb_sec:first-child:before{margin:21px 0 0 0;border:none;}#gs_bdy_sb ul{list-style-type:none;}.gs_bdy_sb_sec a:link,.gs_bdy_sb_sec a:visited{color:#222;}.gs_bdy_sb_sec a:active{color:#d14836;}.gs_bdy_sb_sel a:link,.gs_bdy_sb_sel a:visited{color:#d14836;text-decoration:none;}.gs_el_tc .gs_bdy_sb_sec li.gs_ind,.gs_el_tc .gs_bdy_sb_sec li.gs_ind a{padding-top:8px;padding-bottom:5px;}.gs_el_tc .gs_bdy_sb_sec:first-child li.gs_ind:first-child{margin-top:-8px;}#gs_bdy_sb .gs_ind,#gs_bdy_sb .gs_inw{margin-bottom:4px;}.gs_el_tc #gs_bdy_sb .gs_ind,.gs_el_tc #gs_bdy_sb .gs_inw{margin-bottom:0;}#gs_bdy_ccl{display:table-cell;vertical-align:top;padding:0 24px 0 16px;}.gs_el_sm #gs_bdy_ccl{padding:0 16px;}.gs_el_ta #gs_bdy_ccl,.gs_el_ph #gs_bdy_ccl{padding:0 16px;}.gs_el_ph #gs_bdy_ccl{padding:0;}#gs_ftr_sp{height:62px;}.gs_el_sm #gs_ftr_sp{height:57px;}#gs_ftr{position:absolute;bottom:0;left:0;width:100%;white-space:nowrap;border-top:1px solid #e4e4e4;background-color:#f2f2f2;display:flex;}#gs_ftr_rt{box-sizing:border-box;max-width:100%;overflow-x:auto;margin-left:auto;padding:0 12px;}.gs_el_sm #gs_ftr_rt{padding:0 8px;}.gs_el_ph #gs_ftr_rt:after{content:" ";position:absolute;top:0;right:0;width:16px;height:100%;background-image:linear-gradient(to right,rgba(242,242,242,0),rgba(242,242,242,1) 80%);}#gs_ftr_rt a{display:inline-block;line-height:16px;padding:12px;white-space:nowrap;}.gs_el_sm #gs_ftr_rt a{padding:12px 8px;}#gs_ftr_rt a:link,#gs_ftr_rt a:visited{color:#666}#gs_ftr_rt a:active{color:#d14836}#gsc_a_t{width:100%;table-layout:fixed;}#gsc_a_tr0,#gsc_a_trh{box-sizing:border-box;}#gsc_a_tr0 th.gsc_a_x,#gsc_a_tr0 th.gsc_a_t,#gsc_a_tr0 th.gsc_a_c,#gsc_a_tr0 th.gsc_a_y{height:0;}#gsc_a_trh{z-index:700;background-color:#f5f5f5;height:42px;}.gs_el_ta #gsc_a_trh,.gs_el_ph #gsc_a_trh,.gs_el_ta #gsc_a_t td,.gs_el_ph #gsc_a_t td{background-color:#fff;border-bottom:1px solid #e5e5e5;}#gsc_a_t th.gsc_a_x,#gsc_a_t th.gsc_a_t,#gsc_a_t th.gsc_a_c,#gsc_a_t th.gsc_a_y{box-sizing:border-box;text-transform:uppercase;vertical-align:middle;padding-top:0;padding-bottom:0;}#gsc_x_all{z-index:1;}.gsc_a_x,.gsc_a_t,.gsc_a_c,.gsc_a_y,.gsc_a_e{font-weight:normal;padding:16px 16px 0 16px;vertical-align:top;text-align:right;}.gsc_a_c{padding:16px 8px 0 8px;}.gs_el_sm .gsc_a_x,.gs_el_sm .gsc_a_t,.gs_el_sm .gsc_a_c{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_x,.gs_el_ta .gsc_a_t,.gs_el_ta .gsc_a_c,.gs_el_ph .gsc_a_x,.gs_el_ph .gsc_a_t,.gs_el_ph .gsc_a_c{padding:12px 8px;}.gs_el_sm .gsc_a_y{padding:12px 8px 0 8px;}.gs_el_ta .gsc_a_y{padding-bottom:12px;}.gsc_a_x{width:41px;padding:4px 0 0 0;}.gs_el_sm .gsc_a_x{padding:0;}.gsc_a_t{text-align:left;}.gs_el_ph .gsc_a_t{padding-left:16px;}#gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:16px;}.gs_el_ph #gsc_a_ta{display:none}.gs_el_ph .gsc_a_c{padding-right:16px;}th.gsc_a_c{width:64px;white-space:nowrap;}.gsc_art_sel #gsc_a_ta,.gsc_art_sel #gsc_a_ca,.gsc_art_sel .gsc_a_h{display:none;}.gsc_a_ac,.gsc_a_hc{margin-top:3px;}th.gsc_a_y{width:88px;white-space:nowrap;}.gs_el_sm th.gsc_a_y{width:58px;}.gs_el_ph th.gsc_a_y,.gs_el_ph td.gsc_a_y{width:0;padding:0;}.gs_el_ph .gsc_a_h{display:none}@media print{#gs_top th.gsc_a_y{width:58pt;}#gs_top #gsc_a_tr0{display:none}#gs_top #gsc_a_trh{position:static}}.gsc_a_e{padding:16px;text-align:center;}.gsc_a_a{padding:8px 0}.gsc_a_at{padding:8px 0;font-size:16px}a.gsc_a_acm{text-decoration:line-through;}a.gsc_a_acm:hover,a.gs_a_acm:active{text-decoration:underline;}.gsc_a_m{position:absolute;}.gs_el_ph .gsc_a_m{display:block;position:static;}.gsc_a_am{font-size:24px;position:absolute;top:-18px;left:-2px;padding:8px 12px 4px 8px;}.gs_el_ph .gsc_a_am{display:inline-block;position:static;padding:6px 16px;margin-bottom:-6px;}#gsc_a_sp{visibility:hidden;}#gsc_a_sp.gs_vis{visibility:visible;padding:16px 0;height:25px;border-bottom:1px solid #ccc;}#gsc_a_sp:after{display:block;height:100%;content:" ";background:url('/intl/en/scholar/images/spinner.gif') no-repeat 50% 50%;opacity:0;}#gsc_a_sp.gs_vis:after{opacity:1;transition:opacity 0s .4s;}#gsc_a_err{display:none;padding:28px 0;}#gsc_a_err.gs_vis{display:block;}#gsc_md_iad{width:800px;max-width:94%;}.gs_el_ph #gsc_md_iad{width:100%;max-width:100%;}#gsc_md_iad .gs_md_prg{min-height:400px;}.gs_el_ph #gsc_iads_res .gs_md_prg{margin:0 16px;}#gsc_iad_tart,.gsc_iad_tsel.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tart #gsc_iad_tgrp,.gsc_iad_tsel #gsc_iad_tgrp,#gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tart,#gsc_napb_hdr #gsc_iad_tgrp{display:none;}#gsc_iad_tgrp,.gsc_iad_tart #gsc_iad_tart,.gsc_iad_tsel #gsc_iad_tsel,#gsc_napb_hdr #gsc_iad_tsel{display:inline-block;}#gsc_iad_t:not(.gsc_iad_tsel) #gsc_iad_tsel{pointer-events:none;color:#b5b5b5;}.gs_el_ph #gsc_napb #gsc_iads_frm{margin:0 16px;}#gsc_iads_res{position:relative;margin:8px 0 16px 0;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_md_iad #gsc_iads_res{margin:8px -16px 16px -16px;}.gs_el_ph #gsc_napb #gsc_iads_pp{margin-right:16px;}#gsc_iadb_hdr{display:table;table-layout:fixed;width:100%;}#gsc_iadb_hdr_cb,#gsc_iadb_hdr_instr{display:table-cell;vertical-align:middle;height:41px;}#gsc_iadb_hdr_cb{width:41px;}#gsc_iadb_hdr_cb:empty{width:0;}.gs_el_ph #gsc_iadb_hdr_cb:empty{width:16px;}#gsc_iadb_hdr_instr{font-size:16px;}.gs_el_ph #gsc_iadb_hdr_instr{padding-right:16px;}.gsc_oic{position:relative;}.gsc_oic_cb{font-weight:normal;border-top:1px solid #e5e5e5;border-bottom:1px solid #e5e5e5;background-color:#fcfcfc;padding-right:16px;}.gsc_oict{display:block;overflow:hidden;}.gsc_oict_name{display:block;font-size:16px;line-height:20px;word-wrap:break-word;}.gsc_oict_inf{display:block;float:right;margin-left:16px;white-space:nowrap;}.gsc_oict_all,.gsc_oict_prf{font-size:13px;text-transform:uppercase;line-height:20px;}.gsc_oict_all[data-a]{color:#1a0dab;cursor:pointer;}.gsc_oict_all[data-a]:hover{text-decoration:underline;}.gsc_oict_all[data-a]:active{color:#d14836;}.gsc_oict_prf{padding-left:8px;margin-left:8px;border-left:1px solid #e0e0e0;}.gsc_oict_prf:empty{display:none;}.gs_el_ph .gsc_oict_all,.gs_el_ph .gsc_oict_prf{float:right;clear:both;margin:0;padding:0;border:none;}.gs_el_ph .gsc_oict_prf{margin-top:2px;}.gsc_oic_res{margin:8px 0 12px 41px;}.gs_el_ph .gsc_oic_res{margin-right:16px;}.gsc_oic_res h4{font-size:13px;font-weight:normal;}.gsc_oic_dis .gsc_oic_name,.gsc_oic_dis .gsc_oic_all,.gsc_oic_dis .gsc_oic_prf{color:#777;}.gsc_oic_dis .gsc_oict_all[data-a]{color:#1a0dab;opacity:.66;}.gsc_oic_dis .gsc_oic_res{opacity:.5;}.gsc_iadb_art{border-top:1px solid #e5e5e5;overflow:hidden;}.gsc_iadb_art_cb{float:left;}.gsc_iadb_art_added{float:right;margin:12px;font-size:11px;text-transform:uppercase;color:#777;}.gs_el_ph .gsc_iadb_art_added{display:block;float:none;text-align:right;margin:8px 16px;}.gsc_iadb_art_added:empty{display:none;}.gsc_iadb_art_body{margin:12px 0 12px 41px;}.gs_el_ph .gsc_iadb_art_body{margin:12px 16px 12px 41px;}.gsc_iadb_art_body h3{font-size:13px;font-weight:normal;}.gsc_iadb_art_dis .gsc_iadb_art_body{opacity:.5;}#gsc_md_mopt,#gsc_md_cbyd,#gsc_md_cbym{width:600px;}.gs_el_ta #gsc_md_mopt,.gs_el_ta #gsc_md_cbyd,.gs_el_ta #gsc_md_cbym{width:500px;}.gs_el_ph #gsc_md_mopt,.gs_el_ph #gsc_md_cbyd,.gs_el_ph #gsc_md_cbym{width:100%;}.gsc_mob_art{vertical-align:top;padding:8px 0;}.gs_el_tc .gsc_mob_art>.gs_in_ra{margin-top:-8px;}.gsc_mob_cby{vertical-align:top;text-align:right;padding:8px 12px;position:relative;}.gsc_mob_ttl,.gsc_mob_pub{display:block;}.gsc_mob_pub{color:#666;}.gsc_mob_cbym{text-decoration:line-through}.gsc_mob_cbm{font-size:24px;position:absolute;padding:4px 0 0 4px;line-height:16px;}.gs_fsvg line{stroke:#222222}a:link .gs_fsvg{fill:#1a0dab;}a:link .gs_fsvg line{stroke:#1a0dab;}a:visited .gs_fsvg{fill:#660099;}a:visited .gs_fsvg line{stroke:#660099;}a:active .gs_fsvg{fill:#d14836;}a:active .gs_fsvg line{stroke:#d14836;}a .gs_fsvg{border-bottom:1px solid transparent;}a:hover .gs_fsvg,a:focus .gs_fsvg{border-bottom-color:inherit;}.gs_fsml{font-size:13px}.gs_fscp{font-variant:small-caps}.gsh_clim{display:table-row}.gsh_clil,.gsh_clic{display:table-cell;padding-bottom:8px}.gsh_clil{padding-right:8px;}.gsh_lla{list-style-type:lower-alpha}.gsh_lua{list-style-type:upper-alpha}.gsh_llr{list-style-type:lower-roman}.gsh_lur{list-style-type:upper-roman}.gsh_l>li{margin-left:32px;}.gsh_h3{font-size:inherit;font-weight:normal}.gsh_h3,.gsh_csp{margin:16px 0}.gsh_h3+.gsh_csp{margin-top:-8px}.gsh_ovln{text-decoration:overline}.gsh_small .gsh_l .gsh_csp{margin:8px 0}.gsh_small .gsh_csp:first-child,.gsh_small .gsh_h3:first-child{margin-top:0}.gsh_small .gsh_csp:last-child{margin-bottom:0}.gsh_dspfr{text-align:center}.gsh_dspfr svg{margin:8px 0}.gs_pp_tn,.gs_el_ta .gs_pp_mo_tn,.gs_el_ph .gs_pp_mo_tn{width:32px;height:32px;}.gs_pp_sm,.gs_el_ta .gs_pp_mo_sm,.gs_el_ph .gs_pp_mo_sm{width:56px;height:56px;}.gs_pp_nm,.gs_el_ta .gs_pp_mo_nm,.gs_el_ph .gs_pp_mo_nm{width:128px;height:128px;}.gs_ai_pho{float:left;}.gs_ai_t{margin-left:72px;}.gs_ai_pho_pst+.gs_ai_t{margin-left:48px;}.gs_ai_t.gs_ai_pss{margin-left:64px;}.gs_ai_pho_pst+.gs_ai_t.gs_ai_pss{margin-left:40px;}.gs_ai_name{font-size:17px;font-weight:normal;margin-bottom:4px;}.gs_ai_name a{padding:6px 0 4px 0;}.gs_ai_name.gs_ai_name_nlsb{font-size:15px;}.gs_ai_name.gs_ai_name_nlsb a:link,.gs_ai_name.gs_ai_name_nlsb a:visited{padding:7px 0 5px 0; color:#222;}.gs_ai_name.gs_ai_name_nlsb a:active{color:#d14836;}.gs_ai_int{margin-top:5px;}.gs_ai_eml:empty,.gs_ai_int:empty,.gs_ai_cby:empty{display:none;}.gs_ai_one_int{vertical-align:top;font-size:13px;margin-right:8px;white-space:nowrap;display:inline-block;max-width:200px;text-overflow:ellipsis;overflow:hidden;}.gs_el_tc a.gs_ai_one_int{padding:8px 0 5px 0;}.gs_el_ph .gs_ai_eml,.gs_el_ph .gs_ai_cby{margin-top:8px;}.gs_ai_ilnl .gs_ai_int,.gs_ai_ilnl .gs_ai_cby{margin-top:8px;color:#666;}.gs_ai.gs_ai_chpr{position:relative;}.gs_ai_chpr .gs_ai_t{margin-right:276px;}.gs_el_sm .gs_ai_chpr .gs_ai_t{margin-right:156px;}.gs_el_ph .gs_ai_chpr .gs_ai_t{margin-right:0;}.gs_ai_chpr .gs_ai_cby{position:absolute;top:4px;right:0;text-align:right;}.gs_el_sm .gs_ai_chpr .gs_ai_cby,.gs_el_ta .gs_ai_chpr .gs_ai_cby{width:132px;word-wrap:break-word;}.gs_el_ph .gs_ai_chpr .gs_ai_cby{text-align:left;position:static;width:auto;}#gsc_bdy{position:relative;max-width:1200px;margin:0 auto;}.gs_el_ph #gsc_bdy,.gs_el_ta #gsc_bdy{display:flex;flex-flow:column;}.gsc_lcl{position:relative;margin:0 350px 0 0;order:3;}.gs_el_sm .gsc_lcl{margin-right:334px;}.gs_el_ta .gsc_lcl,.gs_el_ph .gsc_lcl{margin:0;}#gsc_prf_t_wrp{position:relative;order:2;overflow:hidden;}.gs_el_tc #gsc_prf_t_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;right:0;width:12px;height:100%;background-image:linear-gradient(to right,rgba(247,247,247,0),rgba(247,247,247,1) 80%);}#gsc_prf_t{width:100%;background-color:#f5f5f5;display:none;white-space:nowrap;overflow-x:auto;padding:0 4px;}.gs_el_ta #gsc_prf_t,.gs_el_ph #gsc_prf_t{display:block;}#gsc_prf_t:after{content:"\00A0";padding:0 4px;}.gsc_prf_tab,.gsc_prf_tab:link{font-size:13px;text-transform:uppercase;padding:13px 12px;display:inline-block;color:#666;cursor:pointer;}.gsc_prf_tab:hover{color:#000;text-decoration:none}.gsc_prf_tab:active{color:#4d90fe;}.gsc_prf_tab[aria-selected="true"]{border-bottom:2px solid #4d90fe;color:#0461f9;cursor:default;}.gs_el_ta #gsc_art,.gs_el_ph #gsc_art,.gs_el_ta #gsc_rsb_cit,.gs_el_ph #gsc_rsb_cit,.gs_el_ta #gsc_rsb_mnd,.gs_el_ph #gsc_rsb_mnd,.gs_el_ta #gsc_rsb_awd,.gs_el_ph #gsc_rsb_awd,.gs_el_ta #gsc_rsb_co,.gs_el_ph #gsc_rsb_co{display:none;}#gsc_bdy[data-tab="gsc_prf_t-art"] #gsc_art,#gsc_bdy[data-tab="gsc_prf_t-cit"] #gsc_rsb_cit,#gsc_bdy[data-tab="gsc_prf_t-mnd"] #gsc_rsb_mnd,#gsc_bdy[data-tab="gsc_prf_t-awd"] #gsc_rsb_awd,#gsc_bdy[data-tab="gsc_prf_t-ath"] #gsc_rsb_co{display:block;}.gsc_rsb{float:right;width:317px;order:4;border-left:1px solid #eee;margin-top:32px;}.gs_el_sm .gsc_rsb{margin-top:16px;}.gs_el_ph .gsc_rsb,.gs_el_ta .gsc_rsb{float:none;width:auto;border:none;margin:0;}.gsc_rsb_s{margin:0 0 48px 16px;position:relative;}.gs_el_sm .gsc_rsb_s{margin:0 0 32px 16px;}.gs_el_ph .gsc_rsb_s,.gs_el_ta .gsc_rsb_s{margin:0;}.gsc_rsb_s:last-child{margin-bottom:0;}.gsc_rsb_header{padding:8px 8px 12px 8px;border-bottom:1px solid #e5e5e5;font-weight:normal;font-size:15px;}.gs_el_sm .gsc_rsb_header{padding:4px 8px 9px 8px;}.gs_el_ph .gsc_rsb_header,.gs_el_ta .gsc_rsb_header{display:none;}.gsc_rsb_action{position:absolute;top:-3px;right:-2px;}.gs_el_sm .gsc_rsb_action{top:-8px;}.gsc_rsb_tap{display:block;position:absolute;right:2px;top:12px;opacity:.5;z-index:1;}.gs_el_ta .gsc_rsb_tap,.gs_el_ph .gsc_rsb_tap{top:24px;right:10px;}.gsc_rsb_hm{border-bottom:1px solid #e5e5e5;padding:3px 6px;}#gsc_rsb_gpl{display:block;margin-top:3px;padding:6px 16px;line-height:15px;color:#0461f9;border:1px solid #4d90fe;border-radius:2px;text-align:center;text-transform:uppercase;}.gs_el_sm #gsc_rsb_gpl{margin-top:0;}.gs_el_ta #gsc_rsb_gpl,.gs_el_ph #gsc_rsb_gpl{display:none;}#gsc_rsb_st{width:100%;}.gsc_rsb_std{text-align:right;padding-right:8px;}.gs_el_ta .gsc_rsb_std,.gs_el_ph .gsc_rsb_std{padding-right:16px;}.gsc_rsb_sc1{text-align:left;padding:2px 8px;}.gs_el_sm .gsc_rsb_sc1{padding:0 8px;}.gs_el_ta .gsc_rsb_sc1,.gs_el_ph .gsc_rsb_sc1{padding:4px 16px;}.gsc_rsb_sth{font-weight:normal;padding:8px 8px 8px 0;border-bottom:1px solid #e5e5e5;text-align:right;}.gs_el_sm .gsc_rsb_sth{padding:4px 8px 4px 0;}.gs_el_ta .gsc_rsb_sth,.gs_el_ph .gsc_rsb_sth{padding:16px 16px 16px 0;}#gsc_rsb_st tbody:before,#gsc_rsb_st tbody:after{content:'';display:block;height:8px;}.gs_el_sm #gsc_rsb_st tbody:before,.gs_el_sm #gsc_rsb_st tbody:after{height:4px;}.gs_el_ph #gsc_hist_opn,.gs_el_ta #gsc_hist_opn{display:none;}.gsc_rsb_f{max-width:118px;word-wrap:break-word;white-space:normal;}.gs_el_ta .gsc_rsb_f{max-width:none;}.gsc_rsb_f:link,.gsc_rsb_f:visited{color:#222;}.gsc_rsb_m_na{color:#dd4b39;}.gsc_rsb_m_a{color:#006621;float:right;position:relative;}.gsc_rsb_m_bar{width:100%;height:4px;margin:8px 0 8px 0;background:#006621;}.gsc_rsb_m_bar_na{background:#dd4b39;width:100%;height:100%;z-index:1;}.gsc_rsb_m{padding:8px;}.gs_el_ta .gsc_rsb_m,.gs_el_ph .gsc_rsb_m{padding:8px 16px;}.gsc_rsb_m_desc{padding-top:16px;color:#777;}.gsc_rsb_m_s{font-size:24px;position:absolute;line-height:0.3;}#gsc_lwp_mndt_lnk{text-transform:uppercase;margin-left:16px;margin-right:-9px;text-align:right;font-size:13px;padding:12px 9px;border-radius:3px;}#gsc_lwp_mndt_lnk:hover,#gsc_lwp_mndt_lnk:active,#gsc_lwp_mndt_lnk:visited{text-decoration:none;color:#1a0dab;}#gsc_lwp_mndt_lnk:hover{background-color:rgba(0,0,0,.05);}#gsc_lwp_mndt_lnk:active{background-color:rgba(0,0,0,.1);}.gsc_rsb_m_title{padding-bottom:12px;}.gsc_rsb_m_header{display:flex;align-items:flex-end;justify-content:space-between;padding:0 8px;}.gs_el_sm .gsc_rsb_m_header{padding:0 8px;}.gsc_rsb_hmv{text-align:center;padding-top:16px;}.gsc_rsb_a{list-style:none;}.gsc_rsb_a>li{position:relative;}.gs_el_ta .gsc_rsb_a>li,.gs_el_ph .gsc_rsb_a>li{border-bottom:1px solid #e5e5e5;}.gsc_rsb_a>li:first-child{margin-top:8px;}.gsc_rsb_a_pht{float:left;width:32px;height:32px;}.gsc_rsb_a_desc{margin:0 33px 0 48px;min-height:32px;display:block;}.gs_el_ph .gsc_rsb_a_desc,.gs_el_ta .gsc_rsb_a_desc{margin:0 33px 0 64px;min-height:56px;}.gsc_rsb_a_desc a{color:#222;}.gsc_rsb_a_ext{display:block;color:#777;font-size:13px;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;}.gs_el_ph .gsc_rsb_a_ext,.gs_el_ta .gsc_rsb_a_ext{white-space:normal;}.gsc_rsb_a_ext2{display:none;}.gs_el_ph .gsc_rsb_a_ext2,.gs_el_ta .gsc_rsb_a_ext2{display:block;}.gsc_rsb_aa{display:block;padding:8px;line-height:normal;cursor:pointer;}.gs_el_ph .gsc_rsb_aa,.gs_el_ta .gsc_rsb_aa{font-size:17px;padding:12px 16px;}.gsc_rsb_aa:hover,.gsc_rsb_aa:active{text-decoration:none;background:#f1f1f1;}.gsc_rsb_aa a:hover{text-decoration:none;}#gsc_prf_w{order:1;padding:32px 0;overflow:hidden;}.gs_el_sm #gsc_prf_w{padding:16px 0;}#gsc_prf_pu{float:left;width:128px;height:128px;text-align:center;}.gs_el_ph #gsc_prf_pu{float:none;width:100%;margin:0 0 8px 0;}#gsc_prf_pua{line-height:0;width:128px;height:128px;}.gs_el_ph #gsc_prf_pua{margin:0 auto;}#gsc_prf_pufi{width:0;height:0;overflow:hidden;}.gsc_prf_pufo #gsc_prf_pufi{width:auto;height:auto;overflow:visible;position:relative;z-index:10;}.gsc_prf_pufo #gsc_prf_pufi2{display:inline-block;background:#fcfcfc;padding:8px 8px 8px 0;}.gsc_prf_puic{position:absolute;bottom:0;width:100%;padding:8px 0;background-color:#000;opacity:.6;}.gsc_prf_pel{cursor:pointer;}#gsc_prf_i{margin:0 16px 0 160px;}.gs_el_sm #gsc_prf_i{margin:0 16px 0 144px;}.gs_el_ph #gsc_prf_i{margin:0 16px;text-align:center;}#gsc_prf_btne{vertical-align:top;margin:-9px 4px;}.gs_el_ph #gsc_prf_btne{position:absolute;top:60px;right:8px;margin:0;}#gsc_prf_btnf{float:right;margin:3px 0 16px 16px;}.gs_el_sm #gsc_prf_btnf{margin-top:0;}.gs_el_ph #gsc_prf_btnf{float:none;margin:0;position:absolute;top:8px;right:8px;border-radius:50%;}#gsc_prf_btnf .gs_lbl{padding:0 4px;}#gsc_prf_in{font-size:24px;line-height:24px;padding:3px 0 12px 0;word-wrap:break-word;}.gs_el_sm #gsc_prf_in{font-size:22px;padding:3px 0 8px 0;}.gs_el_ph #gsc_prf_in{font-size:20px;padding:0 0 2px 0;}.gsc_prf_il{font-size:15px;line-height:18px;padding:1px 0;}.gs_el_ph .gsc_prf_il{font-size:13px;line-height:16px;}.gsc_prf_ila:link,.gsc_prf_ila:visited{text-decoration:underline;color:#222;}#gsc_prf_int{margin-top:5px;}#gsc_prf_int:empty{display:none;}.gsc_prf_inta{margin-right:16px;white-space:nowrap;max-width:200px;text-overflow:ellipsis;overflow:hidden;vertical-align:top;}.gsc_prf_inta:last-child{margin:0}.gs_el_tc .gsc_prf_ila,.gs_el_tc .gsc_prf_inta{padding:8px 0 5px 0;}.gsc_md_pro_tt,.gsc_md_pro_ch #gsc_md_pro_lgtm,#gsc_md_pro_save{display:none;}.gsc_md_pro_ed #gsc_md_pro_ted,.gsc_md_pro_aa #gsc_md_pro_taa,.gsc_md_pro_ra #gsc_md_pro_tra,.gsc_md_pro_an #gsc_md_pro_tan,.gsc_md_pro_ai #gsc_md_pro_tai,.gsc_md_pro_ch #gsc_md_pro_save{display:inline-block;}.gsc_md_pro_el{color:#777;}.gsc_md_pro_ev{padding:4px 0 16px 0;}#gsc_dd_add-d,#gsc_dd_exp-d,#gsc_dd_sort-d,#gsc_dd_mor-d{top:42px;}#gsc_dd_add-d,#gsc_dd_mor-d,#gsc_dd_sort-d{white-space:normal;word-wrap:break-word;width:208px;width:-webkit-max-content;width:max-content;min-width:100px;max-width:208px;}.gs_el_ph #gsc_dd_add-d{left:-9px;}.gs_el_ph #gsc_dd_exp-d{left:auto;right:12px;}.gs_el_ph #gsc_dd_mor-d{left:-58px;}.gs_el_ph #gsc_dd_sort-d{left:10px;}.gs_el_ph #gsc_dd_sort-r{margin-left:-10px;}.gsc_dd_sec,#gsc_dd_exp-d{padding:8px 0;}.gs_el_tc .gsc_dd_sec,.gs_el_tc #gsc_dd_exp-d{padding:4px 0 8px 0;}.gsc_dd_sep{border-top:1px solid #ebebeb;}#gsc_dd_mor-s .gsc_dd_mor-sel,#gsc_dd_sort-s .gsc_dd_sort-sel{color:#dd4b39;}#gsc_dd_mor-p{padding:14px 44px 14px 16px;color:#777;}.gs_el_tc #gsc_dd_mor-p{padding:18px 44px 18px 16px;}.gsc_art_sel #gsc_dd_add-r,.gsc_art_sel #gsc_dd_mor-r,#gsc_btn_mer,#gsc_btn_del,#gsc_dd_exp-r{display:none;}#gsc_dd_mor-r,.gsc_art_sel #gsc_btn_mer,.gsc_art_sel #gsc_btn_del,.gsc_art_sel #gsc_dd_exp-r{display:inline-block;}html:not(.gs_el_ph) #gsc_dd_sort-r{display:none;}#gsc_lwp{margin:24px 0;text-align:center;}.gs_el_sm #gsc_lwp{margin:16px 0;}#gsc_bpf{display:inline-block;verticle-align:middle;}#gsc_a_nn{display:inline-block;vertical-align:middle;padding-right:16px;font-size:13px;}.gs_el_ph #gsc_a_nn{display:none;}@media print{#gs_top #gs_md_s,#gs_top #gs_md_w,#gs_top #gs_hdr,#gs_top #gs_hdr_drs,#gs_top #gs_hdr_drw,#gs_top #gs_ftr,#gs_top #gsc_nag,#gs_top #gsc_prf_nbar_btns,#gs_top #gsc_prf_btne,#gs_top #gsc_prf_btnf,#gs_top #gsc_prf_ivh,#gs_top #gsc_prf_puf,#gs_top #gsc_rsb_co,#gs_top #gsc_bdy #gsc_rsb_co,#gs_top .gsc_g_hist_wrp,#gs_top #gsc_prf_t_wrp,#gs_top .gsc_rsb_header,#gs_top .gsc_a_tb,#gs_top .gsc_a_x,#gs_top #gsc_lwp,#gs_top .gsc_prf_puic,#gs_top #gsc_dd_add-r,#gs_top #gsc_dd_mor-r,#gs_top #gsc_dd_sort-r{display:none;}#gs_top,#gs_top #gsc_bdy,#gs_top #gsc_prf_w,#gs_top #gsc_prf,#gs_top #gsc_prf_pu,#gs_top #gsc_prf_pua,#gs_top #gsc_prf_i,#gs_top .gsc_rsb_s,#gs_top .gsc_lcl,#gs_top .gsc_rsb,#gs_top #gsc_a_tw,#gs_top #gsc_a_t,#gs_top .gsc_prf_il,#gs_top .gsc_prf_ila,#gs_top .gsc_prf_inta,#gs_top #gsc_rsb_st{background:none;border:none;padding:0;margin:0;height:auto;width:auto;min-width:0;max-width:none;float:none;display:block;position:static;color:black;font-weight:normal;font-size:12pt;text-decoration:none;}#gs_top .gsc_a_ac,#gs_top .gsc_a_a,#gs_top #gsc_a_ca,#gs_top .gsc_a_at,#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std,#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh,#gs_top .gsc_a_m,#gs_top .gsc_a_am{color:black;font-weight:normal;font-size:12pt;padding:0;margin:0;background:none;border:none;}#gs_top #gsc_a_trh,#gs_top #gsc_a_trh th{height:0;}#gs_top #gsc_a_ta,#gs_top #gsc_a_ca,#gs_top #gsc_a_ha,#gs_top .gsc_a_a{font-size:11pt;}#gs_top .gsc_a_ac{font-size:10pt}#gs_top #gsc_prf_pu{width:80pt;height:auto;float:left;margin:0 7pt 7pt 0;}#gs_top #gsc_prf_pua{left:auto;transform:none;border-radius:0;}#gs_top #gsc_prf_pua>img{position:static;}#gs_top #gsc_prf_i{margin:0 7pt 7pt 87pt;text-align:left;}#gs_top #gsc_prf_in{font-size:18pt;line-height:18pt;padding:0 0 4pt 0;}#gs_top .gsc_prf_il{padding:2pt 0;}#gs_top #gsc_prf_w{float:left;width:64%;}#gs_top .gsc_rsb{float:right;width:35%;}#gs_top #gsc_art{clear:both;}#gs_top #gsc_rsb_st{display:table;width:100%;max-width:none;margin-top:3pt;}#gs_top .gsc_rsb_sc1,#gs_top .gsc_rsb_sth,#gs_top .gsc_rsb_std{font-size:10pt;}#gs_top th.gsc_rsb_sc1,#gs_top .gsc_rsb_sth{border-bottom:1pt solid #ccc;}#gs_top .gsc_rsb_f{max-width:60pt;}#gs_top .gsc_rsb_sth{padding-left:14pt;}#gs_top #gsc_bdy .gsc_a_x,#gs_top #gsc_bdy .gsc_a_t,#gs_top #gsc_bdy .gsc_a_c,#gs_top #gsc_bdy .gsc_a_y,#gs_top #gsc_a_trh{padding:6pt 0;}#gs_top #gsc_a_trh{border-bottom:1pt solid #ccc;}#gs_top #gsc_a_ca{display:block;width:auto;}#gs_top #gsc_a_ta{display:inline-block;vertical-align:middle;margin-right:12pt;}#gs_top .gsc_a_h{display:inline;font-size:10pt;}#gs_top .gsc_a_at{color:#008;}#gs_top .gsc_a_m,#gs_top .gsc_a_am{display:inline;position:absolute;}#gs_top .gsc_a_am{padding: 11pt 0 0 8pt;}#gs_top .gsc_a_t .gs_gray{color:black;font-size:10pt;}}.gsc_lwpds_frm{position:relative;height:29px;}.gsc_lwpds_tsiw{position:absolute;top:0;left:0;right:38px;}.gsc_lwpds_tsiw input{border-radius:3px 0 0 3px;}.gsc_lwpds_tsbw{position:absolute;top:0;right:0;}.gsc_lwpds_tsbw button{border-radius:0 3px 3px 0;}.gsc_pgn{text-align:right;font-weight:bold;line-height:29px;}.gsc_pgn_ppn{margin:0 8px;}.gsc_ccb_ck{padding:11px 10px 9px 10px;}.gsc_ccb_svg{stroke:#666;stroke-width:2px;fill:#fff;width:21px;height:21px;vertical-align:top;}.gsc_ccb_lim .gsc_ccb_svg,.gsc_ccb_dis .gsc_ccb_svg{fill:#e2e2e2;stroke:#fff;}.gsc_ccb_lim .gsc_ccb_svg>circle,.gsc_ccb_dis .gsc_ccb_svg>circle{stroke:#e2e2e2;}.gsc_ccb_on .gsc_ccb_svg{fill:#4d90fe;stroke:#fff;}.gsc_ccb_on .gsc_ccb_svg>circle{stroke:#4d90fe;}.gsc_ccb_del:active .gsc_ccb_svg>circle,.gsc_ccb_add:active .gsc_ccb_svg>circle{fill:#2f6de1;}#gsc_md_cod{width:800px;max-width:94%;}.gs_el_ph #gsc_md_cod{width:100%;max-width:100%;}#gsc_md_cod .gs_md_prg{min-height:400px;}.gsc_codb_instr{font-size:16px;margin:1em 0;}#gsc_cods_res{position:relative;margin-bottom:24px;min-height:80px;border-bottom:1px solid #e5e5e5;}.gs_el_ph #gsc_cods_res{margin-bottom:16px;}.gsc_cods_hide,.gsc_cod_sugg #gsc_cod_tedit,.gsc_cod_sugg #gsc_cods_frm,.gsc_cod_sugg #gsc_cods_pp,.gsc_cod_lc #gsc_cod_tadd,.gsc_cod_changed #gsc_cod_tedit,.gsc_cod_changed #gsc_cod_tadd,.gsc_cod_lim #gsc_cod_tedit,.gsc_cod_lim #gsc_cod_tadd{display:none;}#gsc_cods_frm{margin:0 0 24px 0;}.gs_el_ph #gsc_cods_frm{margin:0 0 16px 0;}.gsc_ucoar{padding:24px 0;border-bottom:1px solid #eee;}.gs_el_ph .gsc_ucoar{padding:16px 0px;}.gsc_ucoar:first-child{padding-top:0;}.gsc_ucoar:last-child{border-bottom:none;}.gsc_ucoar_cb{float:right;margin-top:-8px;}#gsc_cod_trev{display:none;color:#666;pointer-events:none;}.gsc_cod_changed #gsc_cod_trev,.gsc_cod_lim #gsc_cod_trev{display:inline-block;}.gsc_cod_changed #gsc_cod_trev{color:#1a0dab;pointer-events:auto;}.gsc_fol_cr{margin:0 0 8px 0;}.gs_el_tc .gsc_fol_cr{margin:0;}.gs_el_tc .gsc_fol_cr:first-child{margin-top:-8px;}#gsc_fol_ml{display:block;color:#777;padding:12px 0 4px 0;}</style><script>!function(GSP){/*

 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
var aa="function"==typeof Object.create?Object.create:function(a){var b=function(){};b.prototype=a;return new b},ba;if("function"==typeof Object.setPrototypeOf)ba=Object.setPrototypeOf;else{var da;a:{var ea={a:!0},fa={};try{fa.__proto__=ea;da=fa.a;break a}catch(a){}da=!1}ba=da?function(a,b){a.__proto__=b;if(a.__proto__!==b)throw new TypeError(a+" is not extensible");return a}:null}
var ha=ba,ia=function(a,b){a.prototype=aa(b.prototype);a.prototype.constructor=a;if(ha)ha(a,b);else for(var c in b)if("prototype"!=c)if(Object.defineProperties){var d=Object.getOwnPropertyDescriptor(b,c);d&&Object.defineProperty(a,c,d)}else a[c]=b[c];a.na=b.prototype},ja=function(){},ka=function(a,b){var c=Array.prototype.slice.call(arguments,1);return function(){var d=c.slice();d.push.apply(d,arguments);return a.apply(this,d)}};var g=function(){this.o=this.o;this.F=this.F};g.prototype.o=!1;g.prototype.isDisposed=function(){return this.o};g.prototype.T=function(){this.o||(this.o=!0,this.H())};g.prototype.H=function(){if(this.F)for(;this.F.length;)this.F.shift()()};function la(a){var b=[],c=0,d;for(d in a)b[c++]=d;return b};function l(a,b){a.classList.add(b)}function n(a,b){a.classList.remove(b)}function p(a,b){return a.classList?a.classList.contains(b):!1}function q(a,b,c){c=void 0!==c?c:!p(a,b);(c?l:n)(a,b)};function r(a){return 0<=(navigator.userAgent||"").indexOf(a)}var ma=r("iPhone")||r("iPad")||r("iPod"),na=r("iPhone")||r("Android")&&r("Mobile");function oa(){if(void 0===b){var a=window.screen;a={width:window.innerWidth,height:window.innerHeight,ma:a.width,la:a.height}}else a=b;var b=a;a=b.width;var c=b.height,d=b.ma;b=b.la;var e=4;if(600>a||48E4>d*b||na)e=1;else if(982>a)e=2;else if(1136>a||590>c)e=3;return e}var pa,qa=/[?&]tc=([01])/.exec(location.search||"");
pa=qa?0<+qa[1]:r("Android")?!0:window.matchMedia&&window.matchMedia("(pointer)").matches?window.matchMedia("(pointer:coarse)").matches:!r("Firefox")||r("Mobile")||r("Tablet")?ma||"ontouchstart"in window||0<(navigator.msMaxTouchPoints||0):!1;function ra(){if(void 0==sa){sa=!1;try{var a=Object.defineProperty({},"passive",{get:function(){sa=!0}});window.addEventListener("testPassive",ja,a);window.removeEventListener("testPassive",ja,a)}catch(b){}}return sa}var sa;var ta=function(a){this.Y=a},ua=new ta("INPUT"),va=new ta("TABLE");function t(a){return document.getElementById(a)}function x(a){return a.id||(a.id="gs_id"+wa++)}function xa(a){a=(void 0===a?null:a)||document.body;return"rtl"==(a?window.getComputedStyle(a,null):null).direction}
function ya(a){var b=[];a=a.elements;for(var c=a.length,d=0;d<c;d++){var e=a[d],f=encodeURIComponent(e.name||""),h=e.type;!f||e.disabled||!("checkbox"!=h&&"radio"!=h||e.checked)||b.push(f+"="+encodeURIComponent(e.value||""))}return b.join("&")}function za(a,b){var c=a.elements[b];c||(c=document.createElement(ua.Y),c.type="hidden",c.name=b,a.appendChild(c));return c}function Aa(a){t("gsc_md_cbyd_c").href=a&&a.match(Ba)?a:"javascript:void(0)"}function Ca(a){a.match(Ba)&&(window.location.href=a)}
var wa=100,Da=/\S+/g,Ba=/^(?:https?:|[^:/?#]*(?:[/?#]|$))/i,Ea=/^(?:#|\/[a-z0-9_-]*(?:[?].*)?$)/i;function y(a){return a.hasOwnProperty("gs_uid")?a.gs_uid:a.gs_uid=++Fa}var Fa=0;var z=function(){this.i=[];this.A={};this.O=this.v=0};z.prototype.add=function(a){var b=y(a);this.A[b]||(this.i.push(a),this.A[b]=this.i.length,++this.v)};z.prototype.remove=function(a){a=y(a);var b=this.A[a];b&&(this.i[b-1]=null,delete this.A[a],2*--this.v<this.i.length&&!this.O&&Ga(this))};z.prototype.notify=function(a){var b=this.i;try{++this.O;for(var c=0;c<b.length;c++){var d=b[c];d&&d.apply(null,arguments)}}finally{!--this.O&&2*this.v<b.length&&Ga(this)}};
var Ga=function(a){var b=a.i,c=b.length;a=a.A;for(var d=0,e=0;e<c;e++){var f=b[e];f&&(b[d]=f,a[y(f)]=++d)}b.length=d};function B(a,b,c,d,e){Ha(a,b,c,void 0===d?!1:d,void 0===e?!1:e,Ia)}function C(a,b,c,d){Ha(a,b,c,void 0===d?!1:d,!1,Ja)}function Ka(a,b,c,d){function e(h){C(f,a,e,c);b(h)}var f=document;c=void 0===c?!1:c;B(f,a,e,c,void 0===d?!1:d)}function D(a){La?La.add(a):a()}var Ma=window.requestAnimationFrame?function(a){window.requestAnimationFrame(a)}:function(a){setTimeout(a,33)};function Na(a){a.stopPropagation();a.preventDefault()}
function Oa(a){return(a.ctrlKey?1:0)|(a.altKey?2:0)|(a.metaKey?4:0)|(a.shiftKey?8:0)}function Ia(a,b,c,d,e){var f=a.addEventListener;e=e&&ra();f.call(a,b,c,e?{passive:e,capture:d}:d)}function Ja(a,b,c,d){a.removeEventListener(b,c,d)}function Ha(a,b,c,d,e,f){if("string"===typeof b)f(a,b,c,d,e);else for(var h=b.length,k=0;k<h;k++)f(a,b[k],c,d,e)}function Pa(){La.notify();La=null}function Qa(){"complete"==document.readyState&&(C(document,"readystatechange",Qa),Pa())}
var La,Ra=!!document.attachEvent,Sa=document.readyState;if(Ra?"complete"!=Sa:"loading"==Sa)La=new z,Ra?B(document,"readystatechange",Qa):Ka("DOMContentLoaded",Pa);function Ta(){Ka(["mousedown","touchstart"],function(){q(document.documentElement,"gs_pfcs",!0);B(document,"keydown",Ua,!0)},!0,!0)}function Ua(a){9==a.keyCode&&(q(document.documentElement,"gs_pfcs",!1),C(document,"keydown",Ua,!0),Ta())}Ta();function Va(a,b,c,d,e){var f=t(a);Wa(f,function(){l(f,"gs_vis");b&&b()},function(){n(f,"gs_vis");c&&c()},d,e)}function Wa(a,b,c,d,e){var f=x(a);if(!E[f]){var h=document.activeElement;Xa(Ya(a),!0);b&&b();G.push(function(k){delete E[f];try{k||(e||h).focus()}catch(m){}c&&c()});E[f]=G.length;h&&a.contains(h)||setTimeout(function(){var k=d,m=k&&"text"==k.type;if(!k||m&&pa)k=a;try{k.focus(),m&&(k.value=k.value)}catch(w){}},0)}}function H(a){Xa((E[a]||1E6)-1,!1)}
function Za(a){a=void 0===a?!1:a;G.pop()(a)}function Xa(a,b){for(b=void 0===b?!1:b;G.length>a;)Za(b||G.length>a+1)}function Ya(a){for(var b=0;a&&!(b=E[a.id]||0);)a=a.parentNode;return b}var G=[],E={};B(document,"click",function(a){var b=G.length;b&&!Oa(a)&&b>Ya(a.target)&&Za(!0)});B(document,"keydown",function(a){27==a.keyCode&&!Oa(a)&&G.length&&Za()});
B(document,"focus",function(a){var b=G.length;if(b)for(var c=Ya(a.target);c<b;){var d="",e;for(e in E)if(E[e]==b){d=e;break}a:{d=(t(d).getAttribute("data-wfc")||"").match(Da)||[];for(var f=0;f<d.length;f++){var h=t(d[f]);if(h&&h.offsetWidth){d=h;break a}}d=void 0}if(d){Na(a);d.focus();break}else Za(!0),--b}},!0);var $a={},ab={},bb;try{bb=window.sessionStorage}catch(a){};function J(a){return"object"==typeof a?a:null}function cb(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.pushState(b,"",a):window.location.assign(a)}function ib(a,b){b=db(b);a=eb(a);a=fb(a)||"#";gb=J(b);hb?window.history.replaceState(b,"",a):window.location.replace(a)}function fb(a){var b=[],c;for(c in a)b.push(encodeURIComponent(c)+"="+encodeURIComponent(a[c]));return(a=b.sort().join("&"))?"#"+a:""}
function jb(a){var b={};a=a.split("&");for(var c=0;c<a.length;c++){var d=a[c],e=d.indexOf("=");if(e+1){var f=d.substr(0,e);d=d.substr(e+1)}else f=d,d="";f&&(b[decodeURIComponent(f)]=decodeURIComponent(d))}return b}function kb(a){var b=a.indexOf("#")+1;return jb(b?a.substr(b):"")}function lb(a){var b=a.indexOf("?")+1;a=b?a.substr(b):"";b=a.indexOf("#");return jb(b+1?a.substr(0,b):a)}function mb(a,b){for(var c in b){var d=b[c];void 0!==d?a[c]=d:delete a[c]}}
function eb(a){var b=kb(window.location.hash);mb(b,a);return b}function db(a){var b=gb||J(window.history.state),c={},d;for(d in b)c[d]=b[d];mb(c,a);return c}function nb(){setTimeout(function(){if(!ob){var a=window.history.state;ob=!0;gb=J(a);rb.notify()}sb=!1},0)}var rb=new z,gb,ob=!1,sb=!0,hb="pushState"in window.history,tb;
if("undefined"==typeof GSP)tb=!1;else{var ub=.001*Date.now(),vb=GSP.eventId,wb=!1,K,xb=bb;if(!("nh"in $a)){var yb=xb&&xb.getItem("nh"),zb;if(yb)try{zb=JSON.parse(yb)}catch(a){}ab.nh=zb}K=ab.nh;K instanceof Array||(K=[]);for(var Ab=K.length,Bb=0,Cb=0;Cb<Ab;Cb++){var Db=K[Cb];if(Db instanceof Array&&2==Db.length){var Eb=Db[1]==vb;wb=wb||Eb;10>=Ab-Cb&&+Db[0]>ub-86400&&!Eb&&(K[Bb++]=Db)}}K.length=Bb;K.push([ub,vb]);var Fb=K,Gb=bb;ab.nh=Fb;try{Gb&&Gb.setItem("nh",JSON.stringify(Fb))}catch(a){}tb=wb}
var Hb=tb;"onpageshow"in window?B(window,"pageshow",nb):D(nb);B(window,hb?"popstate":"hashchange",function(a){"loading"!=document.readyState&&(a=a.state,ob=!0,gb=J(a),rb.notify())});function Ib(){Jb&&(C(t("gs_alrt_l"),"click",Jb),Jb=void 0)}function Kb(){var a=Lb();l(a,"gs_anm");l(a,"gs_vis");B(document,"click",Mb);clearTimeout(Nb);Nb=setTimeout(Mb,4E3);++Ob;setTimeout(Pb,0)}function Mb(){Ob||(C(document,"click",Mb),clearTimeout(Nb),Nb=void 0,Ib(),n(Lb(),"gs_vis"))}function Lb(){return t("gs_alrt")}function Pb(){Ob=0}var Nb,Ob=0,Jb;D(function(){var a=t("gs_alrt_m");a&&(a.innerHTML&&!Hb&&Kb(),B(window,"pagehide",function(){Ob=0;Mb();n(Lb(),"gs_anm")}))});function Qb(a,b,c){var d=new XMLHttpRequest;d.onreadystatechange=function(){if(4==d.readyState){var e=d.status,f=d.responseText,h=d.responseURL,k=window.location,m=k.protocol;k="//"+k.host+"/";h&&h.indexOf(m+k)&&h.indexOf("https:"+k)&&(e=0,f="");c(e,f)}};d.open(b?"POST":"GET",a,!0);d.setRequestHeader("X-Requested-With","XHR");b&&d.setRequestHeader("Content-Type","application/x-www-form-urlencoded");b?d.send(b):d.send();return d}function Rb(a){a&&(a.onreadystatechange=ja,a.abort())};var Sb=function(a,b,c){this.type=a;this.currentTarget=this.target=b;this.g=void 0===c?null:c;this.P=!1};Sb.prototype.stopPropagation=function(){this.g&&this.g.stopPropagation();this.P=!0};var L=function(a){a.g&&Na(a.g);a.P=!0};var M=function(a,b){this.R=a;this.ka=b},Tb=function(a,b,c){this.R=a;this.types=b;this.listener=c};function Ub(a,b){var c=b.length;if(c){var d=y(a),e=Vb[d];if(!e){e=Vb[d]=[];d=Wb(b[0].R);for(var f in d){var h=Xb[f];h||(h=Xb[f]=Object.create(null));for(var k in d[f]){var m=h[k];m||(m=h[k]=[]);m.push(a)}}Yb(a,e,b[0],Zb);for(f=1;f<c;f++)Yb(a,e,b[f],$b)}}}function O(a,b,c){ac(new Sb(a,b,void 0===c?null:c))}
function P(a,b,c){var d=bc;"string"===typeof b&&(cc[0]=b,b=cc);var e=b.length;a=Wb(a);for(var f in a)for(var h in a[f])for(var k=0;k<e;k++)d(f,h,b[k],c)}function Wb(a){"string"===typeof a&&(dc[0]=a,a=dc);for(var b=a.length,c=Object.create(null),d=0;d<b;d++){var e=a[d],f=e.charAt(0),h=e.substr(1);if("#"!=f&&"."!=f||!h)throw Error("bad selector: "+e);(e=c[f])||(e=c[f]=Object.create(null));e[h]=!0}return c}
function bc(a,b,c,d){var e=ec[c];e||("touchstart"!=c&&"mouseover"!=c&&"mouseout"!=c&&B(document,c,fc,"focus"==c||"blur"==c),e=ec[c]=Object.create(null));(c=e[a])||(c=e[a]=Object.create(null));(a=c[b])||(a=c[b]=new z);a.add(d)}function fc(a){var b=a.target;b&&3==b.nodeType&&(b=b.parentNode);ac(new Sb(a.type,b,a))}
function ac(a){for(var b=a.target;b&&b!=document&&!b.disabled&&!p(b,"gs_dis");){a.currentTarget=b;var c=b.id;if(c&&!gc("#",c,a))break;c=b.classList||[];for(var d=c.length,e=0;e<d;e++)if(!gc(".",c[e],a))return;b=b.parentNode}}function gc(a,b,c){var d=ec[c.type];(b=(a=d&&d[a])&&a[b])&&b.notify(c);return!c.P}function Yb(a,b,c,d){var e=c.R;c=c.ka;for(var f in c){var h=ka(d,a,c[f]);P(e,f,h);b.push(new Tb(e,f,h))}}function Zb(a,b,c){var d=c.currentTarget;a=hc(a,d)||a;a=ic(a,d);b.call(a,c)}
function $b(a,b,c){a:{for(var d=c.currentTarget;d&&d!=document;){var e=hc(a,d);if(e){a=ic(e,d);break a}d=d.parentNode}a=void 0}a&&b.call(a,c)}function ic(a,b){var c=jc(b),d=kc[c];d||(d=kc[c]=[]);for(var e=d.length,f=0;f<e;f++){var h=d[f];if(h instanceof a)return h}b=new a(b);d.push(b);a=y(a);(d=lc[a])||(d=lc[a]=[]);d.push(c);return b}function hc(a,b){var c,d=b.id;d&&(c=mc(a,c,"#",d));b=b.classList||[];d=b.length;for(var e=0;e<d;e++)c=mc(a,c,".",b[e]);return c}
function mc(a,b,c,d){c=(d=(c=Xb[c])&&c[d])?d.length:0;for(var e=0;e<c;e++){var f=d[e];!(f===a||f.prototype instanceof a)||b&&!(f===b||f.prototype instanceof b)||(b=f)}return b}function jc(a){var b=a.getAttribute("data-duid");b||a.setAttribute("data-duid",b=""+nc++);return b}var ec=Object.create(null),dc=[""],cc=[""],Xb=Object.create(null),Vb=Object.create(null),lc=Object.create(null),kc=Object.create(null),nc=100;window.gs_evt_dsp=fc;function oc(){var a=".gs_md_li";if("string"===typeof a){var b=a.charAt(0),c=a.slice(1);if("#"==b)a=function(d){return d.id==c&&0<d.offsetWidth};else if("."==b)a=function(d){return p(d,c)&&0<d.offsetWidth};else throw Error("bad selector: "+a);}return a}function pc(a,b){return a&&((void 0===b?0:b)?a.lastElementChild:a.firstElementChild)}function qc(a,b){return a&&((void 0===b?0:b)?a.previousElementSibling:a.nextElementSibling)}function rc(a,b,c){c=void 0===c?!1:c;return sc(a,b,oc(),c,!1)}
function sc(a,b,c,d,e){for(var f;b&&a;){if(c(b)){if(e)return b}else for(f=pc(b,d);f;f=qc(f,d))if(e=sc(f,f,c,d,!0))return e;for(e=!0;;){if(b==a)return null;f=b.parentNode;if(b=qc(b,d))break;b=f}}return null};function tc(a){return!!p(a,"gs_sel")+2*!!p(a,"gs_par")}function uc(a){return+a.getAttribute("data-s")}function vc(a,b,c){c=void 0===c?!1:c;q(a,"gs_sel",1==b);q(a,"gs_par",2==b);a.setAttribute("aria-checked",wc[b]);c||a.setAttribute("data-s",""+b)}var wc=["false","true","mixed"];var Q=function(){this.j=Object.create(null);this.l=0};Q.prototype.clear=function(){this.j=Object.create(null);this.l=0};Q.prototype.has=function(a){return a in this.j};Q.prototype.get=function(a){return this.j[a]};Q.prototype.set=function(a,b){this.has(a)||this.l++;this.j[a]=b};Q.prototype.delete=function(a){this.has(a)&&(delete this.j[a],this.l--)};var xc=function(a){var b=window,c=this;this.i=new z;this.V=0;this.S=[b,a,function(){c.V++||Ma(d)},!1];var d=function(){c.V=0;c.i.notify()}};xc.prototype.addListener=function(a){this.i.v||B.apply(null,this.S);this.i.add(a)};xc.prototype.removeListener=function(a){this.i.remove(a);this.i.v||C.apply(null,this.S)};var yc=new xc("scroll"),zc=new xc("resize");var Ac=new z;function Bc(){var a=document.documentElement,b=oa();b={gs_el_ph:1==b,gs_el_ta:2==b,gs_el_sm:4!=b,gs_el_tc:pa||1==b};var c;for(c in b){var d=b[c];if(p(a,c)!=d){var e=!0;q(a,c,d)}}e&&Ac.notify()}q(document.documentElement,"gs_el_ios",ma);Bc();zc.addListener(Bc);B(window,["pageshow","load"],Bc);function R(a,b,c,d){function e(){var u=ca&&p(h,"gs_el_ph");q(F,"gs_vis",!u);h.style.overflowY=Yd&&!u?"scroll":""}function f(){var u=h.clientHeight,I=+A.getAttribute("data-h");I||(w.style.maxHeight="none",I=m.offsetHeight);I=Math.max((u-I)/2,10);u=Math.max(u-48-2*I,10);var Jc=ca&&p(h,"gs_el_ph");m.style.top=Jc?"auto":I+"px";w.style.maxHeight=Jc?"none":u+"px";Cc(w)}b=void 0===b?"":b;c=void 0===c?"":c;d=void 0===d?"":d;var h=document.documentElement,k=t("gs_top"),m=t(a),w=t(a+"-bdy"),v=t(m.getAttribute("data-cid")||
m.id+"-bdy")||m,F=t(m.getAttribute("data-shd")||"gs_md_s"),A=Dc(m),ca=!!A&&p(A,"gs_md_wmw"),N=window.pageYOffset,Yd=k.scrollHeight>h.clientHeight,pb=!!E[a],qb=pb?"":S,Lc=b&&"#"!=b[0]&&!d,$d=a==S&&b==Ec&&c==T;Fc=b;Lc?(pb?q(v,"gs_md_ldg",!0):Gc(m,v,'<div class="gs_md_prg">'+t("gs_md_ldg").innerHTML+"</div>"),O("gs-md-ldin",v)):(d&&Gc(m,v,d),O("gs-md-lded",v));qb&&(++Hc,H(qb),--Hc);S=a;Ec=b;T=c;Ic=d;$d||Hc||(Kc+=1,(qb?ib:cb)(Mc(),Nc()));pb||Wa(m,function(){A&&l(A,"gs_vis");l(m,"gs_vis");q(m,"gs_abt",
sb);Oc(a);Ac.add(e);e();A&&w&&(f(),zc.addListener(f));l(k,"gs_nscl");k.style.top=-N+"px"},function(){Ac.remove(e);zc.removeListener(f);A&&n(A,"gs_vis");n(m,"gs_vis");n(m,"gs_abt");n(F,"gs_vis");h.style.overflowY="";n(k,"gs_nscl");k.style.top="auto";Rb(U);U=null;window.scrollTo(0,N);S=Ec=T=Ic="";var u=Kc;Kc=0;Hc||(0<u?window.history.go(-u):ib(Mc(),Nc()))},Pc(m),Qc(m));Lc&&(Rb(U),U=null,U=Qb(b,c,function(u,I){U=null;u=200==u;Gc(m,v,u?I:Rc());u&&a==S&&b==Ec&&c==T&&(Ic=I,ib(Mc(),Nc()));O("gs-md-lded",
v)}))}function Dc(a){a=a.parentNode;return p(a,"gs_md_wnw")?a:null}function Pc(a){return(a=a.getAttribute("data-ifc"))?t(a):null}function Qc(a){return(a=a.getAttribute("data-cfc"))?t(a):null}
function Gc(a,b,c){q(b,"gs_md_ldg",!1);for(var d=b.querySelectorAll("[data-duid]"),e=d.length,f={},h=0;h<e;h++){for(var k=jc(d[h]),m=kc[k],w=m?m.length:0,v=0;v<w;v++){var F=m[v],A=y(F.constructor),ca=f[A];ca||(ca=f[A]={});ca[k]=!0;F&&"function"==typeof F.T&&F.T()}delete kc[k]}for(var N in f){N=+N;d=f[N];h=(e=lc[N])?e.length:0;for(m=k=0;m<h;m++)w=e[m],w in d||(e[k++]=w);k?e.length=k:delete lc[N]}b.innerHTML=c;Oc(a.id);Rb(U);U=null}
function Oc(a){if(a=document.querySelector("#"+a+">.gs_md_bdy"))a.scrollTop=a.scrollLeft=0,Cc(a)}function Cc(a){var b=a.style,c="padding"+(xa(a)?"Left":"Right");b[c]="";var d=a.offsetWidth-a.clientWidth;2<d&&(a=parseInt(window.getComputedStyle(a,null)[c],10)||0,b[c]=Math.max(a-d,0)+"px")}function Rc(){return'<div class="gs_md_prg"><div class="gs_alrt">'+t("gs_md_err").innerHTML+"</div></div>"}function Mc(){return{d:S||void 0,u:Ec||void 0,p:T?"1":void 0}}function Nc(){return{n:Kc,p:T,h:Ic}}
var U=null,Fc="",S="",Ec="",T="",Ic="",Kc=0,Hc=0;rb.add(function(){var a=kb(window.location.hash),b=a.d||"",c=b?t(b):null;++Hc;if(c){c=a.u||"";a=0<+a.p;var d=gb||J(window.history.state)||{},e=+d.n||0,f=""+(d.p||"");d=""+(d.h||"");c.match(Ea)||(c="");a!=!!f?R(b,"","",Rc()):b==S&&c==Ec&&f==T&&d==Ic||R(b,c,f,d);Kc=e}else S&&H(S);--Hc});var Sc=function(a){g.call(this);this.D=a;this.K=Object.create(null);this.C=null;a=a.querySelectorAll(".gs_in_txtw>input[type=text]");for(var b=a.length;b--;){var c=a[b],d=c.parentNode.querySelector(".gs_in_txts");c=c.name;d&&c&&(this.K[c]=d.innerHTML)}};ia(Sc,g);Sc.prototype.H=function(){Rb(this.C);this.D=this.C=null;g.prototype.H.call(this)};
Sc.prototype.ga=function(a){var b=this;L(a);if((a=this.D)&&!this.C){var c="json=&"+ya(a);Tc(this,!0);this.C=Qb(a.action,c,function(d,e){b.C=null;Tc(b,!1);var f=b.D,h=f.getAttribute("data-alrt");if(h=h?t(h):null)h.innerHTML="";try{var k=200==d&&JSON.parse(e)}catch(A){}k&&"object"==typeof k||(Uc(h,t("gs_md_err").innerHTML),k={});if(d=k.L)Ca(""+d);else{(d=k.M)&&Uc(h,d);d=1E6;if(h&&h.innerHTML){var m=h;d=h.getBoundingClientRect().top}f=f.elements;k=k.E;"object"==typeof k||(k=Object.create(null));for(var w in b.K){h=
f[w];e=void 0;var v=""+(k[w]||""),F=h.parentNode.querySelector(".gs_in_txts");q(h.parentNode,"gs_in_txte",!!v);F&&(F.innerHTML=v||b.K[w]||"");v&&(e=h.getBoundingClientRect().top)<d&&(m=h,d=e)}m&&m.scrollIntoView&&(0>d||d+20>window.innerHeight)&&m.scrollIntoView()}})}};
var Tc=function(a,b){a=a.D;var c=a.getAttribute("data-bsel");a=c?document.querySelectorAll(c):a.querySelectorAll("button");for(c=a.length;c--;){var d=a[c];d.disabled=b;q(d,"gs_bsp",b)}},Uc=function(a,b){if(a)a.innerHTML=b;else{var c=void 0===c?"":c;var d=void 0===d?"":d;var e=void 0===e?[]:e;t("gs_alrt_m").innerHTML=b;Lb().action=d.match(Ba)?d:"";a=t("gs_alrt_l");a.textContent=c;c=t("gs_alrt_h");c.innerHTML="";for(var f in e)b=document.createElement("input"),b.type="hidden",b.name=f,b.value=e[f],
c.appendChild(b);Ib();q(a,"gs_fm_s",!0);Kb()}};Ub(Sc,[new M(".gs_ajax_frm",{submit:Sc.prototype.ga})]);var Vc=[[1,0,1],[2,0,1]];P(".gs_cb_gen","click",function(a){var b=a.currentTarget,c=tc(b),d=2==+b.getAttribute("data-s");vc(b,Vc[+d][c],!0);O("gs-change",b,a.g)});P(".gs_cb_gen",["keydown","keyup"],function(a){var b=a.currentTarget,c=a.g.keyCode;"BUTTON"!=b.tagName||13!=c&&32!=c||(L(a),"keydown"==a.type&&b.click())});P([".gs_cb_gen",".gs_md_li"],"keydown",function(a){var b=a.currentTarget,c=b.tagName,d=a.g.keyCode;"BUTTON"!=c&&(32==d||13==d&&"A"!=c)&&(L(a),b.click())});var Wc=["click","contextmenu","mouseup"].concat(navigator.sendBeacon?[]:["mousedown","touchstart"]),Xc="",Yc=null;function Zc(){Yc=null}function $c(a){navigator.sendBeacon?navigator.sendBeacon(a):Yc&&a==Yc.src||((Yc=new Image).src=a,setTimeout(Zc,1E3))}function ad(){var a=lb(document.location.href).hl||"";a="/scholar_bfnav?url="+encodeURIComponent(document.location.href)+"&hl="+encodeURIComponent(a)+"&ei="+GSP.eventId;$c(a)}D(function(){Xc=Hb?"&bn=1":"";Hb&&ad()});
B(window,"pageshow",function(a){a.persisted&&(Xc="&bn=1",ad())});
B(document,Wc,function(a){if(!("click"==a.type&&a.button||"mouseup"==a.type&&1!=a.button)){var b,c;a:{for(a=a.target;a;){var d=a.nodeName;if("A"==d)break a;if("SPAN"==d||"B"==d||"I"==d||"EM"==d||"IMG"==d)a=a.parentNode;else break}a=null}a&&(b=a.getAttribute("href"))&&(c=a.getAttribute("data-clk"))&&(b="/scholar_url?url="+encodeURIComponent(b)+"&"+c+"&ws="+window.innerWidth+"x"+window.innerHeight+"&at=",c=encodeURIComponent,a=(a=a.getAttribute("data-clk-atid"))&&t(a),b=b+c(a&&a.innerText||"")+Xc,$c(b))}},
!1,!0);P(".gs_fm_s","click",function(a){a=a.currentTarget.getAttribute("data-fm")||"";(a=t(a))&&a.submit()});var V=function(a){this.m=x(a.querySelector(".gs_md_d"));this.G=x(a.querySelector(".gs_md_tb"))};V.prototype.I=function(a){var b=t(this.m);return void 0!==a?rc(b,b,a):null};V.prototype.open=function(a){a=this.I(a);if(p(t(this.G),"gs_sel"))try{a&&a.focus()}catch(c){}else{var b=t(this.G);Va(this.m,function(){l(b,"gs_sel")},function(){n(b,"gs_sel")},a,b)}};V.prototype.close=function(){H(this.m)};V.prototype.Z=function(a){L(a);p(t(this.G),"gs_sel")?this.close():this.open("keydown"==a.g.type?!1:void 0)};
V.prototype.U=function(a){var b=a.g.keyCode;if(38==b||40==b)L(a),this.open(38==b)};V.prototype.aa=function(a){a.target.id==this.m&&this.U(a)};Ub(V,[new M(".gs_md_rmb",{}),new M(".gs_md_tb",{"gs-press":V.prototype.Z,keydown:V.prototype.U}),new M(".gs_md_d",{keydown:V.prototype.aa})]);var W=function(a){V.call(this,a);this.ia=x(a.querySelector(".gs_md_in"));this.ja=x(a.querySelector(".gs_md_tb .gs_lbl"))};ia(W,V);W.prototype.I=function(){return t(this.m).querySelector(".gs_md_li[aria-selected]")};W.prototype.ba=function(a){bd(this,a)};W.prototype.J=function(a){var b=a.g.keyCode;13!=b&&32!=b||bd(this,a)};
var bd=function(a,b){var c=b.currentTarget,d=t(a.ia),e=a.I();c!=e&&(d.value=c.getAttribute("data-v"),t(a.ja).innerHTML=c.innerHTML,e&&cd(e,!1),cd(c,!0));L(b);a.close();O("gs-change",d,b.g)},cd=function(a,b){q(a,"gs_sel",b);b?a.setAttribute("aria-selected","true"):a.removeAttribute("aria-selected")};Ub(W,[new M(".gs_md_ris",{}),new M(".gs_md_li",{click:W.prototype.ba,keydown:W.prototype.J})]);P("#gs_lp","click",function(a){L(a);R("gs_lp_d")});P("#gs_lp_cur","click",function(a){L(a);H("gs_lp_d")});var dd=function(a){this.W=x(a)};dd.prototype.J=function(a){var b=a.currentTarget,c=a.g.keyCode;if(38==c||40==c){var d=t(this.W);d=rc(d,b,38==c)||rc(d,d,38==c)}else if(37==c||39==c)a:{c=!!(37==c^xa(b.parentNode));d=b.parentNode;var e=d.children,f=e.length;if(d.id!=this.W){for(;e[--f]!=b;);d=qc(d,c)||pc(d.parentNode,c);e=d.children;if(f=Math.min(f+1,e.length))if(d=e[f-1],p(d,"gs_md_li")&&d.offsetLeft!=b.offsetLeft)break a}d=void 0}d&&(L(a),d.focus())};
Ub(dd,[new M(".gs_md_ulr",{}),new M(".gs_md_li",{keydown:dd.prototype.J})]);P("#gs_hdr_mnu","click",function(a){L(a);R("gs_hdr_drw")});P("#gs_hdr_drw_mnu","click",function(a){L(a);H("gs_hdr_drw")});P("#gs_hdr_act_i","click",function(a){L(a);1==oa()?Ca(document.querySelector("#gs_hdr_drw_bot>a").href):Va("gs_hdr_act_d")});P("#gs_hdr_drw","keydown",function(a){var b=a.g.keyCode;if(38==b||40==b){var c=a.currentTarget;if(b=rc(c,c,38==b))L(a),b.focus()}});
P("#gs_hdr_tsi",["focus","blur"],function(a){function b(){var h=d.getBoundingClientRect().top-10;10<Math.abs(h)&&window.scrollBy(0,h);clearTimeout(e);c()}function c(){C(window,f,b)}var d=a.target;a="focus"==a.type;q(t("gs_hdr"),"gs_hdr_ifc",a);if(a&&pa&&!(749<window.innerHeight)){var e=setTimeout(c,1E3),f=["scroll","resize"];B(window,f,b)}});P("#gs_hdr_tsi",["input","gs-change"],function(a){q(t("gs_hdr_frm"),"gs_hdr_tsc",!!a.currentTarget.value)});
P("#gs_hdr_tsc","mousedown",function(a){L(a);var b=t("gs_hdr_tsi");b.value="";b.focus();O("input",b,a.g)});P("#gs_hdr_sre","click",function(a){L(a);var b=t("gs_hdr");Va("gs_hdr_frm",function(){n(b,"gs_hdr_src");l(b,"gs_hdr_srx")},function(){l(b,"gs_hdr_src");n(b,"gs_hdr_srx")},t("gs_hdr_tsi"))});P(".gs_md_x","click",function(a){(a=a.currentTarget.getAttribute("data-mdx"))&&H(a)});var X=function(){},ed,fd;X.prototype.$=function(a){a.g.button||(L(a),gd(a))};X.prototype.ca=function(a){hd(a)&&(L(a),gd(a))};X.prototype.da=function(a){hd(a)&&L(a)};X.prototype.ea=function(a){if(!a.g.button){L(a);var b=a.g;b&&(id=b.clientX||0,jd=b.clientY||0,B(document,kd,ld,!0),clearTimeout(ed),ed=setTimeout(md,2E3));gd(a)}};X.prototype.ha=function(a){L(a);if(nd){var b=a.g;if(b=(b=b&&b.touches)&&1==b.length&&b[0])od=b.clientX,pd=b.clientY,B(document,qd,rd,!0),clearTimeout(fd),fd=setTimeout(sd,2E3)}gd(a)};
var hd=function(a){a=a.g.keyCode;return 32==a||13==a},gd=function(a){O("gs-press",a.currentTarget,a.g)},md=function(){C(document,kd,ld,!0);clearTimeout(ed);ed=void 0},ld=function(a){"mousedown"!=a.type&&10>Math.abs(a.clientX-id)&&10>Math.abs(a.clientY-jd)?(Na(a),"click"==a.type&&md()):md()},sd=function(){C(document,qd,rd,!0);clearTimeout(fd);fd=void 0},rd=function(a){"touchstart"!=a.type&&10>Math.abs(a.clientX-od)&&10>Math.abs(a.clientY-pd)?(Na(a),"click"==a.type&&sd()):sd()},id=0,jd=0,kd=["mousedown",
"mouseup","click"],nd=r("Android")&&!r("Chrome"),od=0,pd=0,qd=["touchstart","mousedown","mouseup","click"];Ub(X,[new M(".gs_press",{click:X.prototype.$,keydown:X.prototype.ca,keyup:X.prototype.da,mousedown:X.prototype.ea,touchstart:X.prototype.ha})]);function td(){var a=0>ud.getBoundingClientRect().top;vd!=a&&(vd=a,q(wd,"gs_sth_vis",a),a?xd():(yd.style.left="",yd.style.width="",zd()))}function xd(){if(vd){var a=ud.getBoundingClientRect();yd.style.left=a.left+"px";yd.style.width=a.width+"px";zd()}}function zd(){O("gs-sth-change",t("gs_sth"))}var wd,ud,yd,vd=!1;D(function(){if(wd=t("gs_sth"))ud=wd.querySelector(".gs_sth_g"),yd=wd.querySelector(".gs_sth_b"),yc.addListener(td),zc.addListener(xd),td()});function Ad(){var a=t("gsc_rsb_co");if(a){a=a.querySelectorAll("img.gs_pp_df");for(var b=0;b<a.length;b++){var c=a[b];c.getAttribute("data-srcset")&&(c.setAttribute("srcset",c.getAttribute("data-srcset")),c.removeAttribute("data-srcset"));c.getAttribute("data-src")&&(c.setAttribute("src",c.getAttribute("data-src")),c.removeAttribute("data-src"))}}};var Bd=/\S+@\S+\.\S+/;function Cd(a){return p(a,"gsc_ccb_dis")||p(a,"gsc_ccb_lim")}function Dd(){for(var a=0>=Ed(),b=t("gsc_cods_res").querySelectorAll(".gsc_ccb_add"),c=b.length;c--;){var d=b[c];p(d,"gsc_ccb_on")||q(d,"gsc_ccb_lim",a)}};var Fd=function(a){this.X=a};Fd.prototype.fa=function(a){L(a);a=a.currentTarget.getAttribute("data-a");this.X.setAttribute("data-a",a||"");O("gsc-navigate",this.X)};var Gd=[new M(".gsc_pgn",{}),new M([".gsc_pgn_ppr",".gsc_pgn_pnx"],{click:Fd.prototype.fa})];function Hd(a,b){b=void 0===b?"":b;var c=t("gsc_md_cod");a+=fb({t:Id});R(c.id,a,"",b)}function Jd(a){if(Id!=a){var b=t("gsc_md_cod");n(b,Id);l(b,a);Id=a}}function Kd(){var a=kb(Fc).t;"gsc_cod_sugg"!=a&&"gsc_cod_lc"!=a||Jd(a)}function Ld(){var a=Md();a=a?a.value:"";var b=(t("gsc_cods_urls").getAttribute("data-sa")||"").replace(Nd,"$1"+encodeURIComponent(a));a=a?b:t("gsc_cods_urls").getAttribute("data-lc")||"";Hd(a)}
function Od(a){var b=t("gsc_cods_frm");if(b){b=b.elements;var c=b[1];b[0].disabled=c.disabled=a;q(c,"gs_bsp",a)}a=a?null:t("gsc_codb_data");if(c=t("gsc_cods_pp")){var d=a&&a.getAttribute("data-prev");b=a&&a.getAttribute("data-next");var e=a&&a.getAttribute("data-start"),f=a&&a.getAttribute("data-end");c.querySelector(".gsc_pgn_ppn").textContent=e&&f?e+" - "+f:"";e=c.querySelector(".gsc_pgn_ppr");e.disabled=!d;e.setAttribute("data-a",d||"");c=c.querySelector(".gsc_pgn_pnx");c.disabled=!b;c.setAttribute("data-a",
b||"")}a&&(Pd=+a.getAttribute("data-max")||0,za(t("gsc_cods_save"),"xsrf").value=a.getAttribute("data-xsrf")||"")}function Qd(){var a=0<Y.l||0<Z.l,b=Ed(),c=0>=b;t("gsc_cod_done").disabled=!a||0>b;q(t("gsc_cod_t"),"gsc_cod_changed",a);a=t("gsc_cod_trev");a.textContent=a.getAttribute(c?"data-lim":"data-txt")||"";q(t("gsc_cod_t"),"gsc_cod_lim",c)}function Ed(){return Pd-Y.l+("gsc_cod_sugg"==Id?0:Z.l)}function Md(){return t("gsc_cods_tsi")}
function Rd(a){for(var b="",c=la(a.j),d=c.length;d--;)b+=a.get(c[d]);return b}var Id="gsc_cod_lc",Pd=0,Nd=/([?&]mauthors=)([^&]*)/,Y=new Q,Z=new Q;function Sd(a){q(t("gsc_a_sp"),"gs_vis",0==a);q(t("gsc_a_err"),"gs_vis",2==a)}function Td(){return document.querySelectorAll("#gsc_a_t input[type=checkbox]")}function Ud(){O("gsc-works-change",t("gsc_a_t"))}function Vd(){var a=t("gsc_x_all");if(a){var b=document.querySelectorAll("#gsc_a_t input[type=checkbox]:checked");var c=b.length;var d=Td().length;c=c?c==d?1:2:0;vc(a,c);2==c&&(Wd=b)}Ud()}var Wd=[];var Xd="",Zd=0,ae=0;function be(a){for(var b=[!1,!1,!1],c=0;c<b.length;c++){var d=t(ce[c]);d&&(b[c]=!!a(d))}return b}function de(){var a=t("gsc_fol_m");if(a){var b=t("gsc_fol_b");if(!(a=!Bd.test(a.value))){a:{a=be(tc);for(var c=be(uc),d=0;d<a.length;d++)if(a[d]!=c[d]){a=!0;break a}a=!1}a=!a}b.disabled=a}}var ce=["gsc_fol_a","gsc_fol_c","gsc_fol_r"],ee=["follow_articles_btn","follow_citations_btn","follow_related_btn"];function fe(){p(document.documentElement,"gs_el_ph")||p(document.documentElement,"gs_el_ta")||Ad()};function ge(a){if(a){a.id&&a.removeAttribute("id");for(var b=0;b<a.children.length;b++)ge(a.children[b])}};function he(){var a=t("gsc_prf_pufii");if(r("MSIE ")){var b=t("gsc_prf_puf");Va("gsc_prf_pufi",function(){l(b,"gsc_prf_pufo")},function(){n(b,"gsc_prf_pufo")},a)}else a.click()};function ie(){var a=document.querySelectorAll(".gsc_prf_pnl"),b=document.documentElement;b=p(b,"gs_el_ph")||p(b,"gs_el_ta");for(var c=0;c<a.length;c++)a[c].setAttribute("role",b?"tabpanel":"region")};var je=kb(window.location.hash),ke=je.u||"";"gs_md_cita-d"==je.d&&ke.match(Ea)&&0<=ke.indexOf("view_citation")&&Ca(ke);P("#gsc_md_cod","gs-md-ldin",function(){Kd();Od(!0)});P("#gsc_md_cod","gs-md-lded",function(){Kd();Od(!1);for(var a=t("gsc_cods_res").querySelectorAll(".gsc_ccb_ck"),b=a.length;b--;){var c=a[b];if(!Cd(c)){var d=c.getAttribute("data-authorid")||"";d=(p(c,"gsc_ccb_add")?Y:Z).has(d);q(c,"gsc_ccb_on",d)}}Dd();Qd();a=lb(Fc);(b=Md())&&(b.value=a.mauthors||"")});
P("#gsc_cods_frm","gsc-lwpds-submit",Ld);P("#gsc_cods_pp","gsc-navigate",function(a){(a=a.currentTarget.getAttribute("data-a"))&&Hd(a)});
P([".gsc_ccb_add",".gsc_ccb_del"],"click",function(a){a=a.currentTarget;if(!Cd(a)){var b=!p(a,"gsc_ccb_on");q(a,"gsc_ccb_on",b);var c=p(a,"gsc_ccb_add")?".gsc_ccb_del":".gsc_ccb_add",d=a.parentNode;(c=d&&d.querySelector(c))&&n(c,"gsc_ccb_on");c=a.getAttribute("data-authorid")||"";Y.delete(c);Z.delete(c);b&&(p(a,"gsc_ccb_add")?Y:Z).set(c,t("gsc_ucoar-"+c).outerHTML);Dd();Qd()}});
P("#gsc_cod_trev","click",function(){var a=t("gsc_cods_res").cloneNode(!0),b=a.querySelector("#gsc_codb_content");b||(b=document.createElement("div"),b.id="gsc_codb_content",a.appendChild(b));var c=Rd(Y)+Rd(Z);b.innerHTML=c;(b=Md())&&(b.value="");Hd("",a.innerHTML)});P("#gsc_cod_done","click",function(){var a=t("gsc_cods_save");za(a,"colleague_add").value=la(Y.j).join(",");za(a,"colleague_del").value=la(Z.j).join(",");a.submit()});
P(["#gsc_coauth_opn",".gsc_rsb_btne",".gsc_rsb_btnv"],"click",function(){Jd("gsc_cod_lc");Pd=0;Y.clear();Z.clear();var a=Md();a&&(a.value="");Ld()});P(".gsc_rsb_aa",["click","keydown"],function(a){if("keydown"!=a.type||a.g&&!Oa(a.g)&&13==a.g.keyCode)a.g&&Na(a.g),(a=(a=a.currentTarget.querySelector("a"))?a.getAttribute("href"):"")&&Ca(a)});P("#gsc_prf_t-ath","click",function(){Ad()});D(function(){Ac.add(fe);fe()});P(".gsc_lwpds_frm","submit",function(a){L(a);O("gsc-lwpds-submit",a.target)});
var le=window.location.href.split("#")[0];Xd=le.replace(/([?&])(cstart|pagesize)=[^&]*/g,"$1");Zd=Math.max(+le.replace(/.*[?&]cstart=([^&]*).*/,"$1")||0,0);ae=+le.replace(/.*[?&]pagesize=([^&]*).*/,"$1")||0;ae=Math.max(Math.min(ae,100),20);
P("#gsc_bpf_more","click",function(a){var b=a.currentTarget,c=ae,d=100>c?100-c:100;a=(Xd+"&cstart="+(Zd+c)+"&pagesize="+d).replace(/([?&])&+/g,"$1");Sd(0);b.disabled=!0;Qb(a,"json=1",function(e,f){b.disabled=!1;try{var h=200==e&&JSON.parse(f)}catch(m){}if(h&&"object"==typeof h){ae=c+=d;Sd(1);e=t("gsc_a_b");f=document.createElement(va.Y);f.innerHTML=""+h.B;f=Array.prototype.slice.call(f.rows);for(var k=0;k<f.length;k++)e.appendChild(f[k]);Vd();if(e=t("gsc_a_nn"))f=e.innerHTML.replace(/[0-9]+$/,""+
t("gsc_a_b").rows.length),e.innerHTML=f;b.disabled=!h.N}else Sd(2)})});P(["#gsc_fol_a","#gsc_fol_c","#gsc_fol_r"],"gs-change",de);P("#gsc_fol_m","input",de);P("#gsc_fol_f","submit",function(a){a.g&&a.g.preventDefault();a=t("gsc_fol_f");var b=t("gsc_fol_inp");b.innerHTML="";for(var c=be(tc),d=be(uc),e=0;e<c.length;e++)if(c[e]!=d[e]){var f=ee[e],h=document.createElement("input");h.type="hidden";h.name=c[e]?f:"un"+f;b.appendChild(h)}O("gsc-fol-submit",a)});P("#gsc_fol_f","gsc-fol-submit",function(a){a.currentTarget.submit()});
P("#gsc_md_hist","gs-md-lded",function(){var a=t("gsc_md_hist_c");if(!a.innerHTML){var b=document.getElementsByClassName("gsc_g_hist_wrp");1==b.length&&(a.appendChild(b[0].cloneNode(!0)),ge(a.lastChild))}});P(["#gsc_hist_opn",".gsc_md_hist_b"],"click",function(){var a=document.documentElement;!t("gsc_hist_opn")||p(a,"gs_el_ph")||p(a,"gs_el_ta")||R("gsc_md_hist")});
P("#gsc_lwp_mndt_lnk","click",function(a){var b=a.currentTarget.getAttribute("href")+"&tzom="+(new Date).getTimezoneOffset();window.location.assign(b);a.g.preventDefault()});P("#gsc_prf_btne","click",function(){var a=t("gsc_md_pro-d");a.setAttribute("data-ifc","");R(a.id,fb({t:"gsc_md_pro_ed"}))});P("#gsc_prf_btnf","click",function(){R("gsc_md_fol")});P("#gsc_md_fol_pub","click",function(){t("gsc_fol_mpf").submit()});P("#gsc_prf_iv_tg","click",function(){q(t("gsc_prf_w"),"gsc_prf_why")});
P(".gsc_prf_pel",["click","keydown"],function(a){("keydown"!=a.type||13==a.g.keyCode&&a.g&&!Oa(a.g))&&he()});P("#gsc_prf_pufii","change",function(){t("gsc_prf_puf").submit()});P(".gsc_prf_tab","click",function(a){var b=t("gsc_bdy");b.setAttribute("data-tab",a.currentTarget.id);b=b.querySelectorAll(".gsc_prf_tab");for(var c=0;c<b.length;c++){var d=b[c];d.setAttribute("aria-selected",""+(d==a.currentTarget))}});D(function(){Ac.add(ie);ie()});
P("#gsc_md_cbyd","gs-md-ldin",function(){var a=t("gsc_md_cbyd_merge");a&&(a.disabled=!0);Aa("")});P("#gsc_md_cbyd","gs-md-lded",function(){var a=t("gsc_md_cbyd_f"),b=t("gsc_md_cbyd_merge"),c=Fc,d=lb(c).s||"";c=kb(c).c||"";a.elements.s.value=d;Aa(c);b&&a.elements.choose&&(b.disabled=!1,b.getBoundingClientRect().bottom<window.innerHeight&&b.focus())});
P("#gsc_md_cbym",["gs-md-ldin","gs-md-lded"],function(){var a=lb(Fc).s||"",b=t("gsc_md_cbym_e");b&&a&&0>a.indexOf("&")&&b.setAttribute("data-href",(b.getAttribute("data-href")||"").replace(/(&citation_for_view=)[^&]*/,"$1"+a))});P("#gsc_md_cbym_e","click",function(a){a=a.currentTarget.getAttribute("data-href")||"";R("gs_md_cita-d",a)});Ub(Fd,Gd);D(function(){return setTimeout(Vd,0)});P(".gsc_a_x","change",Vd);
P("#gsc_x_all","gs-change",function(a){a=tc(a.currentTarget);for(var b=2==a?Wd:Td(),c=b.length;c--;)b[c].checked=0!=a;Ud()});P(".gsc_a_acm","click",function(a){L(a);var b=a.currentTarget;a=b.href;var c=b.getAttribute("data-eid")||"";b=b.getAttribute("data-eud")||"";a=t("gsc_md_cbyd_f").action+"&update_op=merge_options&s="+(b+","+c)+fb({c:a});R("gsc_md_cbyd",a)});
P(".gsc_a_am","click",function(a){a=a.currentTarget.getAttribute("data-eid")||"";a=(t("gsc_md_cbym_l").getAttribute("data-act")||"")+"&update_op=merge_options&s="+a;R("gsc_md_cbym",a)});P("#gs_sth","gs-sth-change",function(a){var b=t("gsc_a_tr0"),c=t("gsc_a_trh"),d=b.querySelector(".gsc_a_t"),e=c.querySelector(".gsc_a_t");p(a.currentTarget,"gs_sth_vis")?(e.style.width=d.offsetWidth+"px",b.style.height=c.offsetHeight+"px"):e.style.width=b.style.height="auto"});
P("#gs_md_cita-b-save","click",function(){var a=t("gsc_ecd_form");za(a,"continue").value=window.location.pathname+window.location.search;O("submit",a)});P(".gsc_ecd_form_tsel","click",function(a){var b=t("gsc_ecd_table"),c=za(t("gsc_ecd_form"),"articletype");a=a.currentTarget;c.value=a.getAttribute("data-type")||"";b.className=a.getAttribute("data-class")||"";b=document.querySelectorAll("#gsc_ecd_citation_type button");for(c=b.length;c--;)q(b[c],"gs_sel",b[c]==a)});
}({"customAC":2,"eventId":"5-Y9YZ7BD8LMsQKvlwo"});</script></head><body><div id="gs_top" onclick=""><style>#gs_md_s,.gs_md_wnw{z-index:1200;position:fixed;top:0;left:0;width:100%;height:100%;visibility:hidden;}#gs_md_s{background-color:#fff;opacity:.5;}.gs_el_ta #gs_md_s,.gs_el_ph #gs_md_s{background-color:#666;}.gs_md_wnw{transition:all 0s .218s;}#gs_md_s.gs_vis,.gs_md_wnw.gs_vis{visibility:visible;transition:all 0s;}.gs_md_wnw>.gs_md_d{position:relative;margin:0 auto;width:464px;box-shadow:2px 2px 8px rgba(0,0,0,.2);white-space:normal;}.gs_el_ta .gs_md_wnw>.gs_md_d,.gs_el_ph .gs_md_wnw>.gs_md_d{box-shadow:2px 2px 8px rgba(0,0,0,.65);}.gs_el_ph .gs_md_wnw>.gs_md_d{width:80%;max-width:440px;}.gs_el_ph .gs_md_wmw>.gs_md_d{width:100%;height:100%;max-width:none;border:none;box-shadow:none;transform:translate(0,100%);transform:translate(0,100vh);transition:transform .27s cubic-bezier(.4,0,.6,1),opacity 0s .27s,visibility 0s .27s,max-height 0s .27s;}.gs_el_ph .gs_md_wmw>.gs_md_d.gs_vis{transform:translate(0,0);transition:transform .3s cubic-bezier(0,0,.2,1);}.gs_md_wmw>.gs_md_d.gs_abt,.gs_el_ph .gs_md_wmw>.gs_md_d.gs_abt{transition:none;}.gs_md_hdr{display:flex;align-items:center;height:47px;border-bottom:1px solid #e0e0e0;border-bottom-color:rgba(0,0,0,.12);background-color:#f5f5f5;}.gs_md_hdr>a,.gs_md_hdr>a.gs_btn_lrge{flex:0 0 auto;width:41px;height:47px;}.gs_el_ph .gs_md_hdr>a{margin:0 2px 0 0;}.gs_el_ph a.gs_md_hdr_c{margin:0 0 0 2px;}.gs_md_hdr_b{margin:0 41px 0 16px;}.gs_el_ph .gs_md_hdr_b{margin:0 16px;}.gs_md_hdr_t:empty~.gs_md_hdr_b{margin-left:0;}.gs_md_hdr_b:empty{width:41px;margin:0;}.gs_el_ph .gs_md_hdr_b:empty{margin-right:2px;}.gs_md_hdr_b:empty:not(:last-child){display:none;}.gs_md_hdr_b>button{min-width:51px;height:33px;}.gs_md_hdr_t{flex:1 1 auto;font-size:18px;font-weight:normal;color:#666;overflow:hidden;text-overflow:ellipsis;white-space:nowrap;text-align:center;}.gs_md_bdy{overflow-y:auto;box-sizing:border-box;padding:24px 41px 0 41px;}.gs_md_bdy:after{display:block;content:"";clear:both;padding-bottom:24px;}.gs_el_ph .gs_md_bdy{padding:16px 16px 0 16px;}.gs_el_ph .gs_md_bdy:after{padding-bottom:16px;}.gs_el_ph .gs_md_wmw .gs_md_bdy{position:absolute;width:100%;top:48px;bottom:0;}.gs_md_lbl{display:block;font-size:16px;margin:0 0 16px 0;word-wrap:break-word;}.gs_md_btns{margin:24px 0 0 0;white-space:nowrap;}.gs_el_ph .gs_md_btns{margin:16px 0 0 0;}.gs_md_btns button{margin-right:16px;}.gs_md_btns button:last-child{margin-right:0;}.gs_md_prg{margin:24px 0;text-align:center;}.gs_md_prg .gs_alrt{padding:4px 16px;}.gs_md_ldg:before{content:"";position:absolute;top:0;left:0;bottom:0;right:0;background-color:#fff;opacity:.5;z-index:100;}</style><div id="gs_md_ldg" style="display:none">Loading...</div><div id="gs_md_err" style="display:none">The system can't perform the operation now. Try again later.</div><div id="gs_md_s"></div><div data-h="0" class="gs_md_wnw"><div id="gsc_md_hist" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_hist-t" data-wfc="gsc_md_hist-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_hist-x" role="button" aria-label="Cancel" data-mdx="gsc_md_hist" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_hist-t" class="gs_md_hdr_t">Citations per year</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_hist-bdy" class="gs_md_bdy"><style>#gsc_md_hist{width:80%;max-width:386px;}#gsc_md_hist_c{position:relative;width:100%;}</style><div id="gsc_md_hist_c"></div></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbyd" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbyd-t" data-cid="gsc_md_cbyd_l" data-wfc="gsc_md_cbyd-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbyd-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbyd" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbyd-t" class="gs_md_hdr_t">Duplicate citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbyd-bdy" class="gs_md_bdy"><form id="gsc_md_cbyd_f" action="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works" method="post"><input type="hidden" name="s" value=""><div class="gs_md_lbl">The following articles are merged in Scholar. Their <a id="gsc_md_cbyd_c" href="javascript:void(0)">combined citations</a> are counted only for the first article.</div><div id="gsc_md_cbyd_l"></div></form></div></div></div><div data-h="600" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cbym" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cbym-t" data-cid="gsc_md_cbym_l" data-wfc="gsc_md_cbym-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cbym-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cbym" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cbym-t" class="gs_md_hdr_t">Merged citations</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_cbym-bdy" class="gs_md_bdy"><div class="gs_md_lbl">This "Cited by" count includes citations to the following articles in Scholar. The ones marked <span id="gsc_md_cbym_s">*</span> may be different from the article in the profile.</div><div id="gsc_md_cbym_l" data-act="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works"></div></div></div></div><div data-h="900" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_cod" class="gs_md_d gs_ttzi gsc_cod_lc" role="dialog" tabindex="-1" aria-labelledby="gsc_md_cod-t" data-cid="gsc_cods_res" data-wfc="gsc_md_cod-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_cod-x" role="button" aria-label="Cancel" data-mdx="gsc_md_cod" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_cod-t" class="gs_md_hdr_t"><span id="gsc_cod_t"><span id="gsc_cod_tadd">Add co-authors</span><span id="gsc_cod_tedit">Co-authors</span><a id="gsc_cod_trev" href="javascript:void(0)" data-txt="Review" data-lim="Limit reached"></a></span></h2><div class="gs_md_hdr_b"><button type="button" id="gsc_cod_done" aria-label="Add co-authors" disabled="" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gsc_md_cod-bdy" class="gs_md_bdy"><div id="gsc_cods_urls" class="gsc_cods_hide" data-ls="" data-lc="/citations?view_op=list_colleagues&amp;hl=en&amp;json=&amp;user=B_fNeq0AAAAJ" data-sa=""></div><form id="gsc_cods_save" action="" method="POST"><input type="hidden" name="colleague_add"><input type="hidden" name="colleague_del"></form><div id="gsc_cods_res"></div></div></div></div><div data-h="800" class="gs_md_wnw gs_md_wmw"><div id="gs_md_cita-d" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gs_md_cita-d-t" data-cid="gs_md_cita-l" data-wfc="gs_md_cita-d-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gs_md_cita-d-x" role="button" aria-label="Cancel" data-mdx="gs_md_cita-d" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gs_md_cita-d-t" class="gs_md_hdr_t"></h2><div class="gs_md_hdr_b"><button type="button" id="gs_md_cita-b-save" aria-label="Save" class="gs_btnDNW gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></div></div><div id="gs_md_cita-d-bdy" class="gs_md_bdy"><style>#gs_md_cita-d{width:90%;max-width:1000px;}.gs_el_ph #gs_md_cita-d{width:100%;max-width:none;}#gs_md_cita-d .gs_md_prg{min-height:600px;}</style><div id="gs_md_cita-l" aria-live="assertive"></div></div></div></div><div data-h="0" class="gs_md_wnw gs_md_wmw"><div id="gsc_md_fol" class="gs_md_d gs_ttzi" role="dialog" tabindex="-1" aria-labelledby="gsc_md_fol-t" data-wfc="gsc_md_fol-x"><div class="gs_md_hdr"><a href="javascript:void(0)" id="gsc_md_fol-x" role="button" aria-label="Cancel" data-mdx="gsc_md_fol" class="gs_btnCLS gs_md_x gs_md_hdr_c gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><h2 id="gsc_md_fol-t" class="gs_md_hdr_t">Follow this author</h2><div class="gs_md_hdr_b"></div></div><div id="gsc_md_fol-bdy" class="gs_md_bdy"><form method="post" id="gsc_fol_f" action="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT84Z4lsODWjQWRXWa8myPgqsL7N11rR"><input type="hidden" name="user" value="B_fNeq0AAAAJ"><div id="gsc_fol_inp"></div><div id="gsc_fol_cb"><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_a" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles by this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_c" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New citations to this author</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div><div class="gsc_fol_cr"><a href="javascript:void(0)" id="gsc_fol_r" role="checkbox" aria-checked="false" data-s="0" class="gs_cb_gen gs_in_cb"><span class="gs_lbl">New articles related to this author's research</span><span class="gs_chk"></span><span class="gs_cbx"></span></a></div></div><div id="gsc_fol_email"><label id="gsc_fol_ml" for="gsc_fol_m">Email address for updates</label><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="email_for_op" value="" id="gsc_fol_m" maxlength="100" autocapitalize="off" autocorrect="off"></div></div><div class="gs_md_btns"><button type="submit" id="gsc_fol_b" disabled="" class=" gs_btn_act gs_btn_lrge gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">Done</span></span></button></div></form></div></div></div><!--[if lte IE 9]><div class="gs_alrt" style="padding:16px"><div>Sorry, some features may not work in this version of Internet Explorer.</div><div>Please use <a href="//www.google.com/chrome/">Google Chrome</a> or <a href="//www.mozilla.com/firefox/">Mozilla Firefox</a> for the best experience.</div></div><![endif]--><div id="gs_hdr_drs"></div><div id="gs_hdr_drw" class="gs_md_ulr" role="dialog" tabindex="-1" data-shd="gs_hdr_drs" data-wfc="gs_hdr_drw_mnu" data-cfc="gs_hdr_mnu"><div id="gs_hdr_drw_in"><div id="gs_hdr_drw_top"><a href="javascript:void(0)" id="gs_hdr_drw_mnu" role="button" aria-controls="gs_hdr_drw" aria-label="Options" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_drw_lgo" href="/schhp?hl=en" aria-label="Homepage"></a></div><div><div class="gs_hdr_drw_sec"><a href="/citations?hl=en" role="menuitem" class="gs_btnPRO gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My profile</span></a><a href="/scholar?scilib=1&amp;hl=en" role="menuitem" class="gs_btnL gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">My library</span></a><a href="/citations?view_op=metrics_intro&amp;hl=en" role="menuitem" class="gs_btnJ gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Metrics</span></a><a href="/scholar_alerts?view_op=list_alerts&amp;hl=en" role="menuitem" class="gs_btnM gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Alerts</span></a></div><div class="gs_hdr_drw_sec"><a href="/scholar_settings?hl=en" role="menuitem" class="gs_btnP gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Settings</span></a></div></div><div id="gs_hdr_drw_bot" class="gs_hdr_drw_sec"><a href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den" class=" gs_in_ib gs_md_li gs_md_lix gs_in_gray"><span class="gs_ico"></span><span class="gs_lbl">Sign in</span></a></div></div></div><div id="gs_hdr" role="banner" class="gs_hdr_src"><a href="javascript:void(0)" id="gs_hdr_mnu" role="button" aria-controls="gs_hdr_drw" class="gs_btnMNT gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><a id="gs_hdr_lgo" class="" href="/schhp?hl=en" aria-label="Homepage"></a><div id="gs_hdr_md"><div id="gs_hdr_srch"><form id="gs_hdr_frm" action="/citations"><input type="hidden" name="view_op" value="search_authors"><input type="hidden" name="hl" value="en"><div class="gs_in_txtw gs_in_txtb"><input type="text" class="gs_in_txt" name="mauthors" value="" id="gs_hdr_tsi" placeholder="Search profiles" size="50" maxlength="2048" autocapitalize="off" aria-label="Search"></div><span id="gs_hdr_tsc"><span class="gs_ico gs_ico_X"></span></span><button type="submit" id="gs_hdr_tsb" name="btnG" aria-label="Search" class="gs_btnG gs_in_ib gs_btn_act gs_btn_half gs_btn_lsb"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl"></span></span></button></form></div></div><a href="javascript:void(0)" id="gs_hdr_sre" role="button" aria-controls="gs_hdr_frm" aria-label="Search" class="gs_btnTSB gs_in_ib gs_btn_lrge"><span class="gs_ico"></span><span class="gs_lbl"></span></a><div id="gs_hdr_act"><a id="gs_hdr_act_s" href="https://accounts.google.com/Login?hl=en&amp;continue=https://scholar.google.com/schhp%3Fhl%3Den">Sign in</a></div></div><style>#gs_alrt{position:fixed;bottom:48px;left:16px;max-width:384px;z-index:1250;display:flex;justify-content:space-between;align-items:center;font-size:13px;line-height:16px;color:#e2e2e2;background:#333;text-align:left;border-radius:3px;box-shadow:0 3px 5px -1px rgba(0,0,0,.2),0 6px 10px 0 rgba(0,0,0,.14),0 1px 18px 0 rgba(0,0,0,.12);visibility:hidden;transform-origin:center;transform:scale(0.8,0.8) translate(0,100%);}.gs_el_ph #gs_alrt{bottom:0;left:0;width:100%;max-width:none;border-radius:0;box-shadow:none;transform:scale(1,1) translate(0,100%);}#gs_alrt.gs_vis{visibility:visible;transform:scale(1,1) translate(0,0);}#gs_alrt.gs_anm{transition:transform .067s cubic-bezier(.4,0,1,1),visibility 0s .067s;}#gs_alrt.gs_vis.gs_anm{transition:transform .067s cubic-bezier(0,0,.2,1);}.gs_el_ph #gs_alrt.gs_anm{transition:transform .084s cubic-bezier(.4,0,1,1),visibility 0s .084s;}.gs_el_ph #gs_alrt.gs_vis.gs_anm{transition:transform .1s cubic-bezier(0,0,.2,1);}#gs_alrt_m{display:block;padding:16px;}#gs_alrt_l{display:block;padding:8px;margin:0 8px 0 -8px;border-radius:3px;color:#fcc934;text-transform:uppercase;text-decoration:none;}#gs_alrt_l:hover{background-color:rgba(255,255,255,.05)}#gs_alrt_l:active{background-color:rgba(255,255,255,.1)}#gs_alrt_l:empty{display:none}#gs_alrt_m a{padding:8px 0;color:#e2e2e2;text-decoration:underline;}#gs_alrt_m a:active{color:#f6aea9}</style><form action="" method="post" id="gs_alrt"><span id="gs_alrt_m"></span><span id="gs_alrt_h"></span><a id="gs_alrt_l" href="javascript:void(0)" class="gs_fm_s" data-fm="gs_alrt"></a></form><div id="gs_bdy"><div id="gs_bdy_sb" role="navigation"><div id="gs_bdy_sb_in"></div></div><div id="gs_bdy_ccl" role="main"><div id="gsc_bdy" class="gs_scl" data-tab="gsc_prf_t-art"><div class="gsc_rsb" role="navigation"><a id="gsc_rsb_gpl" class="gsc_rsb_s" href="/citations?hl=en">Get my own profile</a><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_cit" role="region" aria-labelledby="gsc_prf_t-cit"><h3 class="gsc_rsb_header"><span class="gsc_rsb_title">Cited by</span><button type="button" id="gsc_hist_opn" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu gsc_rsb_action"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></h3><table id="gsc_rsb_st"><thead><tr><th class="gsc_rsb_sth"></th><th class="gsc_rsb_sth">All</th><th class="gsc_rsb_sth">Since 2016</th></tr></thead><tbody><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="This is the number of citations to all publications. The second column has the &quot;recent&quot; version of this metric which is the number of new citations in the last 5 years to all publications.">Citations</a></td><td class="gsc_rsb_std">9394</td><td class="gsc_rsb_std">4274</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="h-index is the largest number h such that h publications have at least h citations. The second column has the &quot;recent&quot; version of this metric which is the largest number h such that h publications have at least h new citations in the last 5 years.">h-index</a></td><td class="gsc_rsb_std">53</td><td class="gsc_rsb_std">36</td></tr><tr><td class="gsc_rsb_sc1"><a href="javascript:void(0)" class="gsc_rsb_f gs_ibl" title="i10-index is the number of publications with at least 10 citations. The second column has the &quot;recent&quot; version of this metric which is the number of publications that have received at least 10 new citations in the last 5 years.">i10-index</a></td><td class="gsc_rsb_std">142</td><td class="gsc_rsb_std">83</td></tr></tbody></table><style>.gsc_g_t{position:absolute;bottom:0;color:#777;font-size:11px;}.gsc_g_a{position:absolute;bottom:13px;width:15px;background:#777;}.gsc_g_a:hover,.gsc_g_a:focus,.gsc_g_a:active{text-decoration:none;cursor:default;}.gsc_g_al{position:absolute;bottom:15px;left:7px;color:#222;background:white;font-size:11px;padding:1px;border:1px solid #777;border-radius:1px;visibility:hidden;opacity:0;transition:opacity .218s,visibility 0s .218s;}.gsc_g_a:hover .gsc_g_al,.gsc_g_a:focus .gsc_g_al,.gsc_g_a:active .gsc_g_al{visibility:visible;opacity:1;transition:all 0s;}#gsc_md_hist{max-width:1026px;}.gsc_md_hist_w{position:relative;overflow:hidden;margin-right:43px;}.gs_md_bdy .gsc_md_hist_w,.gs_el_ph .gsc_md_hist_w,.gs_el_ta .gsc_md_hist_w{overflow-x:auto;padding-bottom:16px;}.gsc_md_hist_b{position:relative;height:174px;width:100%;}.gsc_md_hist_b .gsc_g_a{bottom:auto;}.gsc_md_hist_b .gsc_g_t{bottom:auto;top:161px;}.gsc_md_hist_b:after{position:absolute;right:984px;content:"\00A0";}.gsc_g_hist_x{position:relative;margin-right:45px;}.gsc_g_hist_xl{position:absolute;right:8px;width:35px;}.gs_el_ta .gsc_g_hist_xl,.gs_el_ph .gsc_g_hist_xl{right:16px;}.gsc_g_hist_wrp{padding-top:32px;position:relative;}.gs_el_ta .gsc_g_hist_wrp,.gs_el_ph .gsc_g_hist_wrp{padding-right:8px;}.gs_md_bdy .gsc_g_hist_wrp{border-top:0;}.gs_el_tc .gs_md_bdy .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ph .gsc_g_hist_wrp:after,.gs_el_tc.gs_el_ta .gsc_g_hist_wrp:after{display:block;content:"";position:absolute;z-index:100;top:0;left:0;width:20px;height:100%;background-image:linear-gradient(to left,rgba(255,255,255,0),rgba(255,255,255,1) 80%);}.gsc_g_x,.gsc_g_xt{position:absolute;left:0;border-bottom:1px solid #eee;width:100%;text-align:right;}.gsc_g_x{border-bottom:1px solid #eee;}.gsc_g_xtl{position:absolute;color:#777;}.gsc_g_gtr{position:absolute;}.gsc_g_a:last-child .gsc_g_al{right:0;left:auto;}</style><div class="gsc_g_hist_wrp" dir="rtl"><div class="gsc_g_hist_x"><div class="gsc_g_x" style="top:160px;"></div><div class="gsc_g_xt" style="top:0px;"></div><div class="gsc_g_xt" style="top:80px;"></div><div class="gsc_g_xt" style="top:120px;"></div><div class="gsc_g_xt" style="top:40px;"></div></div><div class="gsc_g_hist_xl"><div class="gsc_g_xtl" style="top:153px;">0</div><div class="gsc_g_xtl" style="top:-7px;">920</div><div class="gsc_g_xtl" style="top:73px;">460</div><div class="gsc_g_xtl" style="top:113px;">230</div><div class="gsc_g_xtl" style="top:33px;">690</div></div><div class="gsc_md_hist_w"><div class="gsc_md_hist_b"><span class="gsc_g_t" style="right:931px">1992</span><span class="gsc_g_t" style="right:899px">1993</span><span class="gsc_g_t" style="right:867px">1994</span><span class="gsc_g_t" style="right:835px">1995</span><span class="gsc_g_t" style="right:803px">1996</span><span class="gsc_g_t" style="right:771px">1997</span><span class="gsc_g_t" style="right:739px">1998</span><span class="gsc_g_t" style="right:707px">1999</span><span class="gsc_g_t" style="right:675px">2000</span><span class="gsc_g_t" style="right:643px">2001</span><span class="gsc_g_t" style="right:611px">2002</span><span class="gsc_g_t" style="right:579px">2003</span><span class="gsc_g_t" style="right:547px">2004</span><span class="gsc_g_t" style="right:515px">2005</span><span class="gsc_g_t" style="right:483px">2006</span><span class="gsc_g_t" style="right:451px">2007</span><span class="gsc_g_t" style="right:419px">2008</span><span class="gsc_g_t" style="right:387px">2009</span><span class="gsc_g_t" style="right:355px">2010</span><span class="gsc_g_t" style="right:323px">2011</span><span class="gsc_g_t" style="right:291px">2012</span><span class="gsc_g_t" style="right:259px">2013</span><span class="gsc_g_t" style="right:227px">2014</span><span class="gsc_g_t" style="right:195px">2015</span><span class="gsc_g_t" style="right:163px">2016</span><span class="gsc_g_t" style="right:131px">2017</span><span class="gsc_g_t" style="right:99px">2018</span><span class="gsc_g_t" style="right:67px">2019</span><span class="gsc_g_t" style="right:35px">2020</span><span class="gsc_g_t" style="right:3px">2021</span><a href="javascript:void(0)" class="gsc_g_a" style="right:936px;top:155px;height:5px;z-index:30"><span class="gsc_g_al">33</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:904px;top:156px;height:4px;z-index:29"><span class="gsc_g_al">23</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:872px;top:156px;height:4px;z-index:28"><span class="gsc_g_al">27</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:840px;top:157px;height:3px;z-index:27"><span class="gsc_g_al">21</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:808px;top:151px;height:9px;z-index:26"><span class="gsc_g_al">52</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:776px;top:151px;height:9px;z-index:25"><span class="gsc_g_al">53</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:744px;top:147px;height:13px;z-index:24"><span class="gsc_g_al">75</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:712px;top:147px;height:13px;z-index:23"><span class="gsc_g_al">75</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:680px;top:144px;height:16px;z-index:22"><span class="gsc_g_al">93</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:648px;top:134px;height:26px;z-index:21"><span class="gsc_g_al">153</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:616px;top:130px;height:30px;z-index:20"><span class="gsc_g_al">176</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:584px;top:125px;height:35px;z-index:19"><span class="gsc_g_al">203</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:552px;top:120px;height:40px;z-index:18"><span class="gsc_g_al">231</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:520px;top:116px;height:44px;z-index:17"><span class="gsc_g_al">254</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:488px;top:116px;height:44px;z-index:16"><span class="gsc_g_al">257</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:456px;top:113px;height:47px;z-index:15"><span class="gsc_g_al">272</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:424px;top:103px;height:57px;z-index:14"><span class="gsc_g_al">329</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:392px;top:110px;height:50px;z-index:13"><span class="gsc_g_al">293</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:360px;top:101px;height:59px;z-index:12"><span class="gsc_g_al">340</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:328px;top:103px;height:57px;z-index:11"><span class="gsc_g_al">333</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:296px;top:97px;height:63px;z-index:10"><span class="gsc_g_al">363</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:264px;top:92px;height:68px;z-index:9"><span class="gsc_g_al">394</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:232px;top:93px;height:67px;z-index:8"><span class="gsc_g_al">387</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:200px;top:80px;height:80px;z-index:7"><span class="gsc_g_al">462</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:168px;top:59px;height:101px;z-index:6"><span class="gsc_g_al">585</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:136px;top:54px;height:106px;z-index:5"><span class="gsc_g_al">610</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:104px;top:41px;height:119px;z-index:4"><span class="gsc_g_al">689</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:72px;top:28px;height:132px;z-index:3"><span class="gsc_g_al">760</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:40px;top:2px;height:158px;z-index:2"><span class="gsc_g_al">910</span></a><a href="javascript:void(0)" class="gsc_g_a" style="right:8px;top:41px;height:119px;z-index:1"><span class="gsc_g_al">687</span></a></div></div></div></div><div class="gsc_rsb_s gsc_prf_pnl" id="gsc_rsb_mnd" role="region" aria-labelledby="gsc_prf_t-mnd"><div class="gsc_rsb_header gsc_rsb_m_header"><div class="gsc_rsb_m_title">Public access</div><a href="/citations?view_op=list_mandates&amp;hl=en&amp;user=B_fNeq0AAAAJ" id="gsc_lwp_mndt_lnk">View all</a></div><div class="gsc_rsb_hm gs_ota gs_oph"><button type="button" onclick="window.location='/citations?view_op\x3dlist_mandates\x26hl\x3den\x26user\x3dB_fNeq0AAAAJ'" class=" gs_btn_flat gs_btn_flact gs_btn_lrge gs_btn_half gs_btn_lsu"><span class="gs_wr"><span class="gs_lbl">View all</span></span></button></div><div class="gsc_rsb_m"><div class="gsc_rsb_m_a"><span>12 articles</span></div><div class="gsc_rsb_m_na"><div class="gs_gray">0 articles</div></div><div class="gsc_rsb_m_bar"><div class="gsc_rsb_m_bar_na" style="width:0%"></div></div><div class="gsc_rsb_m_a"><span>available</span></div><div class="gsc_rsb_m_na"><span class="gs_gray">not available</span></div><div class="gsc_rsb_m_desc">Based on funding mandates</div></div></div></div><div class="gsc_lcl" role="main" id="gsc_prf_w"><div id="gsc_prf"><button type="button" id="gsc_prf_btnf" class="gs_btnMW gs_in_ib gs_btn_act gs_btn_lsu gs_btn_mph"><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Follow</span></span></button><div id="gsc_prf_pu"><div id="gsc_prf_pua" class="gs_rimg"><style>#gsc_prf_pup-img{width:128px;height:128px;}@media print{#gs_top #gsc_prf_pup-img{width:80pt;height:80pt;}}</style><img alt="ANTONIO PAGLIUCA" sizes="print 80px,128px" src="/citations/images/avatar_scholar_128.png" id="gsc_prf_pup-img" srcset="/citations/images/avatar_scholar_128.png 128w,/citations/images/avatar_scholar_256.png 256w"></div></div><div id="gsc_prf_i"><div id="gsc_prf_in">ANTONIO PAGLIUCA</div><div class="gsc_prf_il">Professor of Haematology</div><div class="gsc_prf_il" id="gsc_prf_ivh">Verified email at kcl.ac.uk</div><div class="gsc_prf_il" id="gsc_prf_int"><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:stem_cell_transplantation" class="gsc_prf_inta gs_ibl">Stem Cell Transplantation</a><a href="/citations?view_op=search_authors&amp;hl=en&amp;mauthors=label:cellular_therapy" class="gsc_prf_inta gs_ibl">Cellular therapy</a></div></div></div></div><div id="gsc_prf_t_wrp" role="navigation"><div id="gsc_prf_t" role="tablist"><a id="gsc_prf_t-art" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_art" aria-selected="true">Articles</a><a id="gsc_prf_t-cit" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_cit">Cited by</a><a id="gsc_prf_t-mnd" class="gsc_prf_tab" href="javascript:void(0)" role="tab" aria-controls="gsc_rsb_mnd">Public access</a></div></div><div class="gsc_lcl gsc_prf_pnl" id="gsc_art" role="region" aria-labelledby="gsc_prf_t-art"><form method="post" action="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works"><input type="hidden" name="xsrf" value="AMD79ooAAAAAYT84Z4lsODWjQWRXWa8myPgqsL7N11rR"><div id="gsc_a_tw"><table id="gsc_a_t"><thead><tr id="gsc_a_tr0" aria-hidden="true"><th class="gsc_a_t"></th><th class="gsc_a_c"></th><th class="gsc_a_y"></th></tr><tr id="gsc_a_trh"><th class="gsc_a_t" scope="col"><span id="gsc_a_ta"><a href="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works&amp;sortby=title" class="gsc_a_a">Title</a></span><div id="gsc_dd_sort-r" class="gs_md_r gs_md_rmb gs_md_rmbl"><button type="button" id="gsc_dd_sort-b" aria-controls="gsc_dd_sort-d" aria-haspopup="true" ontouchstart="gs_evt_dsp(event)" class=" gs_in_se gs_btn_mnu gs_btn_flat gs_btn_lrge gs_btn_half gs_btn_lsu gs_press gs_md_tb"><span class="gs_wr"><span class="gs_lbl">Sort</span><span class="gs_icm"></span></span></button><div id="gsc_dd_sort-d" class="gs_md_d gs_md_ulr" role="menu" tabindex="-1"><div id="gsc_dd_sort-s" class="gs_oph gsc_dd_sec gsc_dd_sep"><a role="menuitem" href="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works" tabindex="-1" class="gs_md_li gsc_dd_sort-sel">Sort by citations</a><a role="menuitem" href="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works&amp;sortby=pubdate" tabindex="-1" class="gs_md_li">Sort by year</a><a role="menuitem" href="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works&amp;sortby=title" tabindex="-1" class="gs_md_li">Sort by title</a></div></div></div></th><th class="gsc_a_c" scope="col" dir="rtl"><span id="gsc_a_ca"><div class="gs_nph">Cited by</div><div class="gs_oph">Cited by</div></span></th><th class="gsc_a_y" scope="col"><span class="gsc_a_h" id="gsc_a_ha"><a href="/citations?hl=en&amp;user=B_fNeq0AAAAJ&amp;view_op=list_works&amp;sortby=pubdate" class="gsc_a_a">Year</a></span></th></tr></thead><tbody id="gsc_a_b"><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:p__nRnzSRKYC" class="gsc_a_at">The role of apoptosis, proliferation, and the Bcl-2–related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS</a><div class="gs_gray">JE Parker, GJ Mufti, F Rasool, A Mijovic, S Devereux, A Pagliuca</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 96 (12), 3932-3938<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8075687489354074157" class="gsc_a_ac gs_ibl">422</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:J_g5lzvAfSwC" class="gsc_a_at">Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd–Chiari syndrome</a><div class="gs_gray">RK Patel, NC Lea, MA Heneghan, NB Westwood, D Milojkovic, ...</div><div class="gs_gray">Gastroenterology 130 (7), 2031-2038<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3274392030270170358" class="gsc_a_ac gs_ibl">305</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:TFP_iSt0sucC" class="gsc_a_at">Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood&nbsp;…</a><div class="gs_gray">M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...</div><div class="gs_gray">Bone marrow transplantation 51 (7), 906-912<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2812951843252843879" class="gsc_a_ac gs_ibl">249</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:48xauSegjOkC" class="gsc_a_at">Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation</a><div class="gs_gray">DI Marks, A Pagliuca, CC Kibbler, A Glasmacher, CP Heussel, M Kantecki, ...</div><div class="gs_gray">British journal of haematology 155 (3), 318-327<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13791731905836606810" class="gsc_a_ac gs_ibl">247</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:abG-DnoFyZgC" class="gsc_a_at">Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine&nbsp;…</a><div class="gs_gray">AYL Ho, A Pagliuca, M Kenyon, JE Parker, A Mijovic, S Devereux, ...</div><div class="gs_gray">Blood 104 (6), 1616-1623<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4585457276683597302" class="gsc_a_ac gs_ibl">240</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:_5tno0g5mFcC" class="gsc_a_at">BCSH/BSBMT guideline: diagnosis and management of veno‐occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation</a><div class="gs_gray">FL Dignan, RF Wynn, N Hadzic, J Karani, A Quaglia, A Pagliuca, P Veys, ...</div><div class="gs_gray">British journal of haematology 163 (4), 444-457<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11140666861536453754" class="gsc_a_ac gs_ibl">232</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:ILKRHgRFtOwC" class="gsc_a_at">BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients</a><div class="gs_gray">RD Faulkner, C Craddock, JL Byrne, P Mahendra, AP Haynes, ...</div><div class="gs_gray">Blood 103 (2), 428-434<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8136321362732348722" class="gsc_a_ac gs_ibl">205</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:ML0RJ9NH7IQC" class="gsc_a_at">Nonmyeloablative stem cell transplantation for congenital immunodeficiencies</a><div class="gs_gray">P Amrolia, HB Gaspar, A Hassan, D Webb, A Jones, N Sturt, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 96 (4), 1239-1246<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8064520978668535090" class="gsc_a_ac gs_ibl">183</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:j8SEvjWlNXcC" class="gsc_a_at">Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia</a><div class="gs_gray">JC Marsh, V Gupta, ZY Lim, AY Ho, RM Ireland, J Hayden, V Potter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (8), 2351-2357<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7233777959754632557" class="gsc_a_ac gs_ibl">167</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:Hck25ST_3aIC" class="gsc_a_at">'Low-risk'myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro-versus anti-apoptotic bcl-2-related proteins.</a><div class="gs_gray">JE Parker, KL Fishlock, A Mijovic, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">British journal of haematology 103 (4), 1075-1082<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18146763850885955990" class="gsc_a_ac gs_ibl">156</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:eQOLeE2rZwMC" class="gsc_a_at">Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia</a><div class="gs_gray">JE Parker, A Pagliuca, A Mijovic, JO Cullis, B Czepulkowski, ...</div><div class="gs_gray">British journal of haematology 99 (4), 939-944<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=803135778142644409" class="gsc_a_ac gs_ibl">153</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:AvfA0Oy_GE0C" class="gsc_a_at">ECIL guidelines for the diagnosis of <i>Pneumocystis jirovecii</i> pneumonia in patients with haematological malignancies and stem cell transplant recipients</a><div class="gs_gray">A Alanio, PM Hauser, K Lagrou, WJG Melchers, J Helweg-Larsen, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 71 (9), 2386-2396<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7826903878102515979" class="gsc_a_ac gs_ibl">151</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:HoB7MX3m0LUC" class="gsc_a_at">Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab</a><div class="gs_gray">AGS Buggins, GJ Mufti, J Salisbury, J Codd, N Westwood, M Arno, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 100 (5), 1715-1720<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4005707235138332275" class="gsc_a_ac gs_ibl">150</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:65Yg0jNCQDAC" class="gsc_a_at">Retrospective comparison of bone marrow and granulocyte colony-stimulating factor–mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA&nbsp;…</a><div class="gs_gray">P Guardiola, V Runde, A Bacigalupo, T Ruutu, F Locatelli, MA Boogaerts, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 99 (12), 4370-4378<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18116023627878923594" class="gsc_a_ac gs_ibl">150</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:tkaPQYYpVKoC" class="gsc_a_at">ECIL guidelines for preventing <i>Pneumocystis jirovecii</i> pneumonia in patients with haematological malignancies and stem cell transplant recipients</a><div class="gs_gray">J Maertens, S Cesaro, G Maschmeyer, H Einsele, JP Donnelly, A Alanio, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 71 (9), 2397-2404<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6238720967371262708" class="gsc_a_ac gs_ibl">149</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:dshw04ExmUIC" class="gsc_a_at">Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and&nbsp;…</a><div class="gs_gray">S Corbacioglu, E Carreras, M Ansari, A Balduzzi, S Cesaro, JH Dalle, ...</div><div class="gs_gray">Bone marrow transplantation 53 (2), 138-145<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4836305543881370370" class="gsc_a_ac gs_ibl">144</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:GnPB-g6toBAC" class="gsc_a_at">Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002</a><div class="gs_gray">AR Gennery, K Khawaja, P Veys, RGM Bredius, LD Notarangelo, ...</div><div class="gs_gray">Blood 103 (3), 1152-1157<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3145177382649513272" class="gsc_a_ac gs_ibl">143</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:yFnVuubrUp4C" class="gsc_a_at">Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning</a><div class="gs_gray">K Raj, A Pagliuca, K Bradstock, V Noriega, V Potter, M Streetly, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 20 (6), 890-895<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11946404875754696621" class="gsc_a_ac gs_ibl">132</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:fbc8zXXH2BUC" class="gsc_a_at">Liver transplantation for Budd-Chiari syndrome</a><div class="gs_gray">P Srinivasan, M Rela, A Prachalias, P Muiesan, B Portmann, GJ Mufti, ...</div><div class="gs_gray">Transplantation 73 (6), 973-977<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12886085708451887514" class="gsc_a_ac gs_ibl">129</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;citation_for_view=B_fNeq0AAAAJ:QYdC8u9Cj1oC" class="gsc_a_at">Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis with prior exposure to Janus kinase 1/2 inhibitors</a><div class="gs_gray">M Shanavas, U Popat, LC Michaelis, V Fauble, D McLornan, R Klisovic, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (3), 432-440<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11483425714375889868" class="gsc_a_ac gs_ibl">119</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:e_rmSamDkqQC" class="gsc_a_at">Allogeneic peripheral blood stem cell transplantation for haematological malignancies–an analysis of kinetics of engraftment and GVHD risk</a><div class="gs_gray">G Miflin, NH Russell, RM Hutchinson, G Morgan, M Potter, A Pagliuca, ...</div><div class="gs_gray">Bone marrow transplantation 19 (1), 9-13<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9265263305902419156" class="gsc_a_ac gs_ibl">115</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:Ug5p-4gJ2f0C" class="gsc_a_at">Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia</a><div class="gs_gray">J Clay, AG Kulasekararaj, V Potter, F Grimaldi, D McLornan, K Raj, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 20 (11), 1711-1716<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9857396719966440283" class="gsc_a_ac gs_ibl">112</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:tH6gc1N1XXoC" class="gsc_a_at">Interferon α and zidovudine therapy in adult T‐cell leukaemia lymphoma: response and outcome in 15 patients</a><div class="gs_gray">E Matutes, GP Taylor, J Cavenagh, A Pagliuca, D Bareford, A Domingo, ...</div><div class="gs_gray">British journal of haematology 113 (3), 779-784<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13194434947884578368" class="gsc_a_ac gs_ibl">112</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:nZcligLrVowC" class="gsc_a_at">Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.</a><div class="gs_gray">K Tobal, A Pagliuca, B Bhatt, N Bailey, DM Layton, GJ Mufti</div><div class="gs_gray">Leukemia 4 (7), 486-489<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12513900932607592381" class="gsc_a_ac gs_ibl">110</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:_kc_bZDykSQC" class="gsc_a_at">Correction of the hyper-IgM syndrome after liver and bone marrow transplantation</a><div class="gs_gray">N Hadžić, A Pagliuca, M Rela, B Portmann, A Jones, P Veys, ND Heaton, ...</div><div class="gs_gray">New England Journal of Medicine 342 (5), 320-324<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1482498526306622098" class="gsc_a_ac gs_ibl">107</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:owLR8QvbtFgC" class="gsc_a_at">Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant</a><div class="gs_gray">BE Shaw, GJ Mufti, S Mackinnon, JD Cavenagh, RM Pearce, KE Towlson, ...</div><div class="gs_gray">Bone marrow transplantation 42 (12), 783-789<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14786900869642404912" class="gsc_a_ac gs_ibl">106</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:WAzi4Gm8nLoC" class="gsc_a_at">Myelofibrosis in primary myelodysplastic syndromes: a clinico‐morphological study of 10 cases</a><div class="gs_gray">A Pagliuca, DM Layton, A Manoharan, S Gordon, PJ Green, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 71 (4), 499-504<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16932575369762421915" class="gsc_a_ac gs_ibl">106</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:ziOE8S1-AIUC" class="gsc_a_at">Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced‐intensity conditioning compared with standard preparative&nbsp;…</a><div class="gs_gray">JE Parker, T Shafi, A Pagliuca, A Mijovic, S Devereux, M Potter, ...</div><div class="gs_gray">British journal of haematology 119 (1), 144-154<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16750576901029621779" class="gsc_a_ac gs_ibl">104</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:SjuI4pbJlxcC" class="gsc_a_at">Quality rather than quantity: the cord blood bank dilemma</a><div class="gs_gray">S Querol, SG Gomez, A Pagliuca, M Torrabadella, JA Madrigal</div><div class="gs_gray">Bone Marrow Transplantation 45 (6), 970-978<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15420240974297774680" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:anf4URPfarAC" class="gsc_a_at">Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles</a><div class="gs_gray">BE Shaw, NP Mayor, NH Russell, JF Apperley, RE Clark, J Cornish, ...</div><div class="gs_gray">Leukemia 24 (1), 58-65<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10691999998391141119" class="gsc_a_ac gs_ibl">101</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:rbm3iO8VlycC" class="gsc_a_at">ECIL guidelines for treatment of <i>Pneumocystis jirovecii</i> pneumonia in non-HIV-infected haematology patients</a><div class="gs_gray">G Maschmeyer, J Helweg-Larsen, L Pagano, C Robin, C Cordonnier, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 71 (9), 2405-2413<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17921906313331560687" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:UmS_249rOGwC" class="gsc_a_at">Management of cytomegalovirus infection in haemopoietic stem cell transplantation</a><div class="gs_gray">V Emery, M Zuckerman, G Jackson, C Aitken, H Osman, A Pagliuca, ...</div><div class="gs_gray">British journal of haematology 162 (1), 25-39<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14030083276063945517" class="gsc_a_ac gs_ibl">88</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:F1b5ZUV5XREC" class="gsc_a_at">Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.</a><div class="gs_gray">A Pagliuca, GJ Mufti, D Baldwin, AN Lestas, RM Wallis, AJ Bellingham</div><div class="gs_gray">Journal of clinical pathology 43 (4), 277-281<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13355722909404230026" class="gsc_a_ac gs_ibl">87</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:kh2fBNsKQNwC" class="gsc_a_at"><i>Pneumocystis jirovecii</i> pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients</a><div class="gs_gray">C Cordonnier, S Cesaro, G Maschmeyer, H Einsele, JP Donnelly, ...</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 71 (9), 2379-2385<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10398199334439340406" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:-mN3Mh-tlDkC" class="gsc_a_at">Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?</a><div class="gs_gray">S Querol, GJ Mufti, SGE Marsh, A Pagliuca, AM Little, BE Shaw, R Jeffery, ...</div><div class="gs_gray">haematologica 94 (4), 536<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15106173907100402491" class="gsc_a_ac gs_ibl">86</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:4X0JR2_MtJMC" class="gsc_a_at">Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning&nbsp;…</a><div class="gs_gray">ZY Lim, V Fiaccadori, S Gandhi, J Hayden, M Kenyon, R Ireland, J Marsh, ...</div><div class="gs_gray">Leukemia research 34 (6), 723-727<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13451925016267501346" class="gsc_a_ac gs_ibl">84</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:Mojj43d5GZwC" class="gsc_a_at">Primary myelodysplastic syndrome in children: the clinical experience in 33 cases</a><div class="gs_gray">MA Tuncer, A Pagliuca, G Hicsonmez, S Yetgin, S Ozsoylu, GJ Mufti</div><div class="gs_gray">British journal of haematology 82 (2), 347-353<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6192709558572009668" class="gsc_a_ac gs_ibl">83</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:Ak0FvsSvgGUC" class="gsc_a_at">Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines</a><div class="gs_gray">M Mikulska, D Averbuch, F Tissot, C Cordonnier, M Akova, T Calandra, ...</div><div class="gs_gray">Journal of Infection 76 (1), 20-37<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13308290180207274075" class="gsc_a_ac gs_ibl">80</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:oi2SiIJ9l4AC" class="gsc_a_at">Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection&nbsp;…</a><div class="gs_gray">R Hough, R Danby, N Russell, D Marks, P Veys, B Shaw, R Wynn, A Vora, ...</div><div class="gs_gray">British journal of haematology 172 (3), 360-370<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16627048650203724024" class="gsc_a_ac gs_ibl">78</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:HtEfBTGE9r8C" class="gsc_a_at">Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study&nbsp;…</a><div class="gs_gray">JC Marsh, RM Pearce, MBC Koh, Z Lim, A Pagliuca, GJ Mufti, J Perry, ...</div><div class="gs_gray">Bone marrow transplantation 49 (1), 42-48<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10724695112631765047" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:sSrBHYA8nusC" class="gsc_a_at">Outcome of donor lymphocyte infusion after T cell–depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes</a><div class="gs_gray">P Krishnamurthy, VT Potter, LD Barber, AG Kulasekararaj, ZY Lim, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 19 (4), 562-568<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5458275841040457921" class="gsc_a_ac gs_ibl">72</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:mVmsd5A6BfQC" class="gsc_a_at">Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma</a><div class="gs_gray">A Hodson, S Crichton, S Montoto, N Mir, E Matutes, K Cwynarski, ...</div><div class="gs_gray">Journal of clinical oncology 29 (35), 4696-4701<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5007255188046527367" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:u_35RYKgDlwC" class="gsc_a_at"><i>In Vitro</i> Colony Culture and Chromosomal Studies in Hepatic and Portal Vein Thrombosis—Possible Evidence of an Occult Myeloproliferative State</a><div class="gs_gray">A Pagliuca, GJ Mufti, M Janossa-Tahernia, S Eridani, NB Westwood, ...</div><div class="gs_gray">QJM: An International Journal of Medicine 76 (3), 981-989<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4132145351123940838" class="gsc_a_ac gs_ibl">71</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:raTqNPD5sRQC" class="gsc_a_at">Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies</a><div class="gs_gray">AGS Buggins, WJR Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">British journal of haematology 100 (4), 784-792<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16891512756815714732" class="gsc_a_ac gs_ibl">69</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:3s1wT3WcHBgC" class="gsc_a_at">Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD</a><div class="gs_gray">FL Dignan, D Greenblatt, M Cox, J Cavenagh, H Oakervee, JF Apperley, ...</div><div class="gs_gray">Bone marrow transplantation 47 (6), 824-830<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4068919386362977430" class="gsc_a_ac gs_ibl">68</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:YsrPvlHIBpEC" class="gsc_a_at">Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen–UV-A therapy</a><div class="gs_gray">D Creamer, CL Martyn-Simmons, G Osborne, M Kenyon, JR Salisbury, ...</div><div class="gs_gray">Archives of dermatology 143 (9), 1157-1162<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16751806824225002404" class="gsc_a_ac gs_ibl">66</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:F2UWTTQJPOcC" class="gsc_a_at">Outcome of BEAM‐autologous and BEAM‐alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma</a><div class="gs_gray">W Ingram, S Devereux, EP Das‐Gupta, NH Russell, AP Haynes, JL Byrne, ...</div><div class="gs_gray">British journal of haematology 141 (2), 235-243<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16581683866111832752" class="gsc_a_ac gs_ibl">64</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:2VqYfGB8ITEC" class="gsc_a_at">Impact of ATG-containing reduced-intensity conditioning after single-or double-unit allogeneic cord blood transplantation</a><div class="gs_gray">L Pascal, L Tucunduva, A Ruggeri, D Blaise, P Ceballos, P Chevallier, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (8), 1027-1032<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11156657302906533799" class="gsc_a_ac gs_ibl">62</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:2KloaMYe4IUC" class="gsc_a_at">Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College Hospital</a><div class="gs_gray">M Wang, W Wang, A Abeywardane, M Adikarama, D McLornan, K Raj, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 21 (1), 60-66<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7074453647806359270" class="gsc_a_ac gs_ibl">60</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:foquWX3nUaYC" class="gsc_a_at">Recipients receiving better HLA-matched hematopoietic cell transplantation grafts, uncovered by a novel HLA typing method, have superior survival: a retrospective study</a><div class="gs_gray">NP Mayor, JD Hayhurst, TR Turner, RM Szydlo, BE Shaw, WP Bultitude, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 25 (3), 443-450<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9643926778415471402" class="gsc_a_ac gs_ibl">59</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:jU7OWUQzBzMC" class="gsc_a_at">Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience</a><div class="gs_gray">P Krishnamurthy, ZY Lim, W Nagi, M Kenyon, A Mijovic, R Ireland, ...</div><div class="gs_gray">Bone marrow transplantation 45 (10), 1502-1507<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14968320017915093373" class="gsc_a_ac gs_ibl">57</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:xtoqd-5pKcoC" class="gsc_a_at">Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program</a><div class="gs_gray">S Corbacioglu, E Carreras, M Mohty, A Pagliuca, JJ Boelens, G Damaj, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (10), 1874-1882<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9607455665504777680" class="gsc_a_ac gs_ibl">56</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:6bLC7aUMtPcC" class="gsc_a_at">Lamivudine prophylaxis and treatment of hepatitis B Virus‐exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab</a><div class="gs_gray">SE Moses, ZY Lim, M Sudhanva, S Devereux, AYL Ho, A Pagliuca, ...</div><div class="gs_gray">Journal of medical virology 78 (12), 1560-1563<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15327086648497130870" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:M3ejUd6NZC8C" class="gsc_a_at">The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British&nbsp;…</a><div class="gs_gray">JM Bird, R Fuge, B Sirohi, JF Apperley, A Hunter, J Snowden, ...</div><div class="gs_gray">British journal of haematology 134 (4), 385-390<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1586237658104154956" class="gsc_a_ac gs_ibl">53</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:IUKN3-7HHlwC" class="gsc_a_at">A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent</a><div class="gs_gray">JJ Scarisbrick, FL Dignan, S Tulpule, ED Gupta, S Kolade, B Shaw, ...</div><div class="gs_gray">Bone marrow transplantation 50 (1), 62-67<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11325210524069732959" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:w1MjKQ0l0TYC" class="gsc_a_at">Sclerodermatous graft‐versus‐host disease: clinical spectrum and therapeutic challenges</a><div class="gs_gray">JML White, D Creamer, AWP Du Vivier, A Pagliuca, AY Ho, S Devereux, ...</div><div class="gs_gray">British Journal of Dermatology 156 (5), 1032-1038<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16618232942394156462" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:artPoR2Yc-kC" class="gsc_a_at">Outcomes of alemtuzumab‐based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromes</a><div class="gs_gray">ZY Lim, AYL Ho, W Ingram, M Kenyon, L Pearce, B Czepulkowski, ...</div><div class="gs_gray">British journal of haematology 135 (2), 201-209<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13220997647288620598" class="gsc_a_ac gs_ibl">52</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:1tZ8xJnm2c8C" class="gsc_a_at">British Society for Blood and Marrow Transplantation. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following&nbsp;…</a><div class="gs_gray">FL Dignan, RF Wynn, N Hadzic, J Karani, A Quaglia, A Pagliuca, P Veys, ...</div><div class="gs_gray">Br J Haematol 163 (4), 444-457<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12012606574671458556" class="gsc_a_ac gs_ibl">51</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:Xz60mAmATU4C" class="gsc_a_at">Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King’s College Hospital experience</a><div class="gs_gray">V Shah, T Ko Ko, M Zuckerman, J Vidler, S Sharif, V Mehra, S Gandhi, ...</div><div class="gs_gray">Br J Haematol 190 (5), e279-e282<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16596985191203584929" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:V3AGJWp-ZtQC" class="gsc_a_at">The Seville expert workshop for progress in posttransplant lymphoproliferative disorders</a><div class="gs_gray">D Glotz, JR Chapman, VR Dharnidharka, DW Hanto, MCR Castro, ...</div><div class="gs_gray">Transplantation 94 (8), 784-793<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5972739366541853984" class="gsc_a_ac gs_ibl">49</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:w0F2JDEymm0C" class="gsc_a_at">Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant&nbsp;…</a><div class="gs_gray">EJ Bow, DJ Vanness, M Slavin, C Cordonnier, OA Cornely, DI Marks, ...</div><div class="gs_gray">BMC infectious diseases 15 (1), 1-11<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16518497724317561482" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:bnK-pcrLprsC" class="gsc_a_at">A comprehensive diagnostic approach using galactomannan, targeted β‐<span class="gs_fscp">d</span>‐glucan, baseline computerized tomography and biopsy yields a significant burden of&nbsp;…</a><div class="gs_gray">MM Ceesay, SR Desai, L Berry, J Cleverley, CC Kibbler, S Pomplun, ...</div><div class="gs_gray">British journal of haematology 168 (2), 219-229<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6103263213014548815" class="gsc_a_ac gs_ibl">48</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:35r97b3x0nAC" class="gsc_a_at">Management of adult T‐cell leukaemia/lymphoma</a><div class="gs_gray">R Pawson, GJ Mufti, A Pagliuca</div><div class="gs_gray">British journal of haematology 100 (3), 453-458<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7130761418289616764" class="gsc_a_ac gs_ibl">47</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:SeFeTyx0c_EC" class="gsc_a_at">Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone</a><div class="gs_gray">K Ramasamy, Z Lim, A Pagliuca, GJ Mufti, S Devereux</div><div class="gs_gray">Haematologica 91 (8_Suppl), ECR44-ECR44<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4028785048331335253" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:5qfkUJPXOUwC" class="gsc_a_at">Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning–evidence for a superior outcome using melphalan&nbsp;…</a><div class="gs_gray">HM Hunter, K Peggs, R Powles, A Rahemtulla, P Mahendra, J Cavenagh, ...</div><div class="gs_gray">British journal of haematology 128 (4), 496-502<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10239679271468266688" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:mB3voiENLucC" class="gsc_a_at">Lead poisoning: an age old problem.</a><div class="gs_gray">A Pagliuca, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 300 (6728), 830<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2432027052483536861" class="gsc_a_ac gs_ibl">46</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:0EnyYjriUFMC" class="gsc_a_at">Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants</a><div class="gs_gray">BE Shaw, NP Mayor, RM Szydlo, WP Bultitude, C Anthias, K Kirkland, ...</div><div class="gs_gray">Bone marrow transplantation 52 (5), 717-725<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1097755992351841213" class="gsc_a_ac gs_ibl">45</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:_Ybze24A_UAC" class="gsc_a_at">Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML</a><div class="gs_gray">ZY Lim, W Ingram, R Brand, A Ho, M Kenyon, S Devereux, J Marsh, ...</div><div class="gs_gray">Bone marrow transplantation 45 (4), 633-639<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6816540831743592187" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:9pM33mqn1YgC" class="gsc_a_at">Delayed attainment of full donor chimaerism following alemtuzumab‐based reduced‐intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and&nbsp;…</a><div class="gs_gray">ZY Lim, L Pearce, AY Ho, L Barber, W Ingram, M Usai, K Tobal, ...</div><div class="gs_gray">British journal of haematology 138 (4), 517-526<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10419812596991457910" class="gsc_a_ac gs_ibl">44</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:roLk4NBRz8UC" class="gsc_a_at">Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity&nbsp;…</a><div class="gs_gray">K Matthews, ZY Lim, B Afzali, L Pearce, A Abdallah, S Kordasti, ...</div><div class="gs_gray">haematologica 94 (7), 956<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=985904607723915764" class="gsc_a_ac gs_ibl">43</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:dfsIfKJdRG4C" class="gsc_a_at">Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a&nbsp;…</a><div class="gs_gray">PV O'Donnell, M Eapen, MM Horowitz, BR Logan, A DiGilio, C Brunstein, ...</div><div class="gs_gray">Bone marrow transplantation 51 (12), 1599-1601<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4194827725623557969" class="gsc_a_ac gs_ibl">42</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:1yWc8FF-_SYC" class="gsc_a_at">Guidelines on the use of colony‐stimulating factors in haematological malignancies</a><div class="gs_gray">A Pagliuca, PA Carrington, R Pettengell, S Rule, J Keidan, ...</div><div class="gs_gray">British journal of haematology 123 (1), 22-33<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15180810544620580662" class="gsc_a_ac gs_ibl">41</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:LI9QrySNdTsC" class="gsc_a_at">A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia</a><div class="gs_gray">NH Russell, L Kjeldsen, C Craddock, A Pagliuca, JA Yin, RE Clark, ...</div><div class="gs_gray">Leukemia 29 (7), 1478-1484<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8832290850596264049" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:fFSKOagxvKUC" class="gsc_a_at">High fever occurring 4 to 5 days post-transplant of haploidentical bone marrow or peripheral blood stem cells after reduced-intensity conditioning associated with the use of&nbsp;…</a><div class="gs_gray">P O’Donnell, K Raj, A Pagliuca</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 21 (1), 197-198<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12119811606946355959" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:DrR-2ekChdkC" class="gsc_a_at">Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease</a><div class="gs_gray">ZY Lim, AYL Ho, S Abrahams, A Fensom, M Aldouri, A Pagliuca, C Shaw, ...</div><div class="gs_gray">Bone marrow transplantation 41 (9), 831-832<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17621925745984724048" class="gsc_a_ac gs_ibl">38</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:fQNAKQ3IYiAC" class="gsc_a_at">BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological&nbsp;…</a><div class="gs_gray">FL Dignan, A Clark, C Aitken, M Gilleece, V Jayakar, P Krishnamurthy, ...</div><div class="gs_gray">British journal of haematology 173 (3), 380-393<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5638880409125845544" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:PYBJJbyH-FwC" class="gsc_a_at">An automated method for the simultaneous measurement of azole antifungal drugs in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry</a><div class="gs_gray">L Couchman, SL Buckner, PE Morgan, MM Ceesay, A Pagliuca, ...</div><div class="gs_gray">Analytical and bioanalytical chemistry 404 (2), 513-523<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14773230374807034744" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:gVv57TyPmFsC" class="gsc_a_at">Bilateral adrenal lymphoma presenting as Addison's disease.</a><div class="gs_gray">A Pagliuca, DS Gillett, JR Salisbury, RN Basu, GJ Mufti</div><div class="gs_gray">Postgraduate medical journal 65 (767), 684-686<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13064329853212983329" class="gsc_a_ac gs_ibl">37</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:nVrZBo8bIpAC" class="gsc_a_at">Life-threatening motor neurotoxicity in association with bortezomib</a><div class="gs_gray">S Gupta, A Pagliuca, S Devereux, GJ Mufti, S Schey</div><div class="gs_gray">Haematologica 91 (7), 1001-1001<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12961724241735988546" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:9yKSN-GCB0IC" class="gsc_a_at">Acquired sideroblastic anaemia induced by a copper-chelating agent.</a><div class="gs_gray">AR Perry, A Pagliuca, EJ Fitzsimons, GJ Mufti, R Williams</div><div class="gs_gray">International journal of hematology 64 (1), 69-72<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=53724597812274281" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:Wp0gIr-vW9MC" class="gsc_a_at">Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant.</a><div class="gs_gray">A Pagliuca, DM Layton, S Allen, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 297 (6661), 1456<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1762949566907503332" class="gsc_a_ac gs_ibl">33</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:oNZyr7d5Mn4C" class="gsc_a_at">The prevalence of the activating <i>JAK</i>2 tyrosine kinase mutation in chronic porto‐splenomesenteric venous thrombosis</a><div class="gs_gray">DW Orr, RK Patel, NC Lea, RH Westbrook, JG O’GRADY, ND Heaton, ...</div><div class="gs_gray">Alimentary pharmacology &amp; therapeutics 31 (12), 1330-1336<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9131918602009900734" class="gsc_a_ac gs_ibl">32</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:DUooU5lO8OsC" class="gsc_a_at">Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia&nbsp;…</a><div class="gs_gray">VT Potter, P Krishnamurthy, LD Barber, ZY Lim, M Kenyon, RM Ireland, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 20 (1), 111-117<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11081898502911252280" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:jE2MZjpN3IcC" class="gsc_a_at">Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases</a><div class="gs_gray">R Pawson, DS Richardson, A Pagliuca, SM Kelsey, S Hoque, J Breuer, ...</div><div class="gs_gray">Leukemia &amp; lymphoma 31 (1-2), 177-185<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15697460921981710484" class="gsc_a_ac gs_ibl">31</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:4hFrxpcac9AC" class="gsc_a_at">Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data</a><div class="gs_gray">ZY Lim, A Pagliuca, S Simpson, S Cottam, M Ervine, AYL Ho, S Devereux, ...</div><div class="gs_gray">British journal of haematology 136 (3), 448-450<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10993363254963122082" class="gsc_a_ac gs_ibl">30</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:L8Ckcad2t8MC" class="gsc_a_at">Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: report of three cases and review of literature</a><div class="gs_gray">K Ramasamy, Z Lim, A Pagliuca, S Devereux, AY Ho, GJ Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 48 (2), 290-294<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2029837326721331316" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:M7yex6snE4oC" class="gsc_a_at">Incidence and management of hepatic venoocclusive disease in 237 patients undergoing reduced-intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT)</a><div class="gs_gray">K Ramasamy, ZY Lim, A Pagliuca, R Grundy, S Devereux, AYL Ho, ...</div><div class="gs_gray">Bone marrow transplantation 38 (12), 823-824<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9131874565518286484" class="gsc_a_ac gs_ibl">29</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:hSRAE-fF4OAC" class="gsc_a_at">Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies</a><div class="gs_gray">R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ...</div><div class="gs_gray">The Lancet 396 (10266), 1885-1894<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4680949699471310170" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:vDZJ-YLwNdEC" class="gsc_a_at">Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (±fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion</a><div class="gs_gray">RJ Lush, AP Haynes, JL Byrne, GM Cull, GI Carter, A Pagliuca, JE Parker, ...</div><div class="gs_gray">Cytotherapy 3 (3), 203-210<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13224095591295832366" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:ye4kPcJQO24C" class="gsc_a_at">HTLV-I screening in Britain</a><div class="gs_gray">A Pagliuca, R Pawson, GJ Mufti</div><div class="gs_gray">BMJ 311 (7016), 1313-1314<span class="gs_oph">, 1995</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6428314178286728415" class="gsc_a_ac gs_ibl">28</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1995</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:gKiMpY-AVTkC" class="gsc_a_at">Effect of low-level BCR-ABL1 kinase domain mutations identified by next-generation sequencing in patients with chronic myeloid leukaemia: a population-based study</a><div class="gs_gray">A Kizilors, E Crisà, N Lea, R Passera, S Mian, J Anwar, S Best, FE Nicolini, ...</div><div class="gs_gray">The Lancet Haematology 6 (5), e276-e284<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13179646252612602168" class="gsc_a_ac gs_ibl">27</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:VOx2b1Wkg3QC" class="gsc_a_at">Cancer immunotherapy with CAR-T cells–behold the future</a><div class="gs_gray">C Graham, R Hewitson, A Pagliuca, R Benjamin</div><div class="gs_gray">Clinical Medicine 18 (4), 324<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5646000774784039002" class="gsc_a_ac gs_ibl">26</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:uc_IGeMz5qoC" class="gsc_a_at">Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of adult haematology patients in the UK</a><div class="gs_gray">MM Ceesay, Z Sadique, R Harris, A Ehrlich, EJ Adams, A Pagliuca</div><div class="gs_gray">Journal of Antimicrobial Chemotherapy 70 (4), 1175-1181<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3924518548302231307" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:buQ7SEKw-1sC" class="gsc_a_at">Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA</a><div class="gs_gray">KW Douglas, AN Parker, PJ Hayden, A Rahemtulla, A D'addio, RM Lemoli, ...</div><div class="gs_gray">Bone marrow transplantation 47 (1), 18-23<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13748086331702113014" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:VL0QpB8kHFEC" class="gsc_a_at">Reduced-intensity rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation for follicular lymphoma is feasible and induces durable molecular remissions</a><div class="gs_gray">AYL Ho, S Devereux, GJ Mufti, A Pagliuca</div><div class="gs_gray">Bone marrow transplantation 31 (7), 551-557<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6459477777810266744" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:PVjk1bu6vJQC" class="gsc_a_at">Positron emission scanning with 18-FDG in the diagnosis of deep fungal infections.</a><div class="gs_gray">AY Ho, A Pagliuca, MN Maisey, GJ Mufti</div><div class="gs_gray">British journal of haematology 101 (2), 392-393<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10245177277072616053" class="gsc_a_ac gs_ibl">25</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:O3NaXMp0MMsC" class="gsc_a_at">Mixed T cell chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia using an alemtuzumab-containing regimen is shaped by persistence of&nbsp;…</a><div class="gs_gray">F Grimaldi, V Potter, P Perez-Abellan, JP Veluchamy, M Atif, R Grain, ...</div><div class="gs_gray">Biology of blood and marrow transplantation 23 (2), 293-299<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3171510110444395360" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:2osOgNQ5qMEC" class="gsc_a_at">Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD</a><div class="gs_gray">FL Dignan, S Aguilar, JJ Scarisbrick, BE Shaw, MN Potter, J Cavenagh, ...</div><div class="gs_gray">Bone marrow transplantation 49 (5), 704-708<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=91531500801769578" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:GtLg2Ama23sC" class="gsc_a_at">Fatal donor-derived Epstein–Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for&nbsp;…</a><div class="gs_gray">AYL Ho, S Adams, H Shaikh, A Pagliuca, S Devereux, GJ Mufti</div><div class="gs_gray">Bone marrow transplantation 29 (10), 867-869<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10496978774590248708" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=20&amp;pagesize=80&amp;citation_for_view=B_fNeq0AAAAJ:6_hjMsCP8ZoC" class="gsc_a_at">Idiopathic hyperammonaemia syndrome following allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT)</a><div class="gs_gray">AYL Ho, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone marrow transplantation 20 (11), 1007-1008<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15586293263114599343" class="gsc_a_ac gs_ibl">24</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:bz8QjSJIRt4C" class="gsc_a_at">Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)</a><div class="gs_gray">MM Ceesay, E Matutes, GP Taylor, P Fields, J Cavenagh, S Simpson, ...</div><div class="gs_gray">Leukemia research 36 (7), 857-861<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10405136567259252774" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:bKqednn6t2AC" class="gsc_a_at">Cardiac presentation of ALK positive anaplastic large cell lymphoma</a><div class="gs_gray">ZY Lim, R Grace, JR Salisbury, D Creamer, A Jayaprakasam, AYL Ho, ...</div><div class="gs_gray">European journal of haematology 75 (6), 511-514<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11791879473366649252" class="gsc_a_ac gs_ibl">23</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:L7CI7m0gUJcC" class="gsc_a_at">Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival</a><div class="gs_gray">A Galleu, D Milojkovic, S Deplano, R Szydlo, S Loaiza, R Wynn, DI Marks, ...</div><div class="gs_gray">British journal of haematology 185 (1), 89-92<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8118815915916693340" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:PoWvk5oyLR8C" class="gsc_a_at">Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell&nbsp;…</a><div class="gs_gray">K Matthews, ZY Lim, L Pearce, A Pagliuca, J Alejandro Madrigal, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 149 (6), 879-889<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9483134437414557142" class="gsc_a_ac gs_ibl">22</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:t6usbXjVLHcC" class="gsc_a_at">Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert&nbsp;…</a><div class="gs_gray">M Mohty, F Malard, M Abecasis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...</div><div class="gs_gray">Bone marrow transplantation 55 (3), 485-495<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7772193705873847969" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ClCfbGk0d_YC" class="gsc_a_at">Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms</a><div class="gs_gray">BE Shaw, P Veys, A Pagliuca, J Addada, G Cook, CF Craddock, ...</div><div class="gs_gray">Bone marrow transplantation 44 (1), 7-12<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10084629181238441999" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:qUcmZB5y_30C" class="gsc_a_at">Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation</a><div class="gs_gray">ZY Lim, B Baker, M Zuckermann, JJ Wade, M Ceesay, AYL Ho, ...</div><div class="gs_gray">Journal of Infection 54 (2), e83-e86<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9629773621215116227" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:An6A6Jpfc1oC" class="gsc_a_at">Non-myeloablative stem cell transplantation for congenital immunodeficiencies</a><div class="gs_gray">HB Gaspar, P Amrolia, A Hassan, D Webb, A Jones, N Sturt, G Vergani, ...</div><div class="gs_gray">Immunosurveillance, Immunodeficiencies and Lymphoproliferations, 134-142<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17281414531866013702" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:jgBuDB5drN8C" class="gsc_a_at">Myelosuppressive chemotherapy to mobilize normal stem cells in chronic myeloid leukemia.</a><div class="gs_gray">J Mehta, A Mijović, R Powles, A Pagliuca, S Singhal, B Czepulkowski, ...</div><div class="gs_gray">Bone marrow transplantation 17 (1), 25-29<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13909292167232385748" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:1lhNe0rCu4AC" class="gsc_a_at">Prodromal cutaneous vasculitis in myelodysplastic syndromes</a><div class="gs_gray">A Pagliuca, E Higgins, D Samson, S Humphries, GJ Mufti</div><div class="gs_gray">British journal of haematology 75 (3), 444-446<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13806680361672681185" class="gsc_a_ac gs_ibl">21</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:KlAtU1dfN6UC" class="gsc_a_at">Myelodysplasia syndromes during pregnancy</a><div class="gs_gray">A Pagliuca, GJ Mufti, P Fenaux, C De Silva, I Samaratunga</div><div class="gs_gray">European journal of haematology 47 (4), 310-312<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1367636510392214460" class="gsc_a_ac gs_ibl">20</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:a9-T7VOCCH8C" class="gsc_a_at">Real-world data of high-grade lymphoma patients treated with CD19 CAR-T in England</a><div class="gs_gray">A Kuhnl, C Roddie, N Martinez-Cibrian, TF Menne, K Linton, S Lugthart, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10888111280054767168" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:OP4eGU-M3BUC" class="gsc_a_at">Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative</a><div class="gs_gray">ZY Lim, L Pearce, W Ingram, AYL Ho, GJ Mufti, A Pagliuca</div><div class="gs_gray">Bone marrow transplantation 41 (6), 587-588<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12472728835767270034" class="gsc_a_ac gs_ibl">19</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:g5m5HwL7SMYC" class="gsc_a_at">Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation</a><div class="gs_gray">J Parker, A Pagliuca, T Kitiyakara, M Whitehead, N Heaton, J O'Grady, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 97 (8), 2525-2526<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3911964624129980697" class="gsc_a_ac gs_ibl">18</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_xSYboBqXhAC" class="gsc_a_at">Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure</a><div class="gs_gray">PG Richardson, SA Grupp, A Pagliuca, A Krishnan, VT Ho, S Corbacioglu</div><div class="gs_gray">International journal of hematologic oncology 6 (3), 75-93<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4543478584640617887" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:N5tVd3kTz84C" class="gsc_a_at">Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and&nbsp;…</a><div class="gs_gray">ZY Lim, W Ingram, R Brand, M Akthari, D Milojkovic, AYL Ho, S Devereux, ...</div><div class="gs_gray">Bone marrow transplantation 40 (8), 747-752<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6471386445209487010" class="gsc_a_ac gs_ibl">17</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ZfRJV9d4-WMC" class="gsc_a_at">The impact of advanced patient age on mortality after allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma: a retrospective study by the European Society for&nbsp;…</a><div class="gs_gray">C Kyriakou, A Boumendil, H Finel, NNN Schmitz, NS Andersen, D Blaise, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 25 (1), 86-93<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7010599559861017373" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:SP6oXDckpogC" class="gsc_a_at">Preliminary Results of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a First-in-Human Trial (CALM) in Adult Patients with CD19<sup>+</sup> Relapsed/Refractory&nbsp;…</a><div class="gs_gray">C Graham, D Yallop, A Jozwik, P Patten, A Dunlop, R Ellard, O Stewart, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 887-887<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4850867135985567354" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:mvPsJ3kp5DgC" class="gsc_a_at">Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: trough serum concentrations in relation to outcome</a><div class="gs_gray">MM Ceesay, L Couchman, M Smith, J Wade, RJ Flanagan, A Pagliuca</div><div class="gs_gray">Medical mycology 54 (7), 691-698<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5856901774839176476" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ODE9OILHJdcC" class="gsc_a_at">A practical critique of antifungal treatment guidelines for haemato-oncologists</a><div class="gs_gray">S Agrawal, B Jones, R Barnes, C Kibbler, M Millen, M Ashcroft, S Jain, ...</div><div class="gs_gray">Critical reviews in microbiology 38 (3), 203-216<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11949291285273757523" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_Qo2XoVZTnwC" class="gsc_a_at">Multiple organ failure and severe bone marrow dysfunction in two 18 year‐old Caucasian patients: Epstein–Barr virus and the haemophagocytic syndrome</a><div class="gs_gray">PA Berry, W Bernal, A Pagliuca, E Sizer, JR Salisbury, JA Wendon, ...</div><div class="gs_gray">Anaesthesia 63 (11), 1249-1254<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2546347981986286305" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Br1UauaknNIC" class="gsc_a_at">Intraperitoneal rituximab: an effective measure to control recurrent abdominal ascites due to non-Hodgkin's lymphoma</a><div class="gs_gray">T Ng, A Pagliuca, G Mufti</div><div class="gs_gray">Annals of hematology 81 (7), 405-406<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15155459889668396204" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:0izLItjtcgwC" class="gsc_a_at">Prodromal cutaneous lesions in adult T-cell leukaemia/lymphoma.</a><div class="gs_gray">A Pagliuca, H Williams, J Salisbury, GJ Mufti</div><div class="gs_gray">Lancet (London, England) 335 (8691), 733-734<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10693220008181012227" class="gsc_a_ac gs_ibl">16</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:KNjnJ3z-R6IC" class="gsc_a_at">Mixed donor chimaerism in recipient fingernails following reduced-intensity conditioning haematopoietic SCT</a><div class="gs_gray">L Pearce, ZY Lim, M Usai, AYL Ho, GJ Mufti, A Pagliuca</div><div class="gs_gray">Bone marrow transplantation 42 (5), 361-362<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16466694817820352259" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:vbGhcppDl1QC" class="gsc_a_at">Koebnerizing sclerodermatous graft‐versus‐host disease caused by donor lymphocyte infusion and interferon‐<i>α</i></a><div class="gs_gray">JML White, S Devereux, A Pagliuca, JR Salisbury, AWP Du Vivier, ...</div><div class="gs_gray">British Journal of Dermatology 155 (3), 621-623<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8076343809479849580" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:W5xh706n7nkC" class="gsc_a_at">Disseminated herpes virus (HSV-2) infection with rhabdomyolysis and hemophagocytic lymphohistiocytosis in a patient with bone marrow failure syndrome</a><div class="gs_gray">K Ramasamy, ZY Lim, M Savvas, JR Salisbury, I Dokal, GJ Mufti, ...</div><div class="gs_gray">Annals of hematology 85 (9), 629-630<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6888503702830276029" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-7ulzOJl1JYC" class="gsc_a_at">An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation</a><div class="gs_gray">G Miflin, N Russell, I Franklin, G Cook, DW Milligan, RM Hutchinson, ...</div><div class="gs_gray">Cytotherapy 2 (6), 423-428<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15680668089054489451" class="gsc_a_ac gs_ibl">15</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:SIv7DqKytYAC" class="gsc_a_at">British Society of Blood and Marrow Transplantation; UK Virology Network. Management of cytomegalovirus infection in haemopoietic stem cell transplantation</a><div class="gs_gray">V Emery, M Zuckerman, G Jackson, C Aitken, H Osman, A Pagliuca, ...</div><div class="gs_gray">Br J Haematol 162 (1), 25-39<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4877161633032233562" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:maZDTaKrznsC" class="gsc_a_at">Measurement of posaconazole, itraconazole, and hydroxyitraconazole in plasma/serum by high-performance liquid chromatography with fluorescence detection</a><div class="gs_gray">SL Buckner, MM Ceesay, A Pagliuca, PE Morgan, RJ Flanagan</div><div class="gs_gray">Therapeutic drug monitoring 33 (6), 735-741<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2916630011943732924" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:O0nohqN1r9EC" class="gsc_a_at">Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection&nbsp;…</a><div class="gs_gray">ZY Lim, G Cook, PR Johnson, A Parker, M Zuckerman, D Marks, ...</div><div class="gs_gray">Leukemia research 33 (2), 244-249<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16390358724070109362" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:MLfJN-KU85MC" class="gsc_a_at">Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantation</a><div class="gs_gray">L Gooneratne, ZY Lim, A du Vivier, JR Salisbury, AS Knisely, AYL Ho, ...</div><div class="gs_gray">Bone marrow transplantation 39 (8), 511-512<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8743017924749828122" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ZHo1McVdvXMC" class="gsc_a_at">Fulminant fungal sinusitis following intensive chemotherapy</a><div class="gs_gray">R Kaczmarski, A Pagliuca, H Pullon, J Philpott-Howard, J Salisbury, ...</div><div class="gs_gray">QJM: An International Journal of Medicine 75 (1), 365-370<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4050771858063747421" class="gsc_a_ac gs_ibl">14</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:i2xiXl-TujoC" class="gsc_a_at"><i>Strongyloides</i> hyperinfection in adult T‐cell leukaemia/lymphoma</a><div class="gs_gray">A Pagliuca</div><div class="gs_gray">British journal of haematology 105 (1), 1-1<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9369210220268323717" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:tYavs44e6CUC" class="gsc_a_at">COINFECTION WITH HTLV-IIII AND HIV-1</a><div class="gs_gray">A Pagliuca, GJ Mufti</div><div class="gs_gray">Lancet 336 (8711), 383-383<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8400218681334280636" class="gsc_a_ac gs_ibl">13</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Fu2w8maKXqMC" class="gsc_a_at">Sarcoidosis and haematological malignancies: is there an association?</a><div class="gs_gray">L Gooneratne, W Nagi, Z Lim, AYL Ho, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">British journal of haematology 141 (2), 260-262<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6896936721754065347" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:zLWjf1WUPmwC" class="gsc_a_at">Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200</a><div class="gs_gray">AYL Ho, M Kenyon, I El-Hemaidi, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 101 (2), 779-780<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7662539939050467402" class="gsc_a_ac gs_ibl">12</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:JTqpx9DYBaYC" class="gsc_a_at">Peripheral blood dendritic cells express CD52 and are depleted in-vivo by treatment with CAMPATH-1H.</a><div class="gs_gray">AGS Buggins, GJ Mufti, K Fishlock, M Arno, G Hale, H Waldmann, ...</div><div class="gs_gray">Blood 98 (11), 366A-367A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17862279095505843886" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LO7wyVUgiFcC" class="gsc_a_at">The “G-CSF test”: The response to a single dose of granulocyte colony-stimulating factor predicts mobilization of hemopoietic progenitors in patients with hematologic malignancies</a><div class="gs_gray">A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Experimental hematology 27 (7), 1204-1209<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10683378431665795018" class="gsc_a_ac gs_ibl">11</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:g3aElNc5_aQC" class="gsc_a_at">Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants—single centre pilot study</a><div class="gs_gray">V Mehra, J Clay, GF Cross, A Douiri, T Dew, TN Basu, V Potter, ...</div><div class="gs_gray">Journal of clinical pathology 70 (10), 886-890<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8319562439681719468" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:7PzlFSSx8tAC" class="gsc_a_at">Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant</a><div class="gs_gray">C Solano, M Slavin, AJ Shaul, DI Marks, C Cordonnier, OA Cornely, ...</div><div class="gs_gray">Mycoses 60 (2), 79-88<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2021124425485597238" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:L1USKYWJimsC" class="gsc_a_at">Life coaching following haematopoietic stem cell transplantation: a mixed‐method investigation of feasibility and acceptability</a><div class="gs_gray">M Kenyon, F Young, GJ Mufti, A Pagliuca, Z Lim, E Ream</div><div class="gs_gray">European journal of cancer care 24 (4), 531-541<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15071080050822932268" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:7Hz3ACDFbsoC" class="gsc_a_at">Clinicomorphological features of myelodysplastic syndromes</a><div class="gs_gray">A Pagliuca</div><div class="gs_gray">The myelodysplastic syndromes<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14267905291782180782" class="gsc_a_ac gs_ibl">10</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:v1_lew4L6wgC" class="gsc_a_at">Better HLA matching as revealed only by next generation sequencing technology results in superior overall survival post-allogeneic haematopoietic cell transplantation with&nbsp;…</a><div class="gs_gray">NP Mayor, JD Hayhurst, TR Turner, RM Szydlo, BE Shaw, WP Bultitude, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 24 (3), S63-S64<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14209597457796958978" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:epqYDVWIO7EC" class="gsc_a_at">Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell&nbsp;…</a><div class="gs_gray">MM Ceesay, S Kordasti, E Rufaie, N Lea, M Smith, J Wade, A Douiri, ...</div><div class="gs_gray">Journal of Infection 73 (3), 280-288<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7678779627685031955" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_FxGoFyzp5QC" class="gsc_a_at">Defibrotide for the treatment of hepatic veno-occlusive disease: an update from the international compassionate use program in 710 patients</a><div class="gs_gray">S Corbacioglu, E Carreras, M Mohty, A Pagliuca, M Ballabio, R Hume, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 21 (2), S108<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=936308493480587908,7813391292059644152" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:1sJd4Hv_s6UC" class="gsc_a_at">Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies</a><div class="gs_gray">J Feliu, J Clay, K Raj, L Barber, V Devlia, B Shaw, T Pagliuca, G Mufti</div><div class="gs_gray">British journal of haematology 167 (3), 426-428<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4759552156817948680" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:YohjEiUPhakC" class="gsc_a_at">False positive results of galactomannan ELISA assay in haemato-oncology patients: a single centre experience.</a><div class="gs_gray">ZY Lim, AY Ho, S Devereux, GJ Mufti, A Pagliuca, J Wade, M Smith</div><div class="gs_gray">The Journal of infection 55 (2), 201-202<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10341405686694473832" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Y0pCki6q_DkC" class="gsc_a_at">Novel treatment of Sézary‐like syndrome due to adult T‐cell leukaemia/lymphoma with daclizumab (humanized anti‐interleukin‐2 receptor <i>α</i> antibody)</a><div class="gs_gray">GEN Osborne, A Pagliuca, A Ho, AWP Du Vivier</div><div class="gs_gray">British Journal of Dermatology 155 (3), 617-620<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=539637794454074817" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:MhiOAD_qIWkC" class="gsc_a_at">Increase in allergy following donor lymphocyte infusions</a><div class="gs_gray">PFK Yong, D Grosse-Kreul, S Devereux, A Pagliuca, J Maher, ...</div><div class="gs_gray">Bone marrow transplantation 37 (10), 983-984<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14563816162853290038" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:FiytvqdAVhgC" class="gsc_a_at">Rituximab salvage following relapse after allogeneic bone marrow transplantation for non‐hodgkin's lymphoma</a><div class="gs_gray">D Milojkovic, A Mijovic, CG Taylor, GJ Mufti, A Pagliuca</div><div class="gs_gray">British journal of haematology 110 (4), 1013-1014<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14365619733972626082" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:aqlVkmm33-oC" class="gsc_a_at">Colchicine: an effective treatment for refractory malignant pericardial effusion</a><div class="gs_gray">T Ng, A Gatt, A Pagliuca, GJ Mufti</div><div class="gs_gray">Acta haematologica 104 (4), 217-219<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1683767474591138151" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:U4n9YNQMCAIC" class="gsc_a_at">Familial myelodysplastic syndromes: a key to understanding leukaemogenesis?</a><div class="gs_gray">A Mijovic, P Antunovic, A Pagliuca, G Mufti</div><div class="gs_gray">Leukemia Research 21 (S1), S6-S6<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14127163767356058093" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:7wO8s98CvbsC" class="gsc_a_at">Palmar-plantar erythema associated with combination chemotherapy.</a><div class="gs_gray">A Pagliuca, R Kaczmarski, GJ Mufti</div><div class="gs_gray">Postgraduate medical journal 66 (773), 242-243<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14691710847513158507" class="gsc_a_ac gs_ibl">9</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:zdjWy_NXXwUC" class="gsc_a_at">COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies</a><div class="gs_gray">E Calabretta, JM Moraleda, M Iacobelli, R Jara, I Vlodavsky, P O’Gorman, ...</div><div class="gs_gray">British Journal of Haematology 193 (1), 43<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14986284913649358024" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:SnGPuo6Feq8C" class="gsc_a_at">Incidence of anicteric veno-occlusive disease/sinusoidal obstruction syndrome and outcomes with defibrotide following hematopoietic cell transplantation in adult and pediatric&nbsp;…</a><div class="gs_gray">S Corbacioglu, NA Kernan, A Pagliuca, RJ Ryan, W Tappe, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 26 (7), 1342-1349<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2434012272907565221,17542576202001657523" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4MWp96NkSFoC" class="gsc_a_at">Are the risks of treatment to cure a child with severe sickle cell disease too high?</a><div class="gs_gray">M de Montalembert, V Brousse, S Chakravorty, A Pagliuca, J Porter, ...</div><div class="gs_gray">Bmj 359<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8069649320260618701" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:XiSMed-E-HIC" class="gsc_a_at">The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis</a><div class="gs_gray">G Cook, GH Jackson, GJ Morgan, N Russell, K Kirkland, J Lee, R Pearce, ...</div><div class="gs_gray">Bone marrow transplantation 46 (9), 1210-1218<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5003514848207288945" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:EUQCXRtRnyEC" class="gsc_a_at">The Kingscord model: a public cord blood collection service</a><div class="gs_gray">T Duffy, S Querol, W Dennes, M Tarrio, K Mason, H Busby, W Okeke, ...</div><div class="gs_gray">British Journal of Midwifery 17 (5), 306-313<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4551731718819504510" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:dQ2og3OwTAUC" class="gsc_a_at">Imatinib mesylate in myelofibrosis: Preliminary results show early sustained improvements in platelet counts and splenomegaly.</a><div class="gs_gray">AYL Ho, S Lim, K Fishlock, TH Yang, N Westwood, S Devereux, ...</div><div class="gs_gray">Blood 100 (11), 3155<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6589529945726553346" class="gsc_a_ac gs_ibl">8</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:RGFaLdJalmkC" class="gsc_a_at">Epstein-Barr virus and monoclonal gammopathy of clinical significance in autologous stem cell transplantation for multiple sclerosis</a><div class="gs_gray">V Mehra, E Rhone, S Widya, M Zuckerman, V Potter, K Raj, ...</div><div class="gs_gray">Clinical Infectious Diseases 69 (10), 1757-1763<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3234589195443642368" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:TIZ-Mc8IlK0C" class="gsc_a_at">Patient/donor CMV matching is a critical determinant of survival in unrelated donor haematopoietic stem cell transplantation</a><div class="gs_gray">BE Shaw, NP Mayor, S Richard, WP Bultitude, K Keiren, P Julia, W Marie, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1207-1207<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8514906759873238164" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:MXK_kJrjxJIC" class="gsc_a_at">Addition of anti-viral therapy to chemotherapy improves overall survival in acute and lymphomatous adult T-cell leukaemia/lymphoma (ATLL)</a><div class="gs_gray">A Hodson, S Montoto, N Mir, A Pagliuca, K Cwynarski, KM Ardeshna, ...</div><div class="gs_gray">Blood 116 (21), 3961<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1283365795059951447" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kVjdVfd2voEC" class="gsc_a_at">Coulter S Plus STKR histograms detect spurious elevation of leucocyte and platelet counts associated with cryoglobulinaemia</a><div class="gs_gray">A Pagliuca, H Hambley, GJ Mufti</div><div class="gs_gray">Blut 59 (4), 396-397<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14221547792404190946" class="gsc_a_ac gs_ibl">7</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hC7cP41nSMkC" class="gsc_a_at">Hypoplastic MDS is a distinct clinico-pathological entity with somatic mutations frequent in patients with prior aplastic anaemia with favorable clinical outcome</a><div class="gs_gray">AA Hunt, AB Khan, VT Potter, D McLornan, K Raj, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 3269-3269<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2233204102873114241" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:b1wdh0AR-JQC" class="gsc_a_at">EFFICACY OF PLERIXAFOR PLUS G-CSF FOR STEM CELL MOBILISATION IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA WHO HAVE FAILED PRIOR MOBILISATION-A NAMED PATIENT PROGRAM [NPP&nbsp;…</a><div class="gs_gray">F Apperley, G Cook, A Pagliuca, K Stringaris, K Douglas, A Pozo, ...</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 212-212<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1423773227015522445" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_FM0Bhl9EiAC" class="gsc_a_at">Blast counts in blood progenitor cell (BPC) collections correlate with CD34+ cells and CFU-GM and are a useful predictor of haemopoietic recovery after autologous BPC&nbsp;…</a><div class="gs_gray">A Mijovic, K Fishlock, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone marrow transplantation 21 (9), 869-872<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10535945237228554578" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:UHK10RUVsp4C" class="gsc_a_at">Human parvovirus infection in sickle cell disease</a><div class="gs_gray">A Pagliuca, M Hussain, DM Layton</div><div class="gs_gray">The Lancet 342 (8862), 49<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6612506206676092406" class="gsc_a_ac gs_ibl">6</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HhcuHIWmDEUC" class="gsc_a_at">Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years</a><div class="gs_gray">VS Sheth, V Potter, SA Gandhi, AG Kulasekararaj, H de Lavallade, ...</div><div class="gs_gray">Blood advances 3 (20), 3070-3079<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16507952175383933567" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:5icHVeHT4IsC" class="gsc_a_at">Impact of finding of low level kinase domain mutations using ultra deep next generation sequencing in patients with chronic phase CML</a><div class="gs_gray">A Kizilors, E Crisa, N Lea, S Best, M Syed, RM Ireland, M Aldouri, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 347-347<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13131214442519989924" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:B3FOqHPlNUQC" class="gsc_a_at">Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma</a><div class="gs_gray">V Noriega, H Kaur, S Devereux, J Byrne, R Marcus, A Haynes, D Yallop, ...</div><div class="gs_gray">Leukemia research 38 (7), 737-743<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5419471861702309628" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:rHJHxKgnXwkC" class="gsc_a_at">CMV-specific T-cell therapy improves immune reconstitution following unrelated donor HSCT: results of a randomized controlled trial</a><div class="gs_gray">F Chen, A Peniket, E Tholouli, A Bloor, R Chakraverty, D Marks, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 20 (2), S49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15433949898535566571" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WC9gN4BGCRcC" class="gsc_a_at">Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy</a><div class="gs_gray">D Milojković, M Aldouri, A Pagliuca, GJ Mufti, S Devereux</div><div class="gs_gray">Bone marrow transplantation 38 (6), 461-462<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15357266253066440858" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:1Ye0OR6EYb4C" class="gsc_a_at">T-cell lymphoblastic lymphoma presenting as an intra-muscular mass</a><div class="gs_gray">ZY Lim, S Gupta, JR Salisbury, D Elias, NK Venkatram, GJ Mufti, ...</div><div class="gs_gray">Br J Haematol 132 (5), 537<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15616905141191174886" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:pqnbT2bcN3wC" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) in 75 patients with myelodysplastic syndromes following conditioning with fludarabine, busulphan&nbsp;…</a><div class="gs_gray">AYL Ho, M Kenyon, I El-Hemaidi, A Mijovic, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Blood 102 (11), 263<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3999002054828351630" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:xtRiw3GOFMkC" class="gsc_a_at">Characterization of an AML-derived immunomodulatory factor (s) that inhibit T cell activation and the signal transduction pathways involved.</a><div class="gs_gray">AGS Buggins, MJ Arno, A Milojkovic, A Pagliuca, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">Blood 96 (11), 501A-501A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4689678360496172249" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kw52XkFRtyQC" class="gsc_a_at">The role of apoptosis, proliferation and amifostine in the myelodysplastic syndromes (MDS) and AML secondary to MDS.</a><div class="gs_gray">JE Parker, KL Fishlock, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood 92 (10), 418A-419A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14477926854932261240" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:QD3KBmkZPeQC" class="gsc_a_at">BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma</a><div class="gs_gray">F Brito-Babapulle, R Arya, T Griffiths, A Pagliuca, GJ Mufti</div><div class="gs_gray">Lancet (British edition) 339 (8785), 133-134<span class="gs_oph">, 1992</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13642072518464838425" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1992</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kF1pexMAQbMC" class="gsc_a_at">Development of polycythaemia vera in a patient with myelofibrosis</a><div class="gs_gray">I Dokal, A Pagliuca, M Deenmamode, GJ Mufti, SM Lewis</div><div class="gs_gray">European journal of haematology 42 (1), 96-98<span class="gs_oph">, 1989</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17015987961631180381" class="gsc_a_ac gs_ibl">5</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1989</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:KaMxkj08jr0C" class="gsc_a_at">Carmustine, etoposide, cytarabine, and melphalan (BEAM)–Campath allogeneic stem cell transplantation for aggressive non-Hodgkin lymphoma: an analysis of outcomes from the&nbsp;…</a><div class="gs_gray">E Truelove, C Fox, S Robinson, R Pearce, J Perry, K Kirkland, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 21 (3), 483-488<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15670878763702974809" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:3bvyWxjaHKcC" class="gsc_a_at">Alemtuzumab-based reduced-intensity conditioning allogeneic transplantation for myeloma and plasma cell leukemia–a single-institution experience</a><div class="gs_gray">K Ramasamy, S Mahmood, ZY Lim, S Corderoy, S Devereux, GJ Mufti, ...</div><div class="gs_gray">Clinical Lymphoma Myeloma and Leukemia 11 (2), 242-245<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16519550830776023273" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:5MTHONV0fEkC" class="gsc_a_at">Voriconazole or itraconazole for antifungal prophylaxis in patients with grade II-IV acute or extensive chronic graft-versus-host disease</a><div class="gs_gray">D Marks, C Kibbler, G Cook, A Pagliuca, A Reisman, P Miller, M Kantecki, ...</div><div class="gs_gray">Bone Marrow Transplantation 45 (10), 1578<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12890698964239383628" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:r_AWSJRzSzQC" class="gsc_a_at">Combination Chemotherapy with CHOP-Daclizumab in HTLV-I Associated Adult T-Cell Leukaemia/Lymphoma.</a><div class="gs_gray">S Simpson, M Thanigaikumar, G Taylor, E Matutes, P Fields, S Devereux, ...</div><div class="gs_gray">Blood 108 (11), 2750<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12274704085795977690" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:j7_hQOaDUrUC" class="gsc_a_at">Non-caseating granulomata associated with hypocellular myelodysplastic syndrome</a><div class="gs_gray">T Ng, T Yeghen, A Pagliuca, DS Gillett, GJ Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 39 (3-4), 397-403<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14320153379350565825" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:otzGkya1bYkC" class="gsc_a_at">AML-derived immunomodulatory factor (s) inhibit T cell cytokine secretion and proliferation via inhibition of NF-ATc activation and failure to upregulate C-MYC.</a><div class="gs_gray">AGS Buggins, N Lea, D Milojkovic, A Pagliuca, GJ Mufti, WJR Hirst</div><div class="gs_gray">Blood 94 (10), 596A-596A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13761677945441431281" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LPZeul_q3PIC" class="gsc_a_at">Idarubicin, fludarabine, cytarabine and G-CSF (FLAG-IDA) for the treatment of high risk myeloid malignancies</a><div class="gs_gray">JE Parker, JO Cullis, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood 88 (10), 1803-1803<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5595552749344640141" class="gsc_a_ac gs_ibl">4</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:CdxZDUztZiMC" class="gsc_a_at">The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in&nbsp;…</a><div class="gs_gray">L Floros, A Pagliuca, AA Taie, D Weidlich, M Rita Capparella, ...</div><div class="gs_gray">Journal of medical economics 23 (1), 86-97<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15311782002917845428" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:NMxIlDl6LWMC" class="gsc_a_at">Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning</a><div class="gs_gray">M Robin, K Raj, S Chevret, J Gauthier, H De Lavallade, D Michonneau, ...</div><div class="gs_gray">European journal of haematology 101 (4), 466-474<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3024359756421979478" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:1yQoGdGgb4wC" class="gsc_a_at">Better Hla matching as revealed only by ultra-high resolution Hla typing results in superior overall survival.</a><div class="gs_gray">N Mayor, J Hayhurst, T Turner, R Szydlo, B Shaw, W Bultitude, J Sayno, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6543043475763724216" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:k_7cPK9k7w8C" class="gsc_a_at">Equality of access to transplant for ethnic minority patients through use of cord blood and haploidentical transplants</a><div class="gs_gray">RN Lown, SGE Marsh, H Blake, S Querol, I Evseeva, S Mackinnon, ...</div><div class="gs_gray">Blood 122 (21), 2138<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16023398118862879559" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:NXb4pA-qfm4C" class="gsc_a_at">Early multilineage chimerism predicts the ‘winning’unit in double cord blood transplantation</a><div class="gs_gray">RE Hough, BE Shaw, P Patrick, N Russell, A Pagliuca, CF Craddock, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 300-300<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=176036957837741443" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Z5m8FVwuT1cC" class="gsc_a_at">Primary prophylaxis of invasive fungal disease in allogeneic haematopoietic cell transplant recipients—a mixed treatment comparison of randomised clinical trials: O354</a><div class="gs_gray">E Bow, D Vanness, C Cordonnier, O Cornely, D Marks, A Pagliuca, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7946253083795742841" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:KxtntwgDAa4C" class="gsc_a_at">National, retrospective, multi-centre comparison of alemtuzumab-versus ATG-based conditioning regimens in hematopoietic stem cell transplantation for aplastic anemia: a study&nbsp;…</a><div class="gs_gray">JCW Marsh, RM Pearce, MB Koh, D Tang, ZY Lim, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 52-52<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4821242725463231262" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ufrVoPGSRksC" class="gsc_a_at">Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis</a><div class="gs_gray">W Nagi, ZY Lim, P Krishnamurthy, V Potter, V Tindell, L Reiff-Zall, ...</div><div class="gs_gray">Leukemia research 35 (8), 998-1000<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=888960888783926205" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:8k81kl-MbHgC" class="gsc_a_at">The outcome of high-dose chemotherapy and autologous stem cell transplantation in patients with multiple myeloma: a UK and European bench-marking comparative analysis</a><div class="gs_gray">G Cook, G Jackson, K Kirkland, J Lee, R Pearce, D Marks, A Pagliuca</div><div class="gs_gray">Bone Marrow Transplantation 45, S148-S148<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1243404901842217302" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:zA6iFVUQeVQC" class="gsc_a_at">Mucous membrane pemphigoid following reduced intensity conditioning allogeneic haematopoietic SCT for biphenotypic leukaemia</a><div class="gs_gray">S Mahmood, ZY Lim, E Benton, A du Vivier, B Bhogal, GJ Mufti, ...</div><div class="gs_gray">Bone marrow transplantation 45 (1), 195-196<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4104720684950664642" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:BwyfMAYsbu0C" class="gsc_a_at">Reduced Intensity Allogeneic Transplantation Using BEAM-Alemtuzumab in Patients with Lymphoid Malignancy: Long Term Results and Impact of Intervention with DLI.</a><div class="gs_gray">EP Das-Gupta, JL Byrne, C Craddock, S Robinson, S Devereux, ...</div><div class="gs_gray">Blood 106 (11), 2890<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8072718332382976169" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kzcrU_BdoSEC" class="gsc_a_at">Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome.</a><div class="gs_gray">RK Patel, N Lea, MA Heneghan, N Westwood, D Milojkovic, ...</div><div class="gs_gray">Blood 106 (11), 2588<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6930212072904162730" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Aul-kAQHnToC" class="gsc_a_at">Reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation with or without alemtuzumab in acute myelogenous leukaemia and myelodysplastic syndromes&nbsp;…</a><div class="gs_gray">R Martino, A Ho, J Sierra, M Caballero, J Pérez-Simón, A Pagliuca, ...</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12712844886884675358" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hMod-77fHWUC" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) using fludarabine, busulphan and alemtuzumab conditioning in 63 patients with myelodysplastic&nbsp;…</a><div class="gs_gray">A Ho, M Kenyon, B Czepulkowski, R Padua, N Westwood, I El-Hemaidi, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3001021881554185640" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=100&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:AXPGKjj_ei8C" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation for poor prognosis myelodysplastic syndromes using fludarabine, busulphan and CAMPATH-1H (alemtuzumab&nbsp;…</a><div class="gs_gray">AYL Ho, I El-Hemaidi, M Kenyon, A Pagliuca, S Devereux, G Mufti</div><div class="gs_gray">Blood 100 (11), 621A-621A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6222994902375746813" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:yMeIxYmEMEAC" class="gsc_a_at">Liver transplantation in children with primary immunodeficiencies</a><div class="gs_gray">N Hadzic, G Davies, M Rela, A Pagliuca, G Mufti, P Veys, A Jones, ...</div><div class="gs_gray">Hepatology 30 (4), 182A-182A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12170048068430396551" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:EkHepimYqZsC" class="gsc_a_at">Autologous blood or bone marrow transplantation for relapsed and partially responding low-grade non-Hodgkin's lymphoma.</a><div class="gs_gray">A Mijovic, J Parker, J Salisbury, A Pagliuca, GJ Mufti</div><div class="gs_gray">CANCER RESEARCH THERAPY &amp; CONTROL 5 (4), 253-260<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7660245491697091057" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:lmc2jWPfTJgC" class="gsc_a_at">Autologous blood stem cell transplantation in hematological malignancies</a><div class="gs_gray">A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">Leukemia &amp; lymphoma 13 (1-2), 33-40<span class="gs_oph">, 1994</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8752747139060022330" class="gsc_a_ac gs_ibl">3</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1994</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:KUbvn5osdkgC" class="gsc_a_at">Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)</a><div class="gs_gray">J Feliu, V Potter, F Grimaldi, J Clay, L Floro, C Saha, L Barber, G Orti, ...</div><div class="gs_gray">Bone marrow transplantation 55 (3), 562-569<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7588913619391679164" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:QyXJ3EUuO1IC" class="gsc_a_at">The role of a critical care outreach service in the management of patients with haematological malignancy</a><div class="gs_gray">L Taheri, R Anandanadesan, H de Lavallade, E Pagkalidou, A Pagliuca, ...</div><div class="gs_gray">Journal of the Intensive Care Society 20 (4), 327-334<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15969896767189148958" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_B80troHkn4C" class="gsc_a_at">Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia</a><div class="gs_gray">RS Sellar, V Mehra, TA Fox, A Grigg, A Kulasekararaj, A Sarma, ...</div><div class="gs_gray">British journal of haematology<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6281040958618394600" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:XUvXOeBm_78C" class="gsc_a_at">Clinical intervention using NGS-based kinase domain mutation testing in CML Patients</a><div class="gs_gray">A Kizilors, P Harrington, S Jackson, N Lea, J Newman, R Gale, S Hassan, ...</div><div class="gs_gray">Blood 132, 3025<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15092206645624352681" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:yqoGN6RLRZoC" class="gsc_a_at">Pre-symptomatic (Baseline) computed tomography predicts invasive pulmonary aspergillosis in high-risk adult haemato-oncology patients.</a><div class="gs_gray">MM Ceesay, SR Desai, J Cleverley, L Berry, M Smith, J Wade, GJ Mufti, ...</div><div class="gs_gray">British journal of haematology 182 (5), 723-727<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2251744307100125811" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:0CzhzZyukY4C" class="gsc_a_at">Pre-emptive donor lymphocyte infusion corrects deficiencies in the T-Cell repertoire after allogeneic haematopoietic stem cell transplantation with lymphocyte-depletion for&nbsp;…</a><div class="gs_gray">LD Barber, M Al Rakhayes, J Golding, J Feliu, P Perez-Abellan, L Floro, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (3), S150<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13472411141244072049" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:olpn-zPbct0C" class="gsc_a_at">Feasibility and optimal schedule of using Eculizumab in patients with hemolytic Paroxysmal Nocturnal Hemoglobinuria (hPNH) with Severe Aplastic Anemia (SAA) prior to&nbsp;…</a><div class="gs_gray">AG Kulasekararaj, VT Potter, SA Gandhi, N Benson-Quarm, J Large, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 2482-2482<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2083219953721480519" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:CB2v5VPnA5kC" class="gsc_a_at">The influence of donor KIR repertoire on the clinical outcome after unrelated, T-cell depleted HSCT for patients with AML: O315</a><div class="gs_gray">J Schellekens, B Shaw, N Mayor, L Cooke, J Perry, R Pearce, M Wilson, ...</div><div class="gs_gray">Bone marrow transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6819516921868976155" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:XD-gHx7UXLsC" class="gsc_a_at">HCT-CI Is not a useful predictor for non relapse mortality in older patients (&gt; 60 years old) receiving RIC transplant for AML or MDS</a><div class="gs_gray">V Noriega, H de Lavallade, VT Potter, P Krishnamurthy, JCW Marsh, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 4158-4158<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7414404221467613703" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:mUJArPsKIAAC" class="gsc_a_at">A comprehensive diagnostic approach improves the diagnostic accuracy of invasive fungal disease in adult haemato-oncology patients undergoing HSCT or high-dose chemotherapy&nbsp;…</a><div class="gs_gray">M Ceesay, L Berry, S Desai, J Cleverly, C Kibbler, J Wade, M Smith, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=16685708901707601425" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:yD5IFk8b50cC" class="gsc_a_at">Voriconazole or itraconazole for prevention of invasive fungal infections after allogeneic hematopoietic stem cell transplantation (allohct)-Focus on patient preference and&nbsp;…</a><div class="gs_gray">I Marks, C Kibbler, G Cook, A Glasmacher, C Heussel, A Pagliuca, ...</div><div class="gs_gray">HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 95, 103-103<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4358460879919682990" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:MpfHP-DdYjUC" class="gsc_a_at">Reduced intensity conditioned volunteer unrelated donor transplants using alemtuzumab are safe and effective in older patients with myelodysplastic syndromes.</a><div class="gs_gray">ZY Lim, A Ho, M Kenyon, S Devereux, R Duarte, A Pagliuca, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 444-444<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14298546245554581803" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:cFHS6HbyZ2cC" class="gsc_a_at">Analysis of Beam (Carmustine, Etoposide, Cytosine Arabinoside, Melphalan) Versus High Dose Melphalan (HDM) with Autologous Rescue in Multiple Myeloma (MM).</a><div class="gs_gray">KA Ramasamy, R Branford, R Selvaratnam, AYL Ho, R Duarte, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 5227-5227<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4233342309720786198" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:g5Ck-dwhA_QC" class="gsc_a_at">Acute lymphoblastic leukemia</a><div class="gs_gray">WA Bleyer</div><div class="gs_gray">Therapy of Cancer in Children. New York, Clinical Insights, 8-10<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11721941017828814019" class="gsc_a_ac gs_ibl">2</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:2ywjKiB__4kC" class="gsc_a_at">Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study</a><div class="gs_gray">V Sheth, V Potter, H de Lavallade, S Gandhi, A Kulasekararaj, ...</div><div class="gs_gray">Blood Cancer Journal 11 (7), 1-6<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=11286565287913025703" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ghEM2AJqZyQC" class="gsc_a_at">Intention to Treat Analysis of Real-World Outcomes Following Tisgenlecleucel Therapy for Pediatric and Young Adult ALL through a National Access Programme</a><div class="gs_gray">S Ghorashian, C Furness, M Cummins, JA Snowden, MA O'Reilly, ...</div><div class="gs_gray">Blood 136, 18-19<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12227142256708877870" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:CYCckWUYoCcC" class="gsc_a_at">Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients</a><div class="gs_gray">V Anton-Vazquez, V Mehra, JL Mbisa, D Bradshaw, TN Basu, ML Daly, ...</div><div class="gs_gray">Journal of Clinical Virology 128, 104421<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17422180537958993168" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WqliGbK-hY8C" class="gsc_a_at">Clinical Intervention Using NGS-Based Kinase Domain Mutation Testing in CML Patients</a><div class="gs_gray">P Harrington, S Jackson, A Kizilors, N Lea, J Newman, R Gale, S Hassan, ...</div><div class="gs_gray">Clinical Lymphoma, Myeloma and Leukemia 19, S293-S294<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6395531232328347984" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:M3NEmzRMIkIC" class="gsc_a_at">A reply to Hurley et al. regarding recipients receiving better HLA-matched hematopoietic cell transplantation grafts, uncovered by a novel HLA typing method, have superior&nbsp;…</a><div class="gs_gray">NP Mayor, JD Hayhurst, TR Turner, RM Szydlo, BE Shaw, WP Bultitude, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 25 (8), e270-e271<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2920200090364241168" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Tyk-4Ss8FVUC" class="gsc_a_at">Differential interaction of peripheral blood lymphocyte counts (ALC) with different in vivo depletion strategies in predicting outcomes of allogeneic transplant: an&nbsp;…</a><div class="gs_gray">V Sheth, V Kennedy, H de Lavallade, D Mclornan, V Potter, ...</div><div class="gs_gray">Frontiers in oncology 9, 623<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8540649244162395910" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:5bg8sr1QxYwC" class="gsc_a_at">The importance of early intervention in the treatment of hepatic veno-occlusive disease</a><div class="gs_gray">A Pagliuca</div><div class="gs_gray">International journal of hematologic oncology, IJH15<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17089511211211649419" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:a0OBvERweLwC" class="gsc_a_at">Incidence of Post-Hematopoietic Stem Cell Transplantation (HSCT) Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) without Hyperbilirubinemia at Diagnosis and&nbsp;…</a><div class="gs_gray">S Corbacioglu, NA Kernan, A Pagliuca, R Ryan, W Tappe, P Richardson</div><div class="gs_gray">Blood 132, 2080<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4396306722276065009" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:pS0ncopqnHgC" class="gsc_a_at">Outcomes of Patients with Pre-Existing Invasive Fungal Disease Undergoing Allogeneic Haematopoietic Stem Cell Transplantation—5 Years Single Centre Experience</a><div class="gs_gray">V Mehra, E Barnwell, U Boczek, S Widya, K Raj, H De Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 3216&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17362578965783625426" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:TQgYirikUcIC" class="gsc_a_at">Mesenchymal stromal cells for the treatment of steroid-resistant acute graft versus host disease: factors influencing clinical responses.</a><div class="gs_gray">A Galleu, S Deplano, R Szydlo, D Milojkovic, A Bradshaw, R Wynn, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2460427971700369636" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:QIV2ME_5wuYC" class="gsc_a_at">Feasibility and optimal schedule of eculizumab in patients with haemolytic paroxysmal nocturnal hemoglobinuria (hPNH) with severe aplastic anaemia (SAA) prior to haemopoietic&nbsp;…</a><div class="gs_gray">A Kulasekararaj, A Hill, I Farmer, K Riley, L Arnold, R Allam, S Gandhi, ...</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1858495811937454078" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:OU6Ihb5iCvQC" class="gsc_a_at">Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service: a retrospective analysis on behalf of the&nbsp;…</a><div class="gs_gray">JA Snowden, R Danby, A Ruggeri, DI Marks, RE Hough, A Pagliuca, ...</div><div class="gs_gray">British journal of haematology 172 (3), 478-481<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6226272188635609770" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:bFI3QPDXJZMC" class="gsc_a_at">Outcomes of allogeneic hematopoietic cell transplantation (HCT) in patients with myelofibrosis (MF) exposed to JAK1/2 inhibitors</a><div class="gs_gray">M Shanavas, U Popat, LC Michaelis, V Fauble, D Mclornan, R Klisovic, ...</div><div class="gs_gray">HAEMATOLOGICA 100, 162-163<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4478247098571717150" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:RoXSNcbkSzsC" class="gsc_a_at">Donor attrition at the confirmatory typing stage results in poorer transplant options for patients of all ethnicities</a><div class="gs_gray">RN Lown, SGE Marsh, H Blake, I Evseeva, S Mackinnon, A Pagliuca, ...</div><div class="gs_gray">Blood 122 (21), 3377<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14575772311072012803" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WC23djZS0W4C" class="gsc_a_at">First remission autologous stem cell transplantation (ASCT) with BCNU/thiotepa shows good response in patients with CNS lymphoma: 219</a><div class="gs_gray">A Khan, S Atwal, S Devereux, V Potter, A Pagliuca, R Marcus</div><div class="gs_gray">British Journal of Haematology 157, 85-86<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14713284272111299944" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:CaZNVDsoPx4C" class="gsc_a_at">Pre-Emptive Donor Lymphocyte Infusions (DLI) Lead to High Cure Rates in T-Cell Depleted Allogeneic Haemopoietic Stem Cell Transplants for MDS/AML</a><div class="gs_gray">P Krishnamurthy, VT Potter, ZY Lim, AG Kulasekararaj, AY Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 660-660<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13781045145113608315" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:NDuN12AVoxsC" class="gsc_a_at">Retrospective analysis of 5-azacitidine as induction therapy prior to haematopoietic stem cell transplantation: P1172</a><div class="gs_gray">V Potter, V Tindell, L Jeyaraj-Nallathambi, M Doorga, L Reiff-Zall, A Ho, ...</div><div class="gs_gray">Bone Marrow Transplantation 46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15997998873219946786" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:D_sINldO8mEC" class="gsc_a_at">Cytokine profile of patients with invasive aspergillosis: initial results from the first 100 patients recruited into the aspergillosis study; Great Britain: P1054</a><div class="gs_gray">M Ceesay, S Kordasti, L Berry, J Wade, M Smith, G Mufti, A Pagliuca</div><div class="gs_gray">Bone Marrow Transplantation 46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5668525072462745567" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:3fE2CSJIrl8C" class="gsc_a_at">OP26 Predicting thrombotic complications after liver transplantation in patients with Budd Chiari syndrome</a><div class="gs_gray">R Westbrook, D Orr, N Heaton, J O'Grady, R Patel, N Lea, A Quaglia, ...</div><div class="gs_gray">Gut 59 (Suppl 2), A11-A11<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1311751990038691486" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HJSXoJQnj-YC" class="gsc_a_at">Plerixafor for PBSC mobilization in myeloma patients with advanced renal failure: safety and efficacy data in a series of 12 patients from the US or European Compassionate Use&nbsp;…</a><div class="gs_gray">K Douglas, P Hayden, A Rahemtulla, A D'Addio, K Rao, M Maris, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S323-S324<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=17666941825140548315" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Dem6FJhTUoYC" class="gsc_a_at">Voriconazole Compared To Itraconazole For Primary Prophylaxis Of Invasive Fungal Infections (IFI) In Allogeneic Hematopoietic Cell Transplant (HCT) Recipients–Results Of The&nbsp;…</a><div class="gs_gray">DI Marks, C Kibbler, G Cook, A Glasmacher, CP Heussel, P Ribaud, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 16 (2), S188<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15753475080669998809" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:jL-93Qbq4QoC" class="gsc_a_at">Umbilical cord blood transplantation in adults with haematological malignancies-UK single centre pilot study</a><div class="gs_gray">MM Ceesay, ZY Lim, S Querol, M Kenyon, A Ho, A Mijovic, S Devereux, ...</div><div class="gs_gray">Bone Marrow Transplantation 45, S161-S161<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13633403070864707414" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:P5F9QuxV20EC" class="gsc_a_at">PRE-TRANSPLANT SERUM FERRITIN AS AN INDEPENDENT PROGNOSTIC FACTOR IN MDS PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING HSCT</a><div class="gs_gray">ZY Lim, VF Fiaccadori, SG Gandhi, M Kenyon, AYL Ho, AP Pagliuca, ...</div><div class="gs_gray">Haematologica 93, 95-95<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4760067384701610844" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:KbBQZpvPDL4C" class="gsc_a_at">Use of Intravenous Busulphan for Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT) Is Associated with Delayed T-Cell Full Donor Chimerism and&nbsp;…</a><div class="gs_gray">ZY Lim, M Thanigaikumar, S Gandhi, L Pearce, M Kenyon, AYL Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1994-1994<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12132111355689707626" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:UeHWp8X0CEIC" class="gsc_a_at">Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse after an initial allogeneic transplant</a><div class="gs_gray">B Shaw, G Mufti, S Mackinnon, J Cavenagh, K Towlson, R Pearce, ...</div><div class="gs_gray">Bone Marrow Transplantation 39<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=141622073595555441" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hsZV8lGYWTMC" class="gsc_a_at">Combination chemotherapy with CHOP-daclizumab in HTLV-1 associated adult T-cell leukaemia/lymphoma.</a><div class="gs_gray">S Simpson, M Thanigaikumar, G Taylor, E Matutes, P Fields, S Devereux, ...</div><div class="gs_gray">Blood 108 (11), 778A-778A<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15156315224724737048" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:rmuvC79q63oC" class="gsc_a_at">The Outcome of Lymphoproliferative Disorder in Liver Transplant Recipients May Correlate with Age at Diagnosis and the Use of Chemotherapy: A Single Centre Report.</a><div class="gs_gray">CN Bagot, A Kulasekararaj, S Ramalingam, N Heaton, J O’Grady, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 1435-1435<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10311812012177987826" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Ri6SYOTghG4C" class="gsc_a_at">Clonal gammopathies, immune cytopenias and autoimmune thyroid dysfunction following alemtuzumab containing reduced-intensity allogeneic hematopoietic stem cell transplantation.</a><div class="gs_gray">M Akhtari, K Raj, W Ingram, D Milojkovic, I El-Hemaidi, S Devereux, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1839-1839<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10363785945478185266" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:uLbwQdceFCQC" class="gsc_a_at">Gemtuzumab ozogamicin with donor leucocyte infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following&nbsp;…</a><div class="gs_gray">K Raj, M Aldouri, A Ho, A Pagliuca, S Devereux, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1806-1806<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6793630217979000646" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ZuybSZzF8UAC" class="gsc_a_at">Immunohistochemical characterisation of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR in chronic myeloid leukaemia (CML) patients treated with&nbsp;…</a><div class="gs_gray">D Milojkovic, S Sahu, J Henderson, BH Czepulkowski, JR Salisbury, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1999-1999<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6523769983515912699" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:b0M2c_1WBrUC" class="gsc_a_at">Use of the galactomannan ELISA in the detection of invasive aspergillosis: a retrospective review and potential pitfalls in application</a><div class="gs_gray">Z Lim, A Pagliuca, J Wade, A Ho, S Devereux, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 125, 59-60<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4576247782475006826" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:BUYA1_V_uYcC" class="gsc_a_at">Increased incidence of granulomas in bone marrow trephines following alemtuzumab treatment</a><div class="gs_gray">S Chua, S Robinson, M Kenyan, A Pagliuca, S Devereux, J Salisbury, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7938737002800000269" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:eMMeJKvmdy0C" class="gsc_a_at">Imatinib mesylate in myelofibrosis: sustained improvements in platelet counts and splenomegaly</a><div class="gs_gray">A Ho, S Lim, N Westwood, T Yang, K Fishlock, S Devereux, A Pagliuca, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6228777213186915303" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HGTzPopzzJcC" class="gsc_a_at">A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma</a><div class="gs_gray">HM Hunter, K Peggs, R Powles, J Apperley, P Mahendra, J Cavenagh, ...</div><div class="gs_gray">Blood 102 (11), 2705-<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=15902721761525972073" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:tuHXwOkdijsC" class="gsc_a_at">Alemtuzumab containing reduced intensity conditioning regimen is safe and effective in myelofibrosis.</a><div class="gs_gray">WA Ingram, AYL Ho, M Kenyon, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">Blood 102 (11), 5465<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=8731512353724906928" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:nRpfm8aw39MC" class="gsc_a_at">Reduced intensity allogeneic transplantation using BEAM-Campath in patients with lymphoproliferative disease-GVHD, toxicity and survival in 65 patients.</a><div class="gs_gray">RD Bainton, JL Byrne, C Craddock, P Mahendra, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Blood 100 (11), 40A-40A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=14311043165566357842" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Xl6nMSl579sC" class="gsc_a_at">Peripheral blood cells with the phenotype and function of myeloid dendritic cells express CD52 and are depleted during therapy with CAMPATH-1H</a><div class="gs_gray">A Buggins, K Fishlock, N Westwood, A Pagliuca, G Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=18356428275095073301" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:BrmTIyaxlBUC" class="gsc_a_at">Gemtuzumab ozogamicin: is not associated with an increased risk of veno-occlusive disease in relapsed or refactory AML, when used alone or in combination with flag chemotherapy</a><div class="gs_gray">K Raj, E Kelleher, O Fasan, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=5746689711685251165" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ubry08Y2EpUC" class="gsc_a_at">Reduced-intensity rituximab-BEAM-CAMPATH allogeneic transplantation for indolent non-Hodgkin's lymphoma.</a><div class="gs_gray">AYL Ho, S Devereux, GL Mufti, A Pagliuca</div><div class="gs_gray">Blood 98 (11), 188A-188A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13847519165690785355" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:5nxA0vEk-isC" class="gsc_a_at">CAMPATH-1H reduces the risk of graft versus host disease following allogeneic hematopoietic stem cell transplantation and minimally myelosuppressive conditioning treatment with&nbsp;…</a><div class="gs_gray">S Devereux, JE Parker, T Shafi, A Pagliuca, E Macdonald, GJ Mufti</div><div class="gs_gray">Blood 98 (11), 355B-356B<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=1213405549779121465" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ZzlSgRqYykMC" class="gsc_a_at">Comparison of bone marrow and PBPC for allogeneic SCT in myelodysplastic syndromes. A retrospective study on behalf of the EBMT</a><div class="gs_gray">P Guardiola, V Runde, A Bacigalupo, T Ruutu, F Locatelli, M Boogaerts, ...</div><div class="gs_gray">Bone Marrow Transplantation 27 (11 PART I), S69-S69<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12706556307004903757" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:VLnqNzywnoUC" class="gsc_a_at">ADULT T-CELL LEUKAEMIA/LYMPHOMA IN ENGLAND 1996-1999: HIGH MORTALITY, YOUNGER PATIENTS AND MORE COMMON THAN EXPECTED</a><div class="gs_gray">G Taylor, E Matutes, A Pagliuca, J Tosswill, J Cavenagh</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=7329913061901077246" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:BqipwSGYUEgC" class="gsc_a_at">Suppression of T cell proliferation by AML cells is an early event in G0 to G1 transition involving inhibition of pRB phosphorylation by cyclin D-cdk6/4.</a><div class="gs_gray">D Milojkovic, AGS Buggins, NC Lea, A Pagliuca, GJ Mufti, NSB Thomas, ...</div><div class="gs_gray">Blood 96 (11), 146B-146B<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=3058019331525929296" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:eq2jaN3J8jMC" class="gsc_a_at">Non-myeloablative stem cell transplantation for congenital immunodeficiencies.</a><div class="gs_gray">PJ Amrolia, HB Gaspar, A Hassan, D Webb, A Pagliuca, G Mufti, G Davies, ...</div><div class="gs_gray">Blood 94 (10), 617A-617A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6368995773825379799" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:3htObqc8RwsC" class="gsc_a_at">Effect of leukemia cell microenvironment on the differentiation of dendritic cells from normal monocytes: A phenotypic and functional analysis.</a><div class="gs_gray">GM Rigolin, AGS Buggins, N Lea, G Castoldi, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Blood 94 (10), 70A-71A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=12112007786966388844" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:0N-VGjzr574C" class="gsc_a_at">Gene expression using adenoviral vectors in primary acute myeloid leukaemia cells.</a><div class="gs_gray">NC Lea, AGS Buggins, WJR Hirst, J Gaken, F Farzaneh, GJ Mufti, ...</div><div class="gs_gray">Blood 94 (10), 413B-413B<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10077106443176678364" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:pyW8ca7W8N0C" class="gsc_a_at">Soluble factors produced by primary acute myeloid leukemia cells inhibit Th1 cytokine production; potential role of c-AMP dependent pathways.</a><div class="gs_gray">A Buggins, W Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">Blood 92 (10), 81A-81A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=4426724325524790760" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:2v_ZtQDX9iAC" class="gsc_a_at">Management of adult T-cell leukaemia/lymphoma</a><div class="gs_gray">GJ Mufti, R Pawson, A Pagliuca</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 100 (3), 453-458<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=13947348289888978577" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:JQOojiI6XY0C" class="gsc_a_at">Experience of allogeneic blood stem cell transplantation in the UK.</a><div class="gs_gray">G Miflin, NH Russell, R Hutchinson, G Morgan, A Pagliuca, J Marsh, ...</div><div class="gs_gray">British Journal of Haematology 93, 41-41<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=6753591811884179141" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:r0BpntZqJG4C" class="gsc_a_at">Flag/idarubicin for the treatment of poor risk myeloid malignancies.</a><div class="gs_gray">FN AlRefaie, D Milojkovic, THT Wong, A Pagliuca, R Grace, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 76-76<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2686359326599895910" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:86PQX7AUzd4C" class="gsc_a_at">Warnings over cling film.</a><div class="gs_gray">A Pagliuca, GJ Mufti</div><div class="gs_gray">BMJ: British Medical Journal 302 (6776), 593<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=10247056559679807874" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:blknAaTinKkC" class="gsc_a_at">Co-infection with HTLV-I/II and HIV-1</a><div class="gs_gray">JHC Tosswill, JN Weber, A Pagliuca, GJ Mufti</div><div class="gs_gray">The Lancet 336 (8711), 383<span class="gs_oph">, 1990</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=2923786872758809316" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1990</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:AHdEip9mkN0C" class="gsc_a_at">Mixed treatment comparison of randomised clinical trials of primary antifungal prophylaxis in allogeneic haematopoietic cell transplant recipients–focus on invasive aspergillosis</a><div class="gs_gray">EJ Bow, DJ Vanness, C Cordonnier, OA Cornely, DI Marks, A Pagliuca, ...</div><div class="gs_gray">transplantation (alloHCT) 1, 2<span class="gs_oph">, 0</span></div></td><td class="gsc_a_c"><a href="https://scholar.google.com/scholar?oi=bibs&amp;hl=en&amp;cites=9947397704534303255" class="gsc_a_ac gs_ibl">1</a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:C33y2ycGS3YC" class="gsc_a_at">Risk of COVID-19 death in cancer patients: an analysis from Guy’s Cancer Centre and King’s College Hospital in London</a><div class="gs_gray">B Russell, CL Moss, V Shah, TK Ko, K Palmer, R Sylva, G George, ...</div><div class="gs_gray">British journal of cancer, 1-9<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:AYInfyleIOsC" class="gsc_a_at">Human parainfluenza virus type 3 infections in a haemato-oncology unit: social distancing measures needed in outpatient clinics</a><div class="gs_gray">V Anton-Vazquez, M Smith, V Mehra, D Avenoso, P Krishnamurthy, ...</div><div class="gs_gray">Journal of Hospital Infection<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:eAlLMO4JVmQC" class="gsc_a_at">Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study</a><div class="gs_gray">S Vipul, V Potter, G Shreyans, K Austin, K Pramila, M Varun, F Dazzi, ...</div><div class="gs_gray">Blood Cancer Journal 11 (7)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:0aBXIfxlw9sC" class="gsc_a_at">EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19</a><div class="gs_gray">J Salmanton-García, A Busca, OA Cornely, P Corradini, M Hoenigl, ...</div><div class="gs_gray">HemaSphere 5 (7)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:isU91gLudPYC" class="gsc_a_at">Early Morbidity of Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis-A Real World Experience</a><div class="gs_gray">V Mehra, M Cuadrado, E Rhone, A Mariottini, V Williams, S Ware, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 56 (SUPPL 1), 33-34<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kJDgFkosVoMC" class="gsc_a_at">Human Herpesvirus 6 Encephalitis Following Axicabtagene Ciloleucel Treatment for Refractory Diffuse Large B Cell Lymphoma</a><div class="gs_gray">M Shah, A Kuhnl, G Shields, M Sudhanva, V Metaxa, S Wong, D Yallop, ...</div><div class="gs_gray">HemaSphere 5 (3)<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:X9ykpCP0fEIC" class="gsc_a_at">S103 Baseline CT thorax in patients undergoing allogeneic haematopoetic stem-cell transplantation and risk of invasive fungal disease-a prospective 5-year study</a><div class="gs_gray">CG Stovin, J Periselneris, A Espehana, A Choy, P Siriwardena, ...</div><div class="gs_gray">Thorax 76 (Suppl 1), A62-A63<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:qwy9JoKyICEC" class="gsc_a_at">Early and late‐onset veno‐occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation–a real‐world UK experience</a><div class="gs_gray">V Mehra, S Tetlow, A Choy, H de Lavallade, A Kulasekararaj, ...</div><div class="gs_gray">American Journal of Transplantation 21 (2), 864-869<span class="gs_oph">, 2021</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2021</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:YlPif8NxrbYC" class="gsc_a_at">Comparing Outcomes of Patients Having Mixed T Chimerism and Unrelated Donor Allografts for Acute Leukaemia/MDS to Patients with Complete Chimerism-Single Centre Retrospective Study</a><div class="gs_gray">V Sheth, V Potter, D McLornan, H Delavallade, S Gandhi, A Kulasekararaj, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 123-124<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:wE-fMHVdjMkC" class="gsc_a_at">Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group</a><div class="gs_gray">JM Moraleda, C Carlo-Stella, D Garcia-Bernal, RJ Rubio, E Andreu, ...</div><div class="gs_gray">Blood 136, 6-8<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:qe6vwMD2xtsC" class="gsc_a_at">Spontaneous remission of acute myeloid leukaemia-how should this be handled by haematologists?</a><div class="gs_gray">K Milne, N Igbineweka, S Gurung, A Pagliuca, A Arasaretnam, T Rider, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 189, 188-189<span class="gs_oph">, 2020</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2020</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:uVUOdF_882EC" class="gsc_a_at">Differential Alemtuzumab Dosage Effects in T-Cell Deplete Allogeneic Haematopoietic Stem Cell Transplants for Myeloid Malignancies-King's College Hospital London Experience</a><div class="gs_gray">V Mehra, D Avenoso, XC Castellano, A Choy, S Widya, M Shah, S Inam, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LgRImbQfgY4C" class="gsc_a_at">Post-Transplant Flow Cytometry MRD Predicts Relapse in a Real World AML Cohort</a><div class="gs_gray">H Wood, K Sanchez, V Potter, A Kulasekararaj, H de Lavallade, D Yallop, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 134 (Supplement_1&nbsp;…<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:P7Ujq4OLJYoC" class="gsc_a_at">early and late onset VOD prevalence and outcomes in a single centre retrospective study over 5 years: The King's BMT experience</a><div class="gs_gray">S Gandhi, S Tetlow, V Mehra, H deLavallade, A Kulasekararaj, ...</div><div class="gs_gray">Bone Marrow Transplantation 54, 271-271<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-_dYPAW6P2MC" class="gsc_a_at">Adenoviral infections in adult T-cell depleted allogeneic stem cell transplants for myeloid disorders: Pre-emptive approach and impact on outcomes</a><div class="gs_gray">V Mehra, G Simini, E Barnwell, U Boczek, S Widya, A Choy, K Raj, ...</div><div class="gs_gray">Bone Marrow Transplantation 54, 424-425<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:eflP2zaiRacC" class="gsc_a_at">Outcomes of allogeneic stem cell transplantation (hsct) for older patients (&gt; 50 years) with severe aplastic anaemia using alemtuzumab-based ('FCC') regimen: King's college&nbsp;…</a><div class="gs_gray">V Sheth, I Shafqat, A Kulasekararaj, S Gandhi, H Delavallade, P Muus, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 54, 27-28<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hMsQuOkrut0C" class="gsc_a_at">EBV reactivation associated post-transplant lymphoproliferative disease, clonal gammopathy and outcomes in allogeneic T-cell depleted stem cell transplants for myeloid malignancies</a><div class="gs_gray">V Mehra, E Barnwell, U Boczek, A Bisquera, K Raj, D Mclornan, S Gandhi, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HDshCWvjkbEC" class="gsc_a_at">A Pooled Analysis of Survival By Defibrotide (DF) Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic&nbsp;…</a><div class="gs_gray">PG Richardson, E Carreras, A Pagliuca, RJ Ryan, W Tappe, M Mohty</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 25 (3), S129-S130<span class="gs_oph">, 2019</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2019</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:zCSUwVk65WsC" class="gsc_a_at">A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem&nbsp;…</a><div class="gs_gray">P Richardson, E Carreras, A Pagliuca, R Ryan, W Tappe, M Mohty</div><div class="gs_gray">Blood 132, 815<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Zph67rFs4hoC" class="gsc_a_at">A Review of 1000 Molecular Investigations of Rare Inherited Anaemia and Related Conditions with the Red Cell Gene Panel</a><div class="gs_gray">R Mayhew, F Smith, L Steedman, N Parkin, EM Beiro, P Rushton, ...</div><div class="gs_gray">Blood 132, 3609<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hqOjcs7Dif8C" class="gsc_a_at">KINETICS OF EXPANSION AND PHENOTYPE OF UCART19 CELLS IN THE FIRST CLINICAL TRIAL OF A UNIVERSAL ALLOGENEIC CAR-T CELL PRODUCT</a><div class="gs_gray">A Jozwik, C Graham, A Dunlop, K Sanchez, D Yallop, P Patten, ...</div><div class="gs_gray">HUMAN GENE THERAPY 29 (11), A17-A17<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Bg7qf7VwUHIC" class="gsc_a_at">Importance of peripheral blood absolute lymphocyte counts (ALC) in predicting transplant outcomes in preparative regimens using anti-thymocyte globulin or alemtuzumab: an&nbsp;…</a><div class="gs_gray">V Sheth, V Kennedy, H de Lavallade, D Mclornan, V Potter, B Savani, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 425-426<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LhH-TYMQEocC" class="gsc_a_at">First-in-human study with UCART19, an allogeneic anti-CD19 CAR T-cell product, in high risk adult patients with CD19 (+) R/R B-cell ALL: Preliminary results of CALM study</a><div class="gs_gray">C Graham, D Yallop, A Jozwik, P Patten, A Dunlop, R Ellard, O Stewart, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 21-22<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:nb7KW1ujOQ8C" class="gsc_a_at">Pooled Analysis of Defibrotide Studies in Treatment of Adult Patients with Veno-occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation&nbsp;…</a><div class="gs_gray">PG Richardson, E Carreras, A Pagliuca, RJ Soiffer, JH Antin, VT Ho, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 63-64<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:rO6llkc54NcC" class="gsc_a_at">Peripheral blood stem cell RIC haploidentical transplantation low incidence of GVHD and non relapse mortality: Preliminary results from the prospective phase II UK Haplo study</a><div class="gs_gray">K Raj, R Protheroe, M Smith, M Gilleece, JA Snowden, B Uttenthal, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 53, 752-754<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4OULZ7Gr8RgC" class="gsc_a_at">CME SECTION Haematology</a><div class="gs_gray">S Thomas, M Makris, D Gulati, A Novak, SJ Stanworth, C Graham, ...</div><div class="gs_gray">Age 18 (4)<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:eGYfIraVYiQC" class="gsc_a_at">OTU-005 Targeting expanded gut homing effector T cell lineages in GI-GVHD: a new therapeutic paradigm</a><div class="gs_gray">P Pavlidis, V Mehra, S Kottoor, E Alberts, JD Bell, TL Tsui, C Scotta, ...</div><div class="gs_gray">Gut 67 (Suppl 1), A54-A54<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:AXkvAH5U_nMC" class="gsc_a_at">Peripheral blood stem cell RIC haploidentical stem cell transplantation low TRM, low rates of GVHD: Preliminary results from the prospective Phase II single arm UK Haplo study&nbsp;…</a><div class="gs_gray">K Raj, R Protheroe, M Smith, M Gilleece, J Snowden, B Uttenthal, D Irvine, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 181, 13-13<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:k_IJM867U9cC" class="gsc_a_at">Anti-type M phospholipase A2 receptor antibody-positive membranous nephropathy as a part of multi-system autoimmune syndrome post-allogeneic stem cell transplantation</a><div class="gs_gray">A Tedjaseputra, D McLornan, J McCormick, K Raj, H de Lavallade, ...</div><div class="gs_gray">Internal medicine journal 48 (4), 481-483<span class="gs_oph">, 2018</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2018</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=200&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:silx2ntsSuwC" class="gsc_a_at">Low-Dose Second Generation TKI Is an Effective Approach to Reduce TKI Related Side Effects and Toxicity While Preserving Molecular Response in CML Patients with TKI Intolerance</a><div class="gs_gray">V Mehra, T Oyebamiji, S Widya, RM Ireland, AG Kulasekararaj, K Raj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 5250&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:e5wmG9Sq2KIC" class="gsc_a_at">EBV Reactivation Incidence and Severity in Multiple Sclerosis Patients Treated with Autologous Haematopoietic Stem Cell Transplant and Comparing with Aplastic Anaemia Treated&nbsp;…</a><div class="gs_gray">V Mehra, E Rhone, S Widya, V Potter, K Raj, D McLornan, H De Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 4535&nbsp;…<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:8xutWZnSdmoC" class="gsc_a_at">1: Rovira J, Cid J, Gutiérrez-García G, Pereira A, Fernández-Avilés F, Rosiñol L, Martínez C, Carreras E, Urbano A, Rovira M, Lozano M. Fatal immune hemolytic anemia following&nbsp;…</a><div class="gs_gray">F Moscardó, J de la Rubia, G Sanz, MA Sanz, S Devereux, GJ Mufti, ...</div><div class="gs_gray">Transfusion 57 (10), 2355-2358<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-FonjvnnhkoC" class="gsc_a_at">Effect of alemtuzumab dose de-escalation in reduced intensity conditioned unrelated donor haemataopoietic stem cell transplantation for myeloid malignancy: P405</a><div class="gs_gray">A Sarma, V Potter, L Floro, M DeCastro, K Raj, D McLornan, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:bEWYMUwI8FkC" class="gsc_a_at">Autologous haematopoietic stem cell transplant in multiple sclerosis: Updated results from the Pan-London MS group: P674</a><div class="gs_gray">E Rhone, E Silber, J Mccormick, R Nicholas, O Malik, P Muraro, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:qjMakFHDy7sC" class="gsc_a_at">Investigating frequency of EBV reactivation following autologous HSCT in patients with multiple sclerosis: P699</a><div class="gs_gray">E Rhone, E Silber, J Mccormick, R Nicholas, O Malik, P Muraro, ...</div><div class="gs_gray">Bone Marrow Transplantation 52<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:FPJr55Dyh1AC" class="gsc_a_at">Protocol for a Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care to Prevent Hepatic Veno-Occlusive Disease/Sinusoidal&nbsp;…</a><div class="gs_gray">S Grupp, A Pagliuca, S Corbacioglu, R Hume, W Liang, W Tappe, ...</div><div class="gs_gray">PEDIATRIC BLOOD &amp; CANCER 64, S96-S96<span class="gs_oph">, 2017</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2017</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:DBa1UEJaJKAC" class="gsc_a_at">Graft-versus-host disease or Stevens-Johnson syndrome? Diagnostic challenges in haematopoietic stem cell transplant recipients: BI11</a><div class="gs_gray">Z Shukur, H de Lavallade, V Potter, A Pagliuca, G Mufti, D Creamer, ...</div><div class="gs_gray">British Journal of Dermatology 175, 149-150<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:UxriW0iASnsC" class="gsc_a_at">SINGLE CENTRE OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA</a><div class="gs_gray">T Rider, R Benjamin, M Streetly, A Pagliuca, S Schey, M Kazmi, K Smith, ...</div><div class="gs_gray">HAEMATOLOGICA 101, 785-785<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:UuEBAcK4md4C" class="gsc_a_at">Single UK centre outcomes of peripheral blood stem cell (PBSC) haploidentical transplantation</a><div class="gs_gray">JM O'Sullivan, A Pagliuca, M Streetly, H de Lavallade, V Potter, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 173, 15-15<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:cWzG1nlazyYC" class="gsc_a_at">T-cell depletion with anti-thymocyte globulin (ATG) favours superior overall survival and lowers rates of relapse and GVHD when compared to alemtuzumab in patients undergoing&nbsp;…</a><div class="gs_gray">S Alimam, Y Beauverd, D McLornan, M Ibrahim, C Saha, K Raj, ...</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:RHpTSmoSYBkC" class="gsc_a_at">Anti-phospholipase A2 receptor (Anti-PLA2R) antibody positive-nephrotic syndrome as a manifestation of multi-system, immunemediated complications post allogeneic stem cell&nbsp;…</a><div class="gs_gray">A Tedjaseputra, K Raj, H de Lavallade, D McLornan, V Potter, M Kenyon, ...</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:zYLM7Y9cAGgC" class="gsc_a_at">An audit of stopping antifungal prophylaxis post allogeneic stem cell transplantation: 412</a><div class="gs_gray">P Parekh, K Raj, D Mclornan, H De Lavallade, V Potter, A Pagliuca</div><div class="gs_gray">British Journal of Haematology 173<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:EPG8bYD4jVwC" class="gsc_a_at">The impact of advanced patient age on mortality after allogeneic hematopoietic stem cell Transplantation (alloHSCT) for Non-Hodgkin’s Lymphoma (NHL): A retrospective study by&nbsp;…</a><div class="gs_gray">C Kyriakou, A Boumendil, H Finel, N Schmitz, S Mackinnon, S Lenhoff, ...</div><div class="gs_gray">Bone Marrow Transplantation 51<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:OR75R8vi5nAC" class="gsc_a_at">Holistic Assessment of Patients' Concerns Prior to Autologous High Dose Melphalan (HDM) Haematopoietic Stem Cell Transplant (HSCT) for Plasma Cell Disorders (PCD).: NO005</a><div class="gs_gray">S Ware, C Lim, R Benjamin, V Potter, A Pagliuca, M Kenyon</div><div class="gs_gray">Bone Marrow Transplantation 51<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HtS1dXgVpQUC" class="gsc_a_at">The role of Autologous Haematopoietic Stem Cell Transplant in MS-Updated results from the Pan-London MS group: P710</a><div class="gs_gray">F Collins, R Nicholas, O Malik, E Silber, P Muraro, A Pagliuca, M Kazmi</div><div class="gs_gray">Bone Marrow Transplantation 51<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:nrtMV_XWKgEC" class="gsc_a_at">Single centre outcomes from T cell deplete Allograft for MDS/MPDu: P366</a><div class="gs_gray">E Nuttall, L Floro, V Potter, H De Lavallade, D McLornan, A Pagliuca, ...</div><div class="gs_gray">Bone Marrow Transplantation 51<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hkOj_22Ku90C" class="gsc_a_at">Low Incidence of Hemolysis, Delayed Red Cell Engraftment and Pure Red Cell Aplasia with Post Transplantation Cyclophosphamide following ABO Mismatched Non-Myeloablative&nbsp;…</a><div class="gs_gray">O Fasan, PV O'Donnell, A Pagliuca, EA Copelan, K Raj</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 22 (3), S318-S319<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-DxkuPiZhfEC" class="gsc_a_at">King’s Research Portal</a><div class="gs_gray">MM Ceesay, S Kordasti, E Rufaie, N Lea, M Smith, J Wade, A Pagliuca</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:BzfGm06jWhQC" class="gsc_a_at">Composite Biomarker Panel in Prediction of Severity and Diagnosis of Acute GvHD with T-Depleted Allogeneic Stem Cell Transplants-Single Centre Pilot Study</a><div class="gs_gray">V Mehra, J Clay, G Cross, A Douiri, T Dew, VT Potter, T Basu, ...</div><div class="gs_gray">Blood 128 (22), 2234<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hFOr9nPyWt4C" class="gsc_a_at">Donor Lymphocyte Infusions Correct Deficiency of Naive T Cells and Improve T-Cell Competence after Allogeneic Haematopoietic Stem Cell Transplantation with Lymphocyte Depletion</a><div class="gs_gray">M Al Rukhayes, VT Potter, P Perez-Abellan, J Feliu, L Floro, ...</div><div class="gs_gray">Blood 128 (22), 2233<span class="gs_oph">, 2016</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2016</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:08ZZubdj9fEC" class="gsc_a_at">Immunological Profile of Patients after HSCT Using the FCC Conditioning Regimen for Treatment of Severe Aplastic Anemia Shows Sustained Mixed T-Cell Chimerism Is Due to&nbsp;…</a><div class="gs_gray">F Grimaldi, P Perez-Abellan, S Best, N Lea, J Veluchamy, M Atif, R Grain, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 126 (23), 3129-3129<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4xDN1ZYqzskC" class="gsc_a_at">IMMUNOLOGICAL PROFILE OF PATIENTS AFTER ALEMTUZUMAB-BASED HSCT FOR SEVERE APLASTIC ANEMIA INDICATES POTENTIAL BASIS FOR TOLERANCE WITH MIXED T-CELL CHIMERISM AND EXTREMELY LOW&nbsp;…</a><div class="gs_gray">F Grimaldi, R Grain, P Perez-Abellan, S Best, N Lea, JP Veluchamy, M Atif, ...</div><div class="gs_gray">HAEMATOLOGICA 100, 24-24<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:YOwf2qJgpHMC" class="gsc_a_at">RETROSPECTIVE ANALYSIS OF OPTIA® GRANULOCYTE COLLECTION EFFICIENCY OVER A TWO YEAR PERIOD IN KING'S COLLEGE HOSPITAL, LONDON: P-251A</a><div class="gs_gray">W Perera, D Hess, D Kuruppu, A Herath, C Haili, D McLornan, A Pagliuca, ...</div><div class="gs_gray">Vox Sanguinis 109<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:PkcyUWeTMh0C" class="gsc_a_at">Donor lymphocyte infusion-a retrospective single centre audit: 13</a><div class="gs_gray">C Saha, J Feliu, V Potter, J Clay, L Floro, K Raj, H De Lavallade, ...</div><div class="gs_gray">British Journal of Haematology 169<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:J-pR_7NvFogC" class="gsc_a_at">Immunological profile of patients after HSCT using the FCC conditioning regimen for treatment of severe aplastic anemia indicates potential basis for tolerance with mixed T&nbsp;…</a><div class="gs_gray">F Grimaldi, R Grain, P Perez-Abellan, S Best, N Lea, J Veluchamy, M Atif, ...</div><div class="gs_gray">British Journal of Haematology 169<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:8Xgff_V0N9gC" class="gsc_a_at">Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI)</a><div class="gs_gray">J Feliu, V Potter, J Clay, L Floro, C Saha, L Barber, G Orti, AA Alnagar, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S125-S126<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:BrOSOlqYqPUC" class="gsc_a_at">HLA-DQB1 and-DPB1 mismatches are significantly associated with worse survival in unrelated donor haematopoietic stem cell transplantation</a><div class="gs_gray">BE Shaw, N Mayor, R Szydlo, W Bultitude, K Kirkland, J Perry, A Clark, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S152-S152<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:URolC5Kub84C" class="gsc_a_at">E. coli bacteraemia is more common in autograft patients compared with allogeneic recipients-a single centre analysis</a><div class="gs_gray">C Saha, A Kulasekararaj, J Wade, N Desai, V Potter, A Pagliuca</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S193-S194<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:q3oQSFYPqjQC" class="gsc_a_at">BACK TO WORK AFTER ALLOGENEIC TRANSPLANT: EXPLORING EMPLOYMENT RATES IN THE LONG-TERM FOLLOW-UP CLINIC</a><div class="gs_gray">M Kenyon, J Clay, C Wykes, A Pagliuca, G Mufti, K Raj</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 50, S507-S507<span class="gs_oph">, 2015</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2015</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:sNmaIFBj_lkC" class="gsc_a_at">Increased Mortality in Patients with Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation</a><div class="gs_gray">M Wang, W Wang, A Abeywardane, M Adikarama, D McLornan, K Raj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 2512-2512<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:XvxMoLDsR5gC" class="gsc_a_at">King’s College Hospital FCC Conditioning for Severe Aplastic Anemia Induces Tolerance with Mixed T-Cell Chimerism and Extremely Low Incidence of Gvhd</a><div class="gs_gray">F Grimaldi, LD Barber, P Perez-Abellan, R Grain, VT Potter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1594-1594<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:PELIpwtuRlgC" class="gsc_a_at">Autologous Stem Cell Transplantation Achieves Long-Term Survival in a Selected CNS Lymphoma Population</a><div class="gs_gray">AB Khan, AA Hunt, VT Potter, S Kassam, D Yallop, PEM Patten, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1197-1197<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:wbdj-CoPYUoC" class="gsc_a_at">Busulfan-Dose Escalation in Reduced Intensity Stem Cell Transplantation (RIC-HSCT) Results in Good Outcomes for Patients with MDS and AML without Increased Toxicity</a><div class="gs_gray">A Sarma, VT Potter, J Clay, D McLornan, H de Lavallade, K Raj, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 124 (21), 1236-1236<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:vRqMK49ujn8C" class="gsc_a_at">Early clinical and pathological cutaneous features of chronic graft-versus-host disease: P43</a><div class="gs_gray">M Lynch, A Pagliuca, G Mufti, J Salisbury, T Basu</div><div class="gs_gray">British Journal of Dermatology 171<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LjlpjdlvIbIC" class="gsc_a_at">Equality of access to transplant for ethnic minority patients through improved provision of unrelated donors and use of cord blood and haploidentical transplant</a><div class="gs_gray">RN Lown, SGE Marsh, H Blake, I Evseeva, S MacKinnon, A Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 165, 1-1<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:wvYxNZNCP7wC" class="gsc_a_at">EBV REACTIVATION AND PTLD IN PATIENTS RECEIVING HSCT FOR APLASTIC ANAEMIA: PH-AB075</a><div class="gs_gray">P César, V Potter, M Zuckerman, J Clay, A Kulasekararaj, M Kenyon, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:a3BOlSfXSfwC" class="gsc_a_at">RAPID DONOR IDENTIFICATION AND SHORTER TIME TO TRANSPLANT USING A REGISTRY-BASED GRAFT IDENTIFICATION AND ADVISORY SERVICE (GIAS): PH-O052</a><div class="gs_gray">R Lown, S Marsh, H Blake, I Evseeva, S MacKinnon, A Pagliuca, M Potter, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:FAceZFleit8C" class="gsc_a_at">FEASIBILITY AND OPTIMAL SCHEDULE OF USING ECULIZUMAB IN PATIENTS WITH HEMOLYTIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (HPNH) WITH SEVERE APLASTIC ANEMIA (SAA) PRIOR TO&nbsp;…</a><div class="gs_gray">A Kulasekararaj, V Potter, S Gandhi, D Mclornan, R Kavita, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:tKAzc9rXhukC" class="gsc_a_at">NON MYELOABLATIVE HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST GRAFT HIGH DOSE CYCLOPHOSPHAMIDE FOR REFRACTORY SAA OR AFTER FAILED UNRELATED OR CORD BLOOD TRANSPLANT: PH-P044</a><div class="gs_gray">A Kulasekararaj, V Potter, J Clay, D Mclornan, K Raj, H De Lavallade, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:PR6Y55bgFSsC" class="gsc_a_at">RETROSPECTIVE COMPARISON OF HPC-A COLLECTION EFFICIENCY BETWEEN SPECTRA OPTIA® AND COBE SPECTRA® CELL SEPARATORS IN A LARGE TERTIARY COLLECTION FACILITY.: PH-AB200</a><div class="gs_gray">K Majumder, D Hess, D McLornan, A Mijovic, N Besson, E Tatam, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:5awf1xo2G04C" class="gsc_a_at">ALLOGENEIC STEM CELL TRANSPLANTATION FOR HYPOPLASTIC MDS IS COMPLICATED BY INCREASED REJECTION, WHEREAS DISEASE RELAPSE IS THE PREDOMINANT CAUSE OF TREATMENT FAILURE IN&nbsp;…</a><div class="gs_gray">J Clay, K Raj, D McLornan, De lavallade, H., V Potter, A Kulasekararaj, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 49, S185-S186<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:D03iK_w7-QYC" class="gsc_a_at">PREDICTING FACTORS FOR INPATIENT MORTALITY AND LONG TERM SURVIVAL IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS ADMITTED TO INTENSIVE CARE UNIT: PH-P317</a><div class="gs_gray">L Floro, H de Lavallade, R Szydlo, J Clay, D McLornan, K Raj, M Kenyon, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:W7OEmFMy1HYC" class="gsc_a_at">UK EXPERIENCE OF UNRELATED CORD BLOOD TRANSPLANTATION (UCBT) IN ADULTS: A RETROSPECTIVE ANALYSIS ON BEHALF OF EUROCORD AND THE BRITISH SOCIETY OF BLOOD AND MARROW&nbsp;…</a><div class="gs_gray">J Snowden, R Danby, A Ruggeri, D Marks, R Hough, A Pagliuca, M Potter, ...</div><div class="gs_gray">Bone Marrow Transplantation 49<span class="gs_oph">, 2014</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2014</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:mNrWkgRL2YcC" class="gsc_a_at">Unrelated Cord Blood Transplantation (UCBT) In Adults In The UK: Evolution, Experience and Outcomes. A Retrospective Analysis On Behalf Of The British Society of Blood and&nbsp;…</a><div class="gs_gray">JA Snowden, R Danby, A Ruggeri, DI Marks, RE Hough, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 3394-3394<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WA5NYHcadZ8C" class="gsc_a_at">A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem&nbsp;…</a><div class="gs_gray">JJ Scarisbrick, FL Dignan, S Tulpule, E Das gupta, G Shah, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 122 (21), 4645-4645<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:u5HHmVD_uO8C" class="gsc_a_at">Acute Liver Failure Secondary To Hepatic Malignant Infiltration; Clinical Features Enabling Early Identification</a><div class="gs_gray">P Solis-Munoz, VC Patel, G Auzinger, C Willars, A Quaglia, JB Karani, ...</div><div class="gs_gray">Hepatology 58, 360A-360A<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:8d8msizDQcsC" class="gsc_a_at">THE USE OF PET-CT IN THE DIAGNOSIS OF ADULT T CELL LEUKAEMIA-LYMPHOMA SUBTYPES</a><div class="gs_gray">A Macklin-Doherty, A Danaee, M Moonim, D Wrench, G Mikhaeel, ...</div><div class="gs_gray">HAEMATOLOGICA 98, 633-634<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WHdLCjDvYFkC" class="gsc_a_at">Early cytomegalovirus reactivation is associated with a poorer outcome after an alemtuzumab-based reducedintensity conditioning allogeneic stem cell transplant: P920</a><div class="gs_gray">V Noriega, T Cutino-Moguel, M Zuckerman, V Potter, L Barabino, K Raj, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:iH-uZ7U-co4C" class="gsc_a_at">No difference between ATG and alemtuzumab when used for T-cell depletion in reduced intensity conditioned haematopoietic stem cell transplantation for MDS and AML: P768</a><div class="gs_gray">L Floro, V Potter, V Noriega, M Kenyon, J Marsh, K Raj, H De Lavallade, ...</div><div class="gs_gray">Bone Marrow Transplantation 48<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WbkHhVStYXYC" class="gsc_a_at">Cancer survivorship: A pilot study exploring responses of Bone Marrow Transplant survivors to a life-coaching intervention</a><div class="gs_gray">M Kenyon, F Young, G Mufti, A Pagliuca, Z Lim, E Ream</div><div class="gs_gray">PSYCHO-ONCOLOGY 22, 13-14<span class="gs_oph">, 2013</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2013</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:2tRrZ1ZAMYUC" class="gsc_a_at">BEAM-Campath Allogeneic Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphomas. An Analysis of Outcomes From the BSBMT</a><div class="gs_gray">S Robinson, CP Fox, RM Pearce, J Perry, K Kirkland, CF Craddock, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2039-2039<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4vMrXwiscB8C" class="gsc_a_at">Adverse Effect of Very Poor Cytogenetics and Monosomal Karyotype On Outcomes Following T-Deplete Reduced Intensity Conditioned Stem Cell Transplant for MDS and AML.</a><div class="gs_gray">P Krishnamurthy, VT Potter, AG Kulasekararaj, V Noriega, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 3141-3141<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:OTTXONDVkokC" class="gsc_a_at">Demethylating Agents As a Salvage Treatment in Relapsed Myeloid Diseases Following Allogeneic Bone Marrow Transplantation</a><div class="gs_gray">S Atwal, AB Khan, V Noriega, Y Jethava, M Kenyon, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 4216-4216<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:yB1At4FlUx8C" class="gsc_a_at">Allogeneic Stem Cell Transplantation for Accelerated/Blastic Phase Philadelphia-Chromosome Negative MPN</a><div class="gs_gray">AB Khan, D McLornan, Y Jethava, K Raj, VT Potter, H de Lavallade, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 4532-4532<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:M05iB0D1s5AC" class="gsc_a_at">Outcome of BEAM-Autologous and BEAM-Alemtuzumab Allogeneic Transplantation in Relapsed Advanced Stage Follicular Lymphoma</a><div class="gs_gray">V Noriega, AB Khan, S Devereux, RE Marcus, M Kenyon, VT Potter, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 120 (21), 2022-2022<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:aIdbFUkbNIkC" class="gsc_a_at">COST-EFFECTIVENESS ANALYSIS OF VORICONAZOLE FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN SPANISH PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION</a><div class="gs_gray">D Marks, M Slavin, S Sorensen, C Cordonnier, O Cornely, A Pagliuca, ...</div><div class="gs_gray">HAEMATOLOGICA 97, 413-413<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:wMgC3FpKEyYC" class="gsc_a_at">An untimely reminder of an uncommon complication: severe veno-occlusive disease with extensive hepatocyte necrosis following autologous stem cell transplantation for relapsed&nbsp;…</a><div class="gs_gray">K Lang, M Young, S Patel, J Roy, Y Zen, J Wendon, H de Lavallade, ...</div><div class="gs_gray">British Journal of Haematology 157<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kz9GbA2Ns4gC" class="gsc_a_at">A comprehensive diagnostic approach improves the diagnostic accuracy of invasive fungal disease (IFD) in adult haemato-oncology patients undergoing HSCT or high dose&nbsp;…</a><div class="gs_gray">MM Ceesay, L Berry, SR Desai, J Cleverly, CC Kibbler, J Wade, M Smith, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 157, 2-3<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kRWSkSYxWN8C" class="gsc_a_at">Plerixaforex vivomobilization of placental-derived haematopoietic stem cells: P814</a><div class="gs_gray">M Ceesay, S Tulpule, S Querol, L Barber, T Duffy, B Shaw, J Madrigal, ...</div><div class="gs_gray">Bone Marrow Transplantation 47<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:t7zJ5fGR-2UC" class="gsc_a_at">Long Term Outcomes for Alemtuzumab Based Reduced Intensity Conditioning Transplant for Myelodysplastic Syndromes and Acute Myeloid Leukaemia</a><div class="gs_gray">VT Potter, P Krishnamurthy, VJ Tindell, Z Lim, R Ireland, JC Marsh, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 18 (2), S216<span class="gs_oph">, 2012</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2012</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Y5dfb0dijaUC" class="gsc_a_at">A Comprehensive Diagnostic Approach Improves the Diagnostic Accuracy of Invasive Fungal Disease (IFD) in Adult Haemato-Oncology Patients Undergoing HSCT or High Dose&nbsp;…</a><div class="gs_gray">MM Ceesay, L Berry, SR Desai, J Cleverely, C Kibbler, J Wade, M Smith, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 2972-2972<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:tOudhMTPpwUC" class="gsc_a_at">Long-Term Outcomes of Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation (RIC-HSCT) for AML with Myelodysplasia-Related Changes</a><div class="gs_gray">VT Potter, P Krishnamurthy, ZY Lim, VJ Tindell, S Devereux, RE Marcus, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 3079-3079<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ULOm3_A8WrAC" class="gsc_a_at">Plerixafor <i>Ex Vivo</i> Mobilization of Placental Derived Haematopoietic Stem Cells</a><div class="gs_gray">MM Ceesay, S Tulpule, S Querol, L Barber, T Duffy, BE Shaw, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 118 (21), 4790-4790<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:mlAyqtXpCwEC" class="gsc_a_at">TurboFlow technology for the therapeutic drug monitoring of azole antifungal drugs</a><div class="gs_gray">L Couchman, S Buckner, M Ceesay, A Pagliuca, RJ Flanagan</div><div class="gs_gray">THERAPEUTIC DRUG MONITORING 33 (4), 517-517<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:NhqRSupF_l8C" class="gsc_a_at">TREATMENT OUTCOMES IN LYMPHOMA IN HIV POSITIVE PATIENTS</a><div class="gs_gray">S Gandhi, S Verykiou, M Mansour, S Devereux, A Pagliuca, ...</div><div class="gs_gray">ANNALS OF ONCOLOGY 22, 236-237<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:sszUF3NjhM4C" class="gsc_a_at">Therapeutic drug monitoring of itraconazole and posaconazole: 40</a><div class="gs_gray">S Buckner, M Ceesay, L Berry, H Sikondari, M Smith, J Wade, A Pagliuca, ...</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ruyezt5ZtCIC" class="gsc_a_at">Video-assisted thoracoscopic biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high-dose chemotherapy: P775</a><div class="gs_gray">M Ceesay, L Berry, S Desai, M Marrinan, R Deshpande, D Whitaker, ...</div><div class="gs_gray">Bone Marrow Transplantation 46<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:1qzjygNMrQYC" class="gsc_a_at">Video-assisted thoracoscopic (VATS) biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high dose chemotherapy: 35</a><div class="gs_gray">M Ceesay, L Berry, S Desai, M Marrinan, R Deshpande, D Whitaker, ...</div><div class="gs_gray">British Journal of Haematology 153<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:IjCSPb-OGe4C" class="gsc_a_at">Survivorship following bone marrow transplant: a pilot study exploring responses to a life-coaching intervention</a><div class="gs_gray">M Kenyon, F Young, G Mufti, A Pagliuca, Z Lim, E Ream</div><div class="gs_gray">Bone Marrow Transplantation 46, S407-S408<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:5Ul4iDaHHb8C" class="gsc_a_at">Alemtuzumab vs ATG for T-Cell Depletion in Sibling Donor Reduced Intensity Haematopoietic Stem Cell Transplantation (RIC HSCT) for the Treatment of Acute Myeloid Leukaemia and&nbsp;…</a><div class="gs_gray">VT Potter, VJ Tindell, L Reiff-Zall, A Ho, M Kenyon, J Marsh, A Pagliuca, ...</div><div class="gs_gray">Biology of Blood and Marrow Transplantation 17 (2), S289<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:QsaTk4IG4EwC" class="gsc_a_at">63 Long-term outcomes following RIC HSCT for MDS with fludarabine, busulphan and alemtuzumab</a><div class="gs_gray">V Potter, Z Lim, P Krishnamurthy, R Pinto, M Kenyon, J Marsh, R Ireland, ...</div><div class="gs_gray">Leukemia Research, S23<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LdasjJ6CEcoC" class="gsc_a_at">332 Outcomes of reduced intensity conditioning HSCT for lower-risk MDS: King's college hospital experience</a><div class="gs_gray">R Pinto, V Potter, V Tindell, P Krishnamurthy, J Marsh, R Ireland, ...</div><div class="gs_gray">Leukemia Research, S133<span class="gs_oph">, 2011</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2011</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:q-HalDI95KYC" class="gsc_a_at">Alemtuzumab-Based RIC HSCT with Pre-Emptive DLI as An Effective Strategy to Achieve Long-Term Disease Remission In Patients with High Risk Myelodysplastic Syndrome (MDS) and&nbsp;…</a><div class="gs_gray">SA Gandhi, VT Potter, VJ Tindell, R Kesse-Adu, L Reiff-Zall, M Kenyon, ...</div><div class="gs_gray">Blood 116 (21), 1304<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:IaI1MmNe2tcC" class="gsc_a_at">Cytokine Profile of Patients with Invasive Apsergillosis-Preliminary Results.</a><div class="gs_gray">MM Ceesay, S Kordasti, L Berry, M Smith, J Wade, GJ Mufti, A Pagliuca</div><div class="gs_gray">Blood 116 (21), 1500<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:u-coK7KVo8oC" class="gsc_a_at">Comparative Analysis of An Azacytidine Versus Azacytidine-HSCT Approach for the Treatment of Older Patients with AML/MDS</a><div class="gs_gray">VT Potter, VJ Tindell, R Kesse-Adu, J Hayden, P Pasipanodya, L Reiff-Zall, ...</div><div class="gs_gray">Blood 116 (21), 2375<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:vDijr-p_gm4C" class="gsc_a_at">Serum Ferritin and Cardiac/Liver Magnetic Resonance Imaging In Evaluating Iron Overload for Patients with Bone Marrow Failure Conditions Undergoing Non-Myeloablative HSCT</a><div class="gs_gray">VJ Tindell, VT Potter, R Kesse-Adu, L Reiff-Zall, AY Ho, GJ Mufti, ...</div><div class="gs_gray">Blood 116 (21), 1331<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:UebtZRa9Y70C" class="gsc_a_at">Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.</a><div class="gs_gray">MM Ceesay, O Jaffer, PFC Lung, MT Marrinan, R Deshpande, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 116 (21), 4551-4551<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LkGwnXOMwfcC" class="gsc_a_at">Outcomes of sibling and unrelated donor reduced intensity conditioning allogeneic hsct for patients with MDS RCMD</a><div class="gs_gray">P Krishnamurthy, ZY Lim, A Ho, M Kenyon, MM Ceesay, J Hayden, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S180-S180<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:d1gkVwhDpl0C" class="gsc_a_at">Breaking new ground-The EBMT (UK) NAP group patient, family and friends forum</a><div class="gs_gray">M Kenyon, L Ritchie, T Rintala, A Pagliuca</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 45, S336-S336<span class="gs_oph">, 2010</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2010</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LPtt_HFRSbwC" class="gsc_a_at">A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan&nbsp;…</a><div class="gs_gray">AYL Ho, P Krishnamurthy, ZY Lim, M Kenyon, A Mijovic, S Devereux, ...</div><div class="gs_gray">Blood 114 (22), 2266<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-f6ydRqryjwC" class="gsc_a_at">Late Relapses Following Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation for Myeloid Malignancies Can Be Effectively Salvaged with Intensive&nbsp;…</a><div class="gs_gray">AG Kulasekararaj, Z Lim, P Krishnamurthy, MM Ceesay, M Kenyon, ...</div><div class="gs_gray">Blood 114 (22), 2265<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4TOpqqG69KYC" class="gsc_a_at">Comparative Analysis of Sibling Donor Reduced Intensity Conditioning Regimen for High Risk AML/MDS Using Anti-Thymocyte Globulin Versus Alemtuzumab for T-Cell Depletion.</a><div class="gs_gray">ZY Lim, S Bennett, AYL Ho, AG Kulasekararaj, S Gupta, M Kenyon, ...</div><div class="gs_gray">Blood 114 (22), 3362<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:u-x6o8ySG0sC" class="gsc_a_at">Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations.</a><div class="gs_gray">NC Lea, LN Roberts, RK Patel, R Westbrook, MA Heneghan, ...</div><div class="gs_gray">Blood 114 (22), 434<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kWvqk_afx_IC" class="gsc_a_at">Chronic Myeloid Leukemia-A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line&nbsp;…</a><div class="gs_gray">T Ernst, FX Gruber, O Pelz-Ackermann, J Maier, M Pfirrmann, MC Muller, ...</div><div class="gs_gray">Haematologica 94 (9), 1227<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:8AbLer7MMksC" class="gsc_a_at">Stem Cell Transplantation-Imbalance of effector and regulatory CD4 T cells is associated with graft versus host disease after hematopoietic stem cell transplantation using a&nbsp;…</a><div class="gs_gray">K Matthews, ZY Lim, B Afzali, L Pearce, A Abdallah, S Kordasti, ...</div><div class="gs_gray">Haematologica 94 (7), 956<span class="gs_oph">, 2009</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2009</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WZBGuue-350C" class="gsc_a_at">Pre-transplant serum ferritin as an independent prognostic factor in MDS patients undergoing reduced intensity conditioning HSCT: 146</a><div class="gs_gray">V Fiaccadori, Z Lim, M Kenyon, M Ceesay, J Hayden, A Ho, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology 141<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:VaXvl8Fpj5cC" class="gsc_a_at">Reduced intensity transplantation for myelofibrosis: a single centre experience 155</a><div class="gs_gray">W Nagi, P Krishnamurthy, Z Lim, M Kenyon, G Mufti, A Ho, A Pagliuca</div><div class="gs_gray">British Journal of Haematology 141<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ipzZ9siozwsC" class="gsc_a_at">Single centre experience of allogeneic haematopoietic stem cell transplantation for chronic myelomonocytic leukaemia: 153</a><div class="gs_gray">P Krishnamurthy, W Nagi, Z Lim, M Kenyon, A Ho, G Mufti, A Pagliuca</div><div class="gs_gray">British Journal of Haematology 141, 55-56<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:lgwcVrK6X84C" class="gsc_a_at">Survival in patients receiving a transplant from an HLA-mismatched donor (at 10/10 alleles) can be significantly improved by selecting a donor mismatched for HLA-DPB1</a><div class="gs_gray">B Shaw, N Mayor, A Little, N Russell, A Pagliuca, M Ethell, G Morgan, ...</div><div class="gs_gray">Bone Marrow Transplantation 41<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:5ugPr518TE4C" class="gsc_a_at">No impact on survival is seen when comparing the use of BM or PBSC as the stem cell source in recipients of T-cell depleted myeloablative transplants for leukaemia and MDS</a><div class="gs_gray">B Shaw, N Russell, A Pagliuca, J Apperley, G Cook, S Mackinnon, ...</div><div class="gs_gray">Bone Marrow Transplantation 41<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ALROH1vI_8AC" class="gsc_a_at">MOBILISATION FAILURE IS PREDICTIVE OF POOR OVERALL SURVIVAL AFTER AUTOLOGOUS TRANSPLANTATION</a><div class="gs_gray">K Ramasamy, S Mahmood, ZY Lim, A Mijovic, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Haematologica 93, 261-261<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:6yz0xqPARnAC" class="gsc_a_at">Results of a BSBMT phase I/II-study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following reduced intensity allogeneic stem&nbsp;…</a><div class="gs_gray">Z Lim, G Cook, P Johnson, A Parker, M Zuckerman, D Marks, H Wiltshire, ...</div><div class="gs_gray">British Journal of Haematology 141, 154<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:q3CdL3IzO_QC" class="gsc_a_at">SINGLE UK CENTRE EXPERIENCE OF ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHRONIC MYELOMONOCYTIC LEUKEMIA</a><div class="gs_gray">ZY Lim, PK Krishnamurthy, W Nagi, M Kenyon, AYL Ho, GJ Mufti, ...</div><div class="gs_gray">Haematologica 93, 134-135<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:dhFuZR0502QC" class="gsc_a_at">Use of intravenous busulphan for reduced intensity conditioning (RIC) haematopoietic stem cell transplantation (HSCT) is associated with delayed T-cell full donor chimerism and&nbsp;…</a><div class="gs_gray">Z Lim, S Gandhi, M Thanigaikumar, M Ceesay, L Pearce, M Kenyon, A Ho, ...</div><div class="gs_gray">British Journal of Haematology 141, 152<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Se3iqnhoufwC" class="gsc_a_at">OUTCOMES OF PATIENTS RELAPSING FOLLOWING T-CELL DEPLETED REDUCED INTENSITY CONDITIONING ALLOGENEIC TRANSPLANTATION FOR MDS OR AML</a><div class="gs_gray">ZY Lim, T Munir, SG Gandhi, M Kenyon, AYL Ho, AP Pagliuca, GJ Mufti</div><div class="gs_gray">Haematologica 93, 137-137<span class="gs_oph">, 2008</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2008</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_OXeSy2IsFwC" class="gsc_a_at">Long Term Outcomes of Adults Undergoing Alemtuzumab-Based Reduced Intensity Conditioning Haematopoietic Stem Cell Transplantation.</a><div class="gs_gray">MM Ceesay, ZY Lim, M Kenyon, AYL Ho, S Devereux, S Schey, A Mijovic, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 1665-1665<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:IRz6iEL74y4C" class="gsc_a_at">Progression Free Survival (PFS) in Alemtuzumab Based RIC Allogeneic Transplantation for Myeloma Is Improved with Use of Pre-Emptive DLI (pDLI).</a><div class="gs_gray">K Ramasamy, S Mahmood, L Pearce, ZY Lim, D Ladon, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3034-3034<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HE397vMXCloC" class="gsc_a_at">Results of a phase I/II-Study on PCR-based pre-emptive therapy with vallganciclovir or ganciclovir for active CMV infection following reduced intensity allogeneic stem cell&nbsp;…</a><div class="gs_gray">ZY Lim, G Cook, PR Johnson, A Parker, M Zuckerman, GJ Mufti, D Marks, ...</div><div class="gs_gray">BLOOD 110 (11), 331B-332B<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:f2IySw72cVMC" class="gsc_a_at">Matching for 12 HLA Alleles Is Associated with a Significantly Superior Survival Due to a Lower Mortality in Recipients of Unrelated Donor Haematopoietic Cell Transplants for&nbsp;…</a><div class="gs_gray">BE Shaw, NP Mayor, AM Little, NH Russell, A Pagliuca, ME Ethell, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 3056-3056<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=300&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:2P1L_qKh6hAC" class="gsc_a_at">Results of a Phase I/II-Study on PCR-Based Pre-Emptive Therapy with Valganciclovir or Ganciclovir for Active CMV Infection Following Reduced Intensity Allogeneic Stem Cell&nbsp;…</a><div class="gs_gray">ZY Lim, G Cook, PR Johnson, A Parker, M Zuckerman, GJ Mufti, D Marks, ...</div><div class="gs_gray">Blood 110 (11), 5011<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:IWHjjKOFINEC" class="gsc_a_at">A Comparison of Stem Cell Source in Recipients of T-Cell Depleted Myeloablative Transplants for Leukaemia: No Difference in Mortality Using BM or PBSC.</a><div class="gs_gray">BE Shaw, NH Russell, A Pagliuca, J Apperley, G Cook, S Mackinnon, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 110 (11), 46-46<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:v6i8RKmR8ToC" class="gsc_a_at">Corrigendum to “Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation”[Journal of Infection 54 (2007) e83–e86]</a><div class="gs_gray">ZY Lim, B Baker, M Zuckerman, JJ Wade, M Ceesay, AYL Ho, S Devereux, ...</div><div class="gs_gray">Journal of Infection 55 (1), e11<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:edDO8Oi4QzsC" class="gsc_a_at">Autologous stem cell transplantation versus reduced-intensity allogeneic stem cell transplantation for follicular lymphoma: a matched pair analysis</a><div class="gs_gray">SP Robinson, C Canals, G Taghipour, M Attal, A Pagliuca, D Blaise, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 39, S2-S3<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:evX43VCCuoAC" class="gsc_a_at">B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases Florent Grange, MD, PhD</a><div class="gs_gray">M Beylot-Barry, P Courville, JA Taverna, A Lerner, L Goldberg, S Werth, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_Re3VWB3Y0AC" class="gsc_a_at">Use of autologous bone marrow harvests in patients undergoing volunteer unrelated donor stem cell transplantation: a single-centre experience</a><div class="gs_gray">PS Junagade, S Simpson, A Ho, S Devereux, A Pagliuca, A Mijovic, ...</div><div class="gs_gray">Bone Marrow Transplantation 39 (S1), S129-S129<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:XiVPGOgt02cC" class="gsc_a_at">Persistence of recipient langerhans cells following allogeneic haemopoietic stem cell transplants with reduced intensity conditioning</a><div class="gs_gray">J Richards, L Pearce, PEM Patten, AY Ho, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Haematologica 92, 0590<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:K3LRdlH-MEoC" class="gsc_a_at">Adenovirus infections following allogeneic HSCT. A single UK centre experience</a><div class="gs_gray">L Green, C Bagot, S Ramalingam, Z Lim, M Sudhanva, S Devereux, A Ho, ...</div><div class="gs_gray">Bone Marrow Transplantation 39, S168-S168<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:isC4tDSrTZIC" class="gsc_a_at">Failure to mobilise is not a poor prognostic factor in myeloma</a><div class="gs_gray">K Ramasamy, K Phekoo, A Pagliuca, A Mijovic, GJ Mufti, S Schey</div><div class="gs_gray">Haematologica 92 (6), 196-196<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kNdYIx-mwKoC" class="gsc_a_at">Impact of non-myeloablative conditioning on the frequency of second donation: what should donors be told?</a><div class="gs_gray">K Ramasamy, M Kenyon, Z Lim, A Ho, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone Marrow Transplantation 39, S138-S138<span class="gs_oph">, 2007</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2007</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:k8Z6L05lTy4C" class="gsc_a_at">The Pattern of T-Cell Donor Chimerism Is a Key Predictor of Outcome Following Alemtuzumab Based Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for MDS&nbsp;…</a><div class="gs_gray">ZY Lim, L Pearce, AYL Ho, L Barber, W Ingram, M Usai, S Devereux, ...</div><div class="gs_gray">Blood 108 (11), 42<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:70eg2SAEIzsC" class="gsc_a_at">Outcome of second allogeneic transplants using reduced intensity conditioning following relapse after an initial allogeneic transplant.</a><div class="gs_gray">BE Shaw, GJ Mufti, S Mackinnon, J Cavenagh, K Towlson, R Pearce, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 3660-3660<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:YsMSGLbcyi4C" class="gsc_a_at">Co-Morbidity and Disease Status at the Time of Transplant Predict Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) for Poor Risk Myelodysplastic&nbsp;…</a><div class="gs_gray">W Ingram, ZY Lim, M Kenyon, S Devereux, A Pagliuca, AYL Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 108 (11), 3108-3108<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:CHSYGLWDkRkC" class="gsc_a_at">PREVALENCE OF THE ACTIVATING JAK2 TYROSINE KINASE MUTATION IN CHRONIC PORTO-SPLENOMESENTERIC VENOUS THROMBOSIS: 77</a><div class="gs_gray">D Orr, R Patel, N Lea, P Harrison, N Heaton, J O'Grady, A Pagliuca, ...</div><div class="gs_gray">Hepatology 44<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:LXmCCkuhhTsC" class="gsc_a_at">Use of pre-emptive donor lymphocyte infusions to achieve durable remission following alemtuzumab based reduced intensity conditioning (RIC) transplantation for AML or MDS: 165</a><div class="gs_gray">Z LIM, L Pearce, W Ingram, M Kenyon, S Devereux, A Pagliuca, A HO, ...</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:DkZNVXde3BIC" class="gsc_a_at">Life-threatening motor neurotoxicity with the use of Bortezomib: 272</a><div class="gs_gray">S Gupta, L Green, A Pagliuca, S Devereux, S Schey</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:FiDNX6EVdGUC" class="gsc_a_at">Improved disease free survival following non-myeloablative allogeneic stem cell transplantation compared with autologous transplantation in poor risk follicular lymphoma: 288</a><div class="gs_gray">W Ingram, S Devereux, J Gonzalez, A Ho, G MUFTI, A Pagliuca</div><div class="gs_gray">British Journal of Haematology 133, 110-111<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:PyEswDtIyv0C" class="gsc_a_at">Acute myeloid leukaemia presenting with mediastinal myeloid sarcoma: a single institution experience 120</a><div class="gs_gray">K Ramasamy, Z LIM, A Pagliuca, A HO, S Devereux, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:jFemdcug13IC" class="gsc_a_at">HIV associated Hodgkin's Lymphoma: improved outcome within a single centre 105</a><div class="gs_gray">P JUNAGADE, F Chen, S Simpson, S Devereux, C Taylor, P Easterbrook, ...</div><div class="gs_gray">British Journal of Haematology 133, 59-60<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:3NQIlFlcGxIC" class="gsc_a_at">Haemophagocytic lymphohistiocytosis (HLH) following orthotopic liver transplantation: a single centre report of 37 cases 32</a><div class="gs_gray">A Barnardo, Z LIM, K Ramasamy, S Devereux, A HO, N Heaton, ...</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:dBIO0h50nwkC" class="gsc_a_at">Improved outcome following reduced intensity conditioned allogeneic haematopoietic stem cell transplantation compared with myeloablative conditioning for acute myeloid&nbsp;…</a><div class="gs_gray">W Ingram, Z LIM, A Pagliuca, M Kenyon, S Devereux, A Ho, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:SdhP9T11ey4C" class="gsc_a_at">Use of autologous bone marrow harvests (BMH) in patients undergoing volunteer unrelated donor stem cell transplantation: a single centre experience 130</a><div class="gs_gray">P JUNAGADE, S Simpson, Z LIM, M Kenyon, A HO, S Devereux, ...</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:uWQEDVKXjbEC" class="gsc_a_at">Reduced intensity conditioned volunteer unrelated donor transplants using alemtuzumab are safe and effective in older patients with myelodysplastic syndromes: 126</a><div class="gs_gray">Z LIM, A HO, W Ingram, M Kenyon, S Devereux, A Pagliuca, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ZeXyd9-uunAC" class="gsc_a_at">Association of sarcoidosis with haematological malignancies and secondary dysplastic features. A single centre experience: 198</a><div class="gs_gray">L GOONERATNE, Z LIM, K Raj, A Pagliuca, A HO, S Devereux, G MUFTI</div><div class="gs_gray">British Journal of Haematology 133<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:OBSaB-F7qqsC" class="gsc_a_at">Second reduced-intensity transplants are effective and well tolerated in older patients with relapsed myeloid malignancies</a><div class="gs_gray">F Chen, H Ahmad, P Junagade, Z Lim, S Devereux, A Pagliuca, A Ho, ...</div><div class="gs_gray">Bone Marrow Transplantation 37<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:wKETBy42zhYC" class="gsc_a_at">Incidence and management of veno-occlusive disease following reduced-intensity conditioning haematopoietic stem cell transplantation</a><div class="gs_gray">K Ramasamy, Z Lim, R Grundy, A Pagliuca, A Ho, S Devereux, G Mufti</div><div class="gs_gray">Bone Marrow Transplantation 37<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:IsPWOBWtZBwC" class="gsc_a_at">Cytomegalovirus monitoring in allogeneic haemopoietic stem cell transplant recipients</a><div class="gs_gray">S Ramalingam, Z Lim, P Junagade, M Sudhanva, A Pagliuca, S Devereux, ...</div><div class="gs_gray">Journal of Clinical Virology 36, S45<span class="gs_oph">, 2006</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2006</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:pAkWuXOU-OoC" class="gsc_a_at">Clonal Gammopathies Following Reduced Intensity Conditioning Transplantation with Fludarabine, Busulphan and Alemtuzumab for Myeloid Malignancies Predict Improved Overall Survival.</a><div class="gs_gray">ZY Lim, A Pagliuca, W Ingram, D Milojkovic, M Akthari, A Ho, S Devereux, ...</div><div class="gs_gray">Blood 106 (11), 1410<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:PVgj2kMGcgYC" class="gsc_a_at">Improved disease free survival following reduced intensity conditioned allogeneic stem cell transplantation incorporating alemtuzumab compared with autologous stem cell&nbsp;…</a><div class="gs_gray">W Ingram, S Devereux, J Gonzalez, A Ho, G Mufti, A Pagliuca</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 1144-1144<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:dTyEYWd-f8wC" class="gsc_a_at">Use of pre-emptive donor lymphocyte infusions to achieve durable remission following alemtuzumab based reduced intensity conditioning (RIC) transplantation for AML or MDS.</a><div class="gs_gray">ZY Lim, L Pearce, W Ingram, R Duarte, S Devereux, A Pagliuca, A Ho, ...</div><div class="gs_gray">Blood 106 (11), 1124<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:eJXPG6dFmWUC" class="gsc_a_at">Reduced Intensity Conditioned Allogeneic Stem Cell Transplantation Is as Effective in Poor Risk as Standard Risk Acute Myeloid Leukaemia (AML).</a><div class="gs_gray">W Ingram, Z Lim, A Pagliuca, S Devereux, A Ho, G Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 2901-2901<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:geHnlv5EZngC" class="gsc_a_at">Matched pair analysis of intravenous vs oral busulphan as part of fludarabine-busulphan-campath (alemtuzumab) reduced intensity conditioning (RIC) haematopoietic stem cell&nbsp;…</a><div class="gs_gray">ZY Lim, D Milojkovic, L Pearce, M Kenyon, A Ho, S Devereux, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 1762-1762<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:lSLTfruPkqcC" class="gsc_a_at">Second Reduced Intensity Transplants Are Effective and Well Tolerated in Older Patients with Relapsed Myeloid Malignancies. A Single Centre Report.</a><div class="gs_gray">FE Chen, HN Ahmad, P Junagade, Z Lim, S Devereux, A Pagliuca, A Ho, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 106 (11), 5406-5406<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:rTD5ala9j4wC" class="gsc_a_at">Liver function abnormalities following alemtuzumab (Campath-1H): A previously unrecognised first dose effect 244</a><div class="gs_gray">Z LIM, C BRITTEN, J CHAPPELL, A HO, R DUARTE, A PAGLIUCA, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:lvd772isFD0C" class="gsc_a_at">Retrospective review of prophylaxis for toxoplasmosis following allogeneic bone marrow transplantation</a><div class="gs_gray">ZY Lim, B Baker, M Kenyon, R Duarte, A Ho, J Wade, M Zukermann, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 129, 76-76<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Dip1O2bNi0gC" class="gsc_a_at">Retrospective review of patients with high risk of HBV disease undergoing reduced intensity conditioned (RIC) allogeneic BMT: 110</a><div class="gs_gray">S Moses, Z LIM, M Sudhanva, M Kenyon, R Duarte, A HO, M Zuckermann, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 129<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WF5omc3nYNoC" class="gsc_a_at">Liver function abnormalities following alemtuzumab (Campath-1H): A previously unrecognised first dose effect</a><div class="gs_gray">D Milojkovic, ZY Lim, C Britten, J Chappell, A Ho, R Duarte, A Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 129, 79-79<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:z_wVstp3MssC" class="gsc_a_at">Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome.(Poster# 792-II)</a><div class="gs_gray">RK Patel, N Lea, MA Heneghan, N Westwood, D Milojkovic, ...</div><div class="gs_gray">BLOOD-NEW YORK- 106 (11), 2588<span class="gs_oph">, 2005</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2005</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:PaBasH6fAo0C" class="gsc_a_at">Invasive pulmonary aspergillosis is not a contraindication to reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation (RIC allo-HSCT).</a><div class="gs_gray">AYL Ho, SR Desai, IDP Stanton, SJ Copley, AU Wells, A Pagliuca, ...</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1831-1831<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:sJsF-0ZLhtgC" class="gsc_a_at">Single centre experience of patients with haematological malignancies admitted to intensive care unit: A comparative review of allogenic bone marrow transplant data.</a><div class="gs_gray">ZY Lim, J Graham, S Simpson, S Devereux, A Pagliuca, A Ho, GJ Mufti</div><div class="gs_gray">Blood, The Journal of the American Society of Hematology 104 (11), 1830-1830<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:NJ774b8OgUMC" class="gsc_a_at">A single centre experience of reduced intensity conditioned HSCT using BEAM-campath for low-grade lymphoid malignancies</a><div class="gs_gray">M Lissack, W Ingram, M Lamacchia, A Ho, N Greenwood, G Mufti, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 125<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4DMP91E08xMC" class="gsc_a_at">Retrospective analysis of the use of valganciclovir in the prevention of cytomegalovirus following stem cell transplantation</a><div class="gs_gray">J Subedi, J Chappell, W Ingram, M Zuckerman, S Devereux, A Ho, G Mufti, ...</div><div class="gs_gray">Bone Marrow Transplantation 33<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:OcBU2YAGkTUC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid&nbsp;…</a><div class="gs_gray">AYL Ho, A Pagliuca, M Kenyon, JE Parker, A Mijovic, S Devereux, ...</div><div class="gs_gray">Blood 104 (6), 1616-1623<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:SpbeaW3--B0C" class="gsc_a_at">Prevalence and impact of adenovirus viraemia in adult stem-cell transplant recipients treated with Campath-1H</a><div class="gs_gray">A Geretti, E Nieto, S Ramalingam, A Ho, M Smith, G Mufti, S Devereux, ...</div><div class="gs_gray">Clinical Microbiology &amp; Infection Supplement 10, 83-84<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:tS2w5q8j5-wC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD&nbsp;…</a><div class="gs_gray">RD Faulkner, C Craddock, JL Byrne, P Mahendra, AP Haynes, ...</div><div class="gs_gray">Blood 103 (2), 428-434<span class="gs_oph">, 2004</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2004</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:mWEH9CqjF64C" class="gsc_a_at">Outcome of patients with haematological malignancy transferred to intensive care unit</a><div class="gs_gray">S Simpson, Z Lim, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-nhnvRiOwuoC" class="gsc_a_at">Antibacterial resistance in Gram-negative bacteria recovered from haemato-oncology patients</a><div class="gs_gray">O Fasan, S Devereux, A Pagliuca, G Mufti, J Wade</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:yxmsSjX2EkcC" class="gsc_a_at">Marrow cellularity is predictive of CD34+ bone marrow harvest yield</a><div class="gs_gray">O Fasan, A Mijovic, V Day, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:7BrZ7Jt4UNcC" class="gsc_a_at">Reduced-intensity allogeneic transplantation using BEAM-Campath in patients with lymphoproliferative diseases–GVHD, toxicity and survival in 65 patients</a><div class="gs_gray">R Faulkner, J Byrne, C Craddock, P Mahendra, S Devereux, A Pagliuca, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 121<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:cK4Rrx0J3m0C" class="gsc_a_at">Response to Peggs et al.</a><div class="gs_gray">AYL Ho, S Devereux, A Pagliuca, GJ Mufti</div><div class="gs_gray">Bone Marrow Transplantation 31 (8), 727-727<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kuK5TVdYjLIC" class="gsc_a_at">Secretion of factor (s) that inhibit T cell activation in B cell chronic lymphocytic leukaemia (B-CLL) is associated with clinically aggressive disease and lack of mutation in&nbsp;…</a><div class="gs_gray">A Buggins, J Richards, B Vadher, A Pagliuca, G Mufti, S Devereux</div><div class="gs_gray">British Journal of Haematology-Supplement 121, 28-29<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Ade32sEp0pkC" class="gsc_a_at">Increased incidence of autoimmune cytopenia and paraproteinemia following allogeneic bone marrow transplants conditioned with Alemtuzumab.</a><div class="gs_gray">K Raj, W Ingram, A Ho, D Milojkovic, S Devereaux, A Pagliuca, G Mufti</div><div class="gs_gray">Blood 102 (11), 3603<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:tzM49s52ZIMC" class="gsc_a_at">Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15&nbsp;…</a><div class="gs_gray">AYL Ho, L Pearce, N Westwood, R Padua, M Kenyon, S Devereux, ...</div><div class="gs_gray">Blood 102 (11), 5459<span class="gs_oph">, 2003</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2003</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:7T2F9Uy0os0C" class="gsc_a_at">Venous thrombosis in the black population</a><div class="gs_gray">RK Patel, L Bonner, J Lambie, R Arya, A Pagliuca</div><div class="gs_gray">BLOOD 100 (11), 116B-116B<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:qxL8FJ1GzNcC" class="gsc_a_at">Late events in reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with alemtuzumab (CAMPATH-1H) containing regimens impact on outcome compared with&nbsp;…</a><div class="gs_gray">AYL Ho, M Kenyon, JE Parker, I El-Hemaidi, M Zuckerman, S Devereux, ...</div><div class="gs_gray">BLOOD 100 (11), 414A-414A<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:jSAVyFp_754C" class="gsc_a_at">Reduced intensity conditioning (RIC) containing CAMPATH-1H, a comparison of sibling versus voluntary unrelated donor (VUD) haemopoietic stem cell transplantation (HSCT)</a><div class="gs_gray">A Ho, I El-Hemaidi, A Pagliuca, A Mijovic, S Devereux, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 39-40<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-95Q15plzcUC" class="gsc_a_at">Reduced-intensity Rituximab-BEAM-CAMPATH allogeneic haematopoietic stem cell transplantation (HSCT) for follicular lymphoma with quantitative monitoring of minimal residual disease</a><div class="gs_gray">A Ho, S Devereux, G Mufti, A Pagliuca</div><div class="gs_gray">British Journal of Haematology-Supplement 117, 37-38<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Ehil0879vHcC" class="gsc_a_at">Reduced intensity conditioned (RIC) voluntary unrelated donor transplantation (VUD) in poor risk MDS and myeloid leukaemia using Fludarabine, Busulphan and CAMPATH-1H (FBC)</a><div class="gs_gray">I El-Hemiadi, J Parker, M Kenyon, A Ho, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:DJbcl8HfkQkC" class="gsc_a_at">Allogeneic stem-cell transplantation (allo-SCT) following reduced-intensity conditioning in MDS: 4.5 years follow-up</a><div class="gs_gray">J Parker, I El-Hemaidi, A Pagliuca, S Devereux, J Yin, M Potter, H Prentice, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 117<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:QUX0mv85b1cC" class="gsc_a_at">POST-TRANSPLANT COMPLICATIONS-Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated&nbsp;…</a><div class="gs_gray">AYL Ho, S Adams, H Shaikh, A Pagliuca, S Devereux, GJ Mufti</div><div class="gs_gray">Bone Marrow Transplantation 29 (10), 867-870<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:F9fV5C73w3QC" class="gsc_a_at">Depletion of dendritic cells (DCs) from the blood and skin of patients undergoing allogeneic hematopoietic stem cell transplants (allo-HSCT) by alemtuzumab containing regimens.</a><div class="gs_gray">G Osborne, AGS Buggins, D Creamer, K Fishlock, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Blood 100 (11), 1586<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:6ZxmRoH8BuwC" class="gsc_a_at">18FDG-PET positron emission tomography (PET) is highly predictive of outcome following autograft for relapsed lymphoma. A retrospective study of 41 patients.</a><div class="gs_gray">P Fields, T Nunnan, S Devereaux, P Patten, A Ho, A Pagliuca, E Wegner, ...</div><div class="gs_gray">Blood 100 (11), 3042<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:gsN89kCJA0AC" class="gsc_a_at">Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?</a><div class="gs_gray">AYL Ho, A Pagliuca</div><div class="gs_gray">Hematology 7 (6), 345-354<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:p2g8aNsByqUC" class="gsc_a_at">CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS-Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood&nbsp;…</a><div class="gs_gray">P Guardiola, V Runde, A Bacigalupo, T Ruutu, F Locatelli, MA Boogaerts, ...</div><div class="gs_gray">Blood 99 (12), 4370-4378<span class="gs_oph">, 2002</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2002</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:MAUkC_7iAq8C" class="gsc_a_at">Allogeneic bone marrow transplantation in chronic lymphocytic leukaemia (CLL) and prolymphocytic leukaemia (PLL) using BEAM-Campath reduced intensity conditioning.</a><div class="gs_gray">RJ Lush, S Devereux, JL Byrne, AP Haynes, AY Ho, GJ Mufti, A Pagliuca, ...</div><div class="gs_gray">BLOOD 98 (11), 378B-378B<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:hCrLmN-GePgC" class="gsc_a_at">UPDATED RESULTS OF NON-MYELOABLATIVE ALLOGRAFTING WITH BEAM-CAMPATH CONDITIONING IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASE.</a><div class="gs_gray">R Lush, A Haynes, J Byrne, A Pagliuca, J Parker, G Mufti, P Mahendra, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 113<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4fKUyHm3Qg0C" class="gsc_a_at">Results of allogeneic transplantation using BEAM (+/-Fludarabine) with in vivo pre-transplant campath combined with Donor Leucocyte Infusion (DLI) in patients with&nbsp;…</a><div class="gs_gray">RJ Lush, AP Haynes, JL Byrne, A Pagliuca, JE Parker, P Mahendra, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 27, S278-S278<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:SGW5VrABaM0C" class="gsc_a_at">Increased activity and infidelity of non homologous end-joining (NHEJ) DNA repair in Bloom's syndrome and myeloid leukemias (MDS/AML).</a><div class="gs_gray">TJ Gaymes, PS North, ID Hickson, A Pagliuca, GJ Mufti, FV Rassool</div><div class="gs_gray">Blood 98 (11), 455A-455A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ldfaerwXgEUC" class="gsc_a_at">Primary AML cell supernatant inhibits T cell and neutrophil apoptosis.</a><div class="gs_gray">D Milojkovic, AGS Buggins, NC Lea, A Pagliuca, GJ Mufti, NSB Thomas</div><div class="gs_gray">Blood 98 (11), 324A-324A<span class="gs_oph">, 2001</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2001</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:GFxP56DSvIMC" class="gsc_a_at">Results of a UK neutropenia audit of lymphoma patients (the UK lymphoma audit group).</a><div class="gs_gray">J Sweetenham, P Hoskin, A McMillan, R Thomas, R Pettengell, ...</div><div class="gs_gray">BLOOD 96 (11), 732A-732A<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:S16KYo8Pm5AC" class="gsc_a_at">INTERFERON-α AND ZIDOVUDINE THERAPY IN ADULT T-CELL LEUKAEMIA LYMPHOMA (ATLL). RESPONSE AND OUTCOME IN 15 PATIENTS FROM THE UK.</a><div class="gs_gray">E Matutes, G Taylor, D Bareford, J Cavenagh, M Hamblin, S Kelsey, N Mir, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:EYYDruWGBe4C" class="gsc_a_at">ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROMES (MDS): A SINGLE CENTRE EXPERIENCE.</a><div class="gs_gray">J Parker, M Kenyon, A Mijovic, S Devereux, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 108<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:7H_MAutzIkAC" class="gsc_a_at">Comparison of bone marrow and PBPC FOU allogeneic sct in myelodysplastic syndromes. A retrospective study on behalf of the EBMT</a><div class="gs_gray">P Guardiola, V Runde, A Bacigalupo, T Ruutu, F Locatelli, MA Boogaerts, ...</div><div class="gs_gray">Blood 96 (11 PART I)<span class="gs_oph">, 2000</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">2000</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:uJ-U7cs_P_0C" class="gsc_a_at">Non-Myeloablative Preparative Regimen in Children with Severe Organ Dysfunction Undergoing Bone Marrow Transplantation</a><div class="gs_gray">PA Veys, EG Davies, D Webb, A Jones, A Hassan, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">Pediatric Research 45 (5), 768-768<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:_axFR9aDTf0C" class="gsc_a_at">THE ROLE OF CD34+ CELL PROLIFERATION, APOPTOSIS AND AMIFOSTINE IN THE MYELODYSPLASTIC SYNDROMES (MDS) AND AML SECONDARY TO MDS</a><div class="gs_gray">JE Parker, KL Fishlock, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 105 (1S)<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:U_HPUtbDl20C" class="gsc_a_at">The'G-CSF test': Response to a single dose of rhGCSF predicts mobilisation of haemopoietic progenitors in patients with haematological malignancies.</a><div class="gs_gray">A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 23, S217-S217<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ns9cj8rnVeAC" class="gsc_a_at">Patients with myelodysplastic syndromes (MDS) often mobilise abnormal haemopoietic progenitors.</a><div class="gs_gray">A Mijovic, J Howard, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 23, S153-S153<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HIFyuExEbWQC" class="gsc_a_at">Non-myeloablative preparative regimen in children with severe organ dysfunction undergoing unrelated related donor BMT.</a><div class="gs_gray">P Vevs, G Davies, D Webb, A Jones, A Hassan, A Pagliuca, GJ Mufti, ...</div><div class="gs_gray">BRIT J HAEMATOL 105, 66-66<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:738O_yMBCRsC" class="gsc_a_at">In myelodysplastic syndromes (MDS) dendritic cells are phenotypically and functionally different from those obtained in healthy subjects.</a><div class="gs_gray">GM Rigolin, J Howard, AGS Buggins, C Sneddon, G Castoldi, A Pagliuca, ...</div><div class="gs_gray">Blood 94 (10), 389A-389A<span class="gs_oph">, 1999</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1999</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:RYcK_YlVTxYC" class="gsc_a_at">Rejection by MHC-unrestricted effectors prevents the generation of anti-leukemic immunity.</a><div class="gs_gray">W Hirst, A Buggins, D Darling, J Gaken, A Pagliuca, F Farzaneh, GJ Mufti</div><div class="gs_gray">BLOOD 92 (10), 616A-617A<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:TlpoogIpr_IC" class="gsc_a_at">ABSENCE OF COSTIMULATION AND SECRETION OF TH1 CYTOKINE INHIBITORS CONTRIBUTE TO EVASION OF ANTI-LEUKAEMIC IMMUNITY</a><div class="gs_gray">A Buggins, W Hirst, D Darling, J Gaken, A Pagliuca, F Farzaneh, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 102 (1-I)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:HeT0ZceujKMC" class="gsc_a_at">INDUCTION OF T-CELL DYSFUNCTION BY LEUKAEMIA-DERIVED FACTOR (S): DIRECT AND INDIRECT MECHANISMS</a><div class="gs_gray">W Hirst, A Buggins, A Pagliuca, G Mufti</div><div class="gs_gray">British Journal of Haematology 102 (1-I), 82-83<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:Tiz5es2fbqcC" class="gsc_a_at">Analysis of graft versus host disease and outcome in 100 patients undergoing allogeneic peripheral blood stem cell transplantation.</a><div class="gs_gray">G Miflin, G Cook, I Franklin, A Morrison, R Green, RM Hutchinson, ...</div><div class="gs_gray">BONE MARROW TRANSPLANTATION 21, S107-S107<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:43bX7VzcjpAC" class="gsc_a_at">Cyclophosphamide, cytosine arabinoside, idarubicin and methylprednisolone (CAIP) as a debulking regimen prior to stem cell mobilisation in relapsed/refractory lymphomas.</a><div class="gs_gray">AYL Ho, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 101, 42-42<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:BJbdYPG6LGMC" class="gsc_a_at">CENTRAL ROLE OF SOLUBLE IMMUNOSUPPRESSIVE FACTORS IN THE DEVELOPMENT OF LEUKAEMIA-ASSOCIATED IMMUNE DYSFUNCTION</a><div class="gs_gray">WJR Hirst, AGS Buggins, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:umqufdRvDiIC" class="gsc_a_at">Refractory anaemia with isolated del (16)(q22q24)</a><div class="gs_gray">GM Crotty, B Czepulkowski, D Milojkovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:fPk4N6BV_jEC" class="gsc_a_at">'LOW RISK'MYELODYSPLASTIC SYNDROME (MDS) IS ASSOCIATED WITH EXCESSIVE APOPTOSIS AND AN INCREASED RATIO OF PROVERSUS ANTI-APOPTOTIC BCL-2 RELATED PROTEINS</a><div class="gs_gray">JE Parker, KL Fishlock, A Mijovic, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:9ZlFYXVOiuMC" class="gsc_a_at">SUBVERSION OF CELL-MEDIATED IMMUNITY BY LEUKAEMIC CELLS: LESSONS FOR CLINICAL IMMUNOTHERAPY</a><div class="gs_gray">AGS Buggins, WJR Hirst, D Darling, J Gaken, A Pagliuca, F Farzaneh, ...</div><div class="gs_gray">British Journal of Haematology-Supplement 101 (1S)<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:YFjsv_pBGBYC" class="gsc_a_at">Haematological malignancy-RESEARCH PAPERS-'Low-risk'myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro-versus anti-apoptotic bcl-2&nbsp;…</a><div class="gs_gray">JE Parker, KL Fishlock, A Mijovic, B Czepulkowski, A Pagliuca, GJ Mufti</div><div class="gs_gray">British Journal of Haematology 103 (4), 1075-1082<span class="gs_oph">, 1998</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1998</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:VN7nJs4JPk0C" class="gsc_a_at">Provision of costimulatory molecules on myeloid leukemic cells enhances T-cell proliferation but fails to induce cytokine production.</a><div class="gs_gray">A Buggins, W Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 90 (10), 1231-1231<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:u9iWguZQMMsC" class="gsc_a_at">Mechanisms of T-cell dysfunction in acute leukemia: Intrinsic T-cell defect or soluble inhibitory factor.</a><div class="gs_gray">W Hirst, A Buggins, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 90 (10), 84-84<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:0KyAp5RtaNEC" class="gsc_a_at">Idarubicin, fludarabine, cytarabine and G-CSF (FLAG-Ida) for the treatment of high risk MDS or AML</a><div class="gs_gray">JE Parker, J Cullis, A Mijovic, A Pagliuca, S Rassam, I Samaratunga, ...</div><div class="gs_gray">Leukemia Research 21 (S1), S45-S45<span class="gs_oph">, 1997</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1997</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:69ZgNCALVd0C" class="gsc_a_at">Post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation: The role of combination chemotherapy.</a><div class="gs_gray">JO Cullis, M McCarthy, N Heaton, R Williams, R JanMohamed, A Pagliuca, ...</div><div class="gs_gray">BLOOD 88 (10), 359-359<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:-jrNzM816MMC" class="gsc_a_at">Autologous blood or bone marrow transplantation for relapsed and partially responding low-grade non-Hodgkin lymphoma (NHL).</a><div class="gs_gray">A Mijovic, J Parker, J Salisbury, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 88 (10), 3866-3866<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:JoZmwDi-zQgC" class="gsc_a_at">Allogeneic PBSCT-An evaluation of engraftment kinetics and GVHD risk.</a><div class="gs_gray">G Millin, NH Russell, RM Hutchinson, G Morgan, A Pagliuca, J Marsh, ...</div><div class="gs_gray">BLOOD 88 (10), 2452-2452<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:JV2RwH3_ST0C" class="gsc_a_at">CD3-zeta expression in NK and T-cells from patients with myeloid malignancies.</a><div class="gs_gray">AGS Buggins, WJR Hirst, A Pagliuca, GJ Mufti</div><div class="gs_gray">BLOOD 88 (10), 2326-2326<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:l7t_Zn2s7bgC" class="gsc_a_at">AN ANALYSIS OF FACTORS AFFECTING POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION (OLT)</a><div class="gs_gray">M McCarthy, J Ramage, E Gar, B Portmann, M Rela, N Heaton, ...</div><div class="gs_gray">Journal of Gastroenterology &amp; Hepatology 11 (10)<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:prdVHNxh-e8C" class="gsc_a_at">Transfusion-associated graft-versus-host disease in immunocompromised patients: A single centre experience.</a><div class="gs_gray">JO Cullis, R JanMohamed, CB Taylor, N Heaton, R Williams, A Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 176-176<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:1taIhTC69MYC" class="gsc_a_at">Bone marrow stem cell transplantation in myelodysplastic syndromes</a><div class="gs_gray">D Milojkovic, A Pagliuca, A Mijovic, B Czepulkowski, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 73-73<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:9c2xU6iGI7YC" class="gsc_a_at">Chemotherapy can offer a long term remission in post transplant lymphoproliferative disorder (PTLD) following orthotopic liver transplantation (OLT).</a><div class="gs_gray">M McCarthy, J Ramage, E Gane, B Portmann, M Rela, N Heaton, ...</div><div class="gs_gray">GASTROENTEROLOGY 110 (4), A1264-A1264<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=400&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:9Nmd_mFXekcC" class="gsc_a_at">Autologous stem cell transplantation (ASCT) for relapsed low-grade non-Hodgkin lymphoma (NHL): A single centre study.</a><div class="gs_gray">A Mijovic, J Parker, A Pagliuca, J Salisbury, GJ Mufti</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 165-165<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:R3hNpaxXUhUC" class="gsc_a_at">Post-transplant lymphoproliferative disorders (PTLD) following solid organ transplantation: A single centre experience.</a><div class="gs_gray">JO Cullis, M McCarthy, N Heaton, R Williams, R JanMohamed, A Pagliuca, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 93, 213-213<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:kzcSZmkxUKAC" class="gsc_a_at">Therapy at adult T-cell leukaemia/lymphoma: Experience of two London hospitals</a><div class="gs_gray">DS Richardson, R Pawson, SM Kelsey, A Pagliuca, S Hoque, J Breuer, ...</div><div class="gs_gray">BRIT J HAEMATOL 93, 1169-1169<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:WJVC3Jt7v1AC" class="gsc_a_at">Adult T-cell leukaemia/lymphoma in London: Clinical experience of 21 cases.</a><div class="gs_gray">R Pawson, D Richardson, A Pagliuca, S Kelsey, S Hoque, J Breuer, ...</div><div class="gs_gray">BRIT J HAEMATOL 93, 285-285<span class="gs_oph">, 1996</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1996</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:vV6vV6tmYwMC" class="gsc_a_at">LONG-TERM CULTURE OF PERIPHERAL-BLOOD STEM-CELLS (PBSC)</a><div class="gs_gray">RS KACZMARSKI, A MIJOVIC, A PAGLIUCA, GJ MUFTI</div><div class="gs_gray">BLOOD 82 (10), A485-A485<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:ce2CqMG-AY4C" class="gsc_a_at">ADULT T-CELL LEUKEMIA-LYMPHOMA IN SOUTH LONDON-CLINICAL-EXPERIENCE OVER 10 YEARS</a><div class="gs_gray">A PAGLIUCA, GJ MUFTI</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 40-40<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:j3f4tGmQtD8C" class="gsc_a_at">AUTOMATED EXCHANGE RED-CELL TRANSFUSION IN SICKLE-CELL DISEASE USING THE COBE SPECTRA CELL SEPARATOR</a><div class="gs_gray">W HIRST, A PAGLIUCA, R ARYA, DM LAYTON, H HAMBLEY, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 84, 65-65<span class="gs_oph">, 1993</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1993</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:uDGL6kOW6j0C" class="gsc_a_at">Direct sequencing of c-fms in myelodysplastic syndrome and AML.</a><div class="gs_gray">A Pagliuca, MG Thomas, K Tobal, F Farzaneh, GJ Mufti</div><div class="gs_gray">Leukemia research 15, 7-<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:NaGl4SEjCO4C" class="gsc_a_at">(B9) Childhood MDS in Turkey—clinical experience in 25 cases</a><div class="gs_gray">AM Tuncer, A Pagliuca, G Hicsonmez, GJ Mufti</div><div class="gs_gray">Leukemia Research 15, 5<span class="gs_oph">, 1991</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1991</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:zGdJYJv2LkUC" class="gsc_a_at">MYELOFIBROSIS IN PRIMARY MYELODYSPLASTIC SYNDROMES-A CLINICOMORPHOLOGICAL STUDY OF 10 CASES</a><div class="gs_gray">A PAGLIUCA, DM LAYTON, RM IRELAND, A MANOHARAN, S GORDON, ...</div><div class="gs_gray">BRITISH JOURNAL OF HAEMATOLOGY 69 (1), 122-122<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:NyGDZy8z5eUC" class="gsc_a_at">PRENATAL-DIAGNOSIS OF SEVERE INHERITED PLATELET DISORDERS BY EARLY 2ND TRIMESTER ANALYSIS OF PURE FETAL BLOOD</a><div class="gs_gray">DS Millar, RS Mibashan, A Pagliuca, KH NICOLAIDES, CH RODECK, ...</div><div class="gs_gray">British Journal of Haematology 69 (1), 109-109<span class="gs_oph">, 1988</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1988</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:35N4QoGY0k4C" class="gsc_a_at">Treatment for myelodysplastic syndromes</a><div class="gs_gray">A Pagliuca, DM Layton, GJ Mufti</div><div class="gs_gray">The Lancet 330 (8567), 1095<span class="gs_oph">, 1987</span></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl">1987</span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:4fGpz3EwCPoC" class="gsc_a_at">BEAM-Campath reduced intensity allogeneic stem cell transplantation</a><div class="gs_gray">G Mufti, JL Yin, NH Russell, G Prentice, M Potter, A Pagliuca, A Ho, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:XoXfffV-tXoC" class="gsc_a_at">265 Why have Pneumocystis carinii trophozoites been ignored? JMW Chatterton, AW L Joss, MM Davidson, D 0 Ho-Yen</a><div class="gs_gray">A Pagliuca, GJ Mufti, AN Baldwin, AJ Wallis, GE Wilson, A Curry, ...</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr><tr class="gsc_a_tr"><td class="gsc_a_t"><a href="/citations?view_op=view_citation&amp;hl=en&amp;user=B_fNeq0AAAAJ&amp;cstart=500&amp;pagesize=100&amp;citation_for_view=B_fNeq0AAAAJ:9vf0nzSNQJEC" class="gsc_a_at">Quality of life assessment after Haematopoietic Stem Cell Transplant (HSCT)</a><div class="gs_gray">M Kenyon, A Pagliuca, Z Lim, J Hayden, GJ Mufti</div><div class="gs_gray"></div></td><td class="gsc_a_c"><a href="" class="gsc_a_ac gs_ibl"></a></td><td class="gsc_a_y"><span class="gsc_a_h gsc_a_hc gs_ibl"></span></td></tr></tbody></table><div id="gsc_a_sp" class=""></div><div id="gsc_a_err" class="gs_alrt">The system can't perform the operation now. Try again later.</div></div><div id="gsc_lwp"><span id="gsc_a_nn">Articles 1–514</span><div id="gsc_bpf"><button type="button" id="gsc_bpf_more" class="gs_btnPD gs_in_ib gs_btn_flat gs_btn_lrge gs_btn_lsu" disabled=""><span class="gs_wr"><span class="gs_ico"></span><span class="gs_lbl">Show more</span></span></button></div></div></form></div></div></div></div><div id="gs_ftr_sp" role="presentation"></div><div id="gs_ftr" role="contentinfo"><div id="gs_ftr_rt"><a href="/intl/en/scholar/about.html">Help</a><a href="//www.google.com/intl/en/policies/privacy/">Privacy</a><a href="//www.google.com/intl/en/policies/terms/">Terms</a></div></div></div></body></html>